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1. BRIEF INTRODUCTION INTO 
SPINAL CORD INJURY
Injuries to the central nervous system 
(CNS) cause irreversible loss of function 
since the CNS of higher vertebrae has a 
very limited capacity to appropriately re-
generate damaged axonal connections. 
This failing regenerative capacity is one 
of the main reasons for the catastrophic 
outcome of most CNS injuries in humans. 
Traumatic insults to the spinal cord are 
particularly devastating since the spinal 
cord contains both the motor and sensory 
connections between higher brain centers 
such as the cortex and the brainstem and 
effectors like muscles and glands within 
a very small area. Therefore, even limited 
injuries of the spinal cord parenchyma 
can lead to complete and life-long loss 
of voluntary motor and sensory function 
below the level of injury. Additionally, re-
ﬂexes of the autonomic nervous system 
often become dysfunctional after spinal 
cord injury (SCI), leading to impairment of 
autonomic functions such as blood pres-
sure dysregulation, loss of bladder and 
bowel control. 
The regenerative failure of CNS axons 
has been described in detail for the ﬁrst 
time in the early 20th century by Santia-
go Ramon y Cajal. By employing novel 
methods that enabled reliable staining of 
axon proﬁles, Cajal described the dys-
trophic endbulbs of lesioned CNS axons 
and concluded that after axonal injury in 
the adult mammalian CNS, only abor-
tive sprouting of lesioned axons occurs 
1. For several decades, there has been 
a general assumption that this failure of 
regeneration represented a fundamental 
property of CNS axons. A series of experi-
ments by the laboratory of Albert Aguayo, 
however, proved that CNS axons are able 
to regenerate over long distances when 
the tip of a severed CNS axon is exposed 
to a peripheral nerve environment, sug-
gesting that CNS axons have the intrinsic 
capacity to regenerate 2, 3. These ﬁndings 
dramatically accelerated research efforts 
to further augment SCI regeneration. 
During the last decades, biomedical re-
search gained a lot of insight in the patho-
morphological mechanisms of SCI and 
was able to identify many factors that play 
a role for the failure of the CNS to recuper-
ate following injury. This knowledge has 
lead to the development of experimental 
therapy approaches that employed nu-
merous interventions including cellular 
replacement, neurotrophic factor delivery, 
axon guidance, neutralization of growth 
inhibitory molecules, breakdown of scar 
tissue, manipulation of intracellular sig-
naling, bridging using artiﬁcial conduits, 
and modulation of the immune response 
4-13. Although some of these approaches 
induced a modest functional recovery in 
animal models of SCI, a real breakthrough 
justifying the hope for an effective therapy, 
which promotes robust functional recov-
ery after SCI in humans, is still missing. 
Thus far, only 2 therapeutic interventions 
are routinely employed to ameliorate the 
pathomorphological changes following 
SCI, namely surgical stabilization of the 
fractured vertebral column and the ad-
ministration of high dose steroids. The 
surgical removal of bone fragments, 
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which is intended to reduce the ongoing 
compression of the spinal cord, is able 
to limit secondary damage. However, al-
ready severed spinal cord parenchyma is 
irreversibly lost preventing intrinsic struc-
tural and functional restoration. The intra-
venous administration of high doses of 
steroids within 8 hours of injury has been 
shown to decrease secondary damage by 
reducing the injury induced edema and by 
neutralizing free radicals 14. The efﬁcacy 
of these approaches in humans is mod-
est at best and alternative strategies are 
actively sought 15.
2. EPIDEMIOLOGY OF SPINAL 
CORD INJURY
The incidence of SCI in developed coun-
tries varies between 30 and 50 cases per 
million inhabitants per year 16-18. Since 
many investigators used different deﬁni-
tions and methods in their research, the 
epidemiological data in the existing lit-
erature can be compared only to a lim-
ited extent. Nevertheless, it is clear that 
the combination of decreased mortality of 
acute SCI victims and a longer life expec-
tancy of the chronic SCI patient raises the 
prevalence of SCI in developed countries 
19. In the USA, the prevalence of SCI cur-
rently is between 721 and 906 per million 
population 19. 
The severity of the neurological outcome 
after a traumatic insult of the spinal col-
umn strongly correlates with the extent of 
damaged long distance axonal connec-
tions. After a functionally complete SCI, 
there is no detectable voluntary motor or 
conscious sensory function of the body 
below the lesion site, in contrast to in-
complete injuries, where residual function 
is observed. Approximately 45% of all SCI 
cases are neurologically complete 20. Dur-
ing the last decades, the relative distribu-
tion of complete versus incomplete SCI 
has changed in favor of the incomplete 
injury 21, 22. This can be attributed to the 
improved avoidance of secondary dam-
age during transport and the much more 
aggressive intervention to avoid hypoten-
sion and hypoxia directly after trauma. 
Nevertheless, even after a complete le-
sion functionally, spared white matter can 
be detected most frequently. These cases 
are referred to as anatomically incomplete 
lesions 23. Since function is lost below the 
lesion site, it is evident that the location 
of the injury greatly determines the extent 
of the functional deﬁcits. Injuries to the 
thoracic or lumbar spinal cord only affect 
axon projections innervating the lower 
extremities resulting in a more or less 
severe paresis of both lower extremities 
(paraplegia). Injury to the cervical spinal 
cord disrupts axon pathways to both low-
er and upper extremities with respective 
functional deﬁcits in all four extremities 
(quadriplegia) and potentially respiration. 
Of all SCI cases, a majority of 55% of the 
injuries is located at cervical level 20. 
The average age of SCI victims is around 
31 years and the most frequently occur-
ring age at injury is 19 years 24. Consider-
ing the severe outcome of most SCI and 
the lack of a therapeutic perspective for 
the patient, the fact that an over-propor-
tional part of the victims are young adults 
adds to the devastating nature of the inju-
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ry. The main causes for SCI in developed 
countries are trafﬁc accidents, workplace-
related accidents and recreational activity 
related accidents, which further indicates 
that a major part of the SCI victims are 
active young adults 20. Additionally, more 
than 75% of the victims are male 20. For 
many patients, a SCI leads to severe im-
pairments, loss of economic productivity 
and a life-long dependency on nursing. A 
SCI therefore is not only a tragedy for the 
patient personally but also leads to enor-
mous costs for the society in general. 
3. THE PATHOMORPHOLOGY OF 
SPINAL CORD INJURY
The pathological response to SCI can be 
divided into three different phases. In the 
acute injury phase, which starts at the mo-
ment of injury and extends over the ﬁrst 
few days, the force of the traumatic insult 
causes direct mechanical damage to the 
spinal cord tissue. Additionally, the cor-
rect ionic segregation in cells at the lesion 
epicenter is disturbed, causing axolemmal 
depolarization and localized edema, which 
results in a state of spinal shock25. Spinal 
shock represents a transient generalized 
failure of circuitry of the spinal neural net-
work that is characterized by the absence 
of spinal reﬂexes, a typical hallmark of 
the acute injury phase 26. In the follow-
ing secondary injury phase ranging from 
days to months after the initial injury, the 
pathophysiological disturbances that are 
initiated by the primary injury in the acute 
injury phase persist leading to a progres-
sive loss of spinal cord parenchyma. As 
a result, the size of the ﬁnal lesion is re-
markably larger as compared to the lesion 
area immediately after injury. Finally, in the 
chronic injury phase the typical cytoarchi-
tecture of the spinal cord has been irre-
versibly changed. Necrosis and apoptosis 
at the lesion epicenter has lead to exten-
sive tissue degeneration and the develop-
ment of cystic lesion defects 27. Apoptosis 
of oligodendrocytes causes demyelin-
ation, which leads to conduction defects 
of spared axons 28. Moreover, extracellular 
matrix produced by inﬁltrated ﬁbroblasts, 
reactive astrocytes and macrophages/ac-
tivated microglia promotes ﬁbroglial scar 
formation delineating the lesion center 
from the surrounding spinal cord paren-
chyma 29. In some instances, even in the 
later stage chronic SCI, progression of 
degenerative events can be observed. A 
blockade of cerebrospinal ﬂuid circulation 
through the central canal for instance can 
induce a centrally located cyst formation, 
so called syringomyelia, which can lead to 
secondary pressure damage of the spinal 
cord tissue rostral to the actual injury site 
30. 
Injury induced plasticity phenomena rep-
resent an often-underestimated aspect 
of SCI in chronic stages. Compensatory 
collateral sprouting, activation of redun-
dant pathways and alterations in the re-
ceptor number/phenotype or excitability 
of surviving neurons and glia of partially 
denervated targets can be observed af-
ter incomplete lesions. In rodent animal 
models, injury induced plasticity is shown 
to be associated with functional recovery 
after SCI 31. Also in humans, many SCI 
patients exhibit a modest degree of func-
11
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Figure 1: Schematic representation of spinal cord injury. (A) In the intact spinal cord, neurons innervate 
distant targets with their axons (blue). In most ﬁber tracts, the axons are myelinated by oligodendroglia, 
whereas the astroglia give structural and homeostatic support (grey). The resident microglia are in a resting 
state (red). (B) After a traumatic insult, the mostly blunt injury leads to disruption of axon ﬁber tracts. Necrosis 
at the lesion center and degeneration of the distal portion of the lesioned axons induces microglia activation 
and the invasion of peripheral macrophages. Furthermore, proliferation and hypertrophy of astrocytes leads 
to reactive gliosis. (C) In the chronically injured spinal cord, a cystic lesion cavity that is surrounded by 
reactive astrocytes has developed. Apoptosis of oligodendrocytes has lead to demyelination of otherwise 
intact axons. Furthermore, lack of trophic support can lead to neuronal loss.
12
General Introduction
tional recovery over weeks to months af-
ter the initial injury 32.
The steady progression of tissue damage 
in the proximity of the injury site exceed-
ing by far the size of the initial damage 
is typical for SCI in particular and CNS 
injuries in general. It therefore is gener-
ally accepted that there are two separate 
mechanisms of damage after acute spinal 
cord injury: the primary injury and second-
ary injury mechanisms 33, 34. Although both 
mechanisms cannot be strictly temporar-
ily separated, the primary and secondary 
damage events possess distinct patho-
physiological characteristics.
3.1 Primary injury mechanisms
The primary injury includes the tissue 
damage that can be directly attributed to 
the force of the traumatic insult. The pri-
mary injury induces disruption of the axon 
pathways, cell membrane damage and 
mechanical damage to the spinal cord 
vasculature. Particularly in the lower spi-
nal cord, the initial traumatic insult most 
frequently causes the deformation of the 
spinal canal, leading to a contusion injury 
that is followed by an acute compression 
of the soft spinal cord tissue. Additionally, 
the mechanical impact can cause the dis-
location of bony fragments and disc ma-
terial, which leads to penetration and lac-
eration of the spinal cord 35. Sharp insults 
or direct transection of the spinal cord tis-
sue on the contrary is a less frequent oc-
curring injury type that often takes place 
after gun shot or knife wounds 19. At the 
cervical region of the spinal cord, hy-
perextension injuries are occurring more 
frequently than crush injuries because of 
the greater ﬂexibility of the cervical spinal 
column. Hyperextension injuries directly 
cause disruption of axons and typically 
occur due to falls on the head for instance 
after diving in shallow water 20. 
3.2 Secondary injury mechanisms
The primary damage to the spinal cord 
tissue elicits the autocatalytic processes 
that are involved in the secondary dam-
age phase. The secondary damage phase 
consists of a wide repertoire of vascular 
events, biochemical disturbances and 
cellular responses that evolve over min-
utes to hours after the primary injury, 
leading to massive additional loss of spi-
nal cord tissue, scar tissue formation and 
demyelination. Since it predominantly is 
the loss of white matter that is decisive for 
the loss of function after SCI, it is hypoth-
esized that therapeutical interventions 
that prevent secondary damage could be 
able to improve functional outcome after 
SCI 14. It therefore is of obvious interest to 
better understand the pathophysiology of 
the secondary injury processes.
3.2.1 Vascular events
Within minutes after the primary injury, 
vasospasms and the loss of vascular au-
toregulation cause a reduced perfusion at 
the injury site 36. Particularly in the spinal 
cord grey matter, this leads to a remark-
ably impaired microcirculation 37. In com-
bination with the systemic hypotension 
and the reduced cardiac output typically 
occurring after SCI 38, the vascular chang-
es cause post traumatic ischemia of the 
13
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spinal cord parenchyma in the segments 
surrounding the injury site 34. Especially in 
hemorrhagic regions of the injured spinal 
cord, the posttraumatic ischemia leads to 
infarction and necrosis of the spinal cord 
tissue 39. Furthermore, damage to the 
vasculature endothelial lining causes dis-
ruption of the blood-brain barrier (BBB), 
which leads to a progressive edema that 
spreads to adjacent segments of the in-
jured spinal cord 40.
3.2.2 Biochemical alterations 
Directly following the primary injury, syn-
aptic overactivity leads to the uncon-
trolled release of the amino acid gluta-
mate, the major excitatory neurotrans-
mitter in the adult mammalian CNS 41, 42. 
Elevated levels of glutamate cause the 
activation of the NMDA subclass of gluta-
mate receptors, which have been shown 
to induce Ca2+ inﬂux resulting in a cellular 
Ca2+ overload 43. A further disturbance of 
the ionic homeostasis is caused by a re-
duction of the Na+/K+-ATPase activity in 
cells at the lesion epicenter 44. In physi-
ological normal CNS tissue, the intracel-
lular concentration of Na+ and Ca2+ is kept 
at a low level, while cell organelles such 
as the endoplasmatic reticulum and mi-
tochondria function as intracellular Ca2+ 
storage. The increase of intracellular Na+ 
and Ca2+, however, is thought to reverse 
the normal action of the intracellular Na+/
Ca2+ exchanger by pumping out Ca2+ that 
is accumulated in the intracellular Ca2+ 
stores in reverse of Na+ 44. It is the in-
crease of cytoplasmic Ca2+ levels, which 
starts a detrimental cascade of events in-
ducing both axon degeneration and cell 
death 45. First, increased levels of cyto-
solic Ca2+ concentrations are shown to 
destabilize the cytoskeleton and the cell 
membrane, causing impaired axoplasmic 
transport 46, 47. Furthermore, high concen-
trations of cytosolic Ca2+ activate a series 
of cell death inducing catabolic enzymes 
such as proteinases, cysteine proteases, 
and phospholipases 48-50. The state of im-
paired Ca2+ homeostasis is autocatalytic 
and self-propagating since it can lead 
to the opening of the mitochondrial per-
meability transition pore. This is not only 
detrimental for the cell’s ATP production, 
which further reduces the Na+/K+-ATPase 
activity, but also leads to release of cyto-
chrome c, which induces apoptotic cell 
death by caspase 3 activation 51. 
After collapse of the oxidative metabolism, 
incomplete electron transport in the respi-
ratory chain causes the overproduction of 
free radicals such as super oxide (O2-) 52. 
Free radicals are highly reactive oxygen 
metabolites that possess an extra electron 
in the outer orbit. The enzyme superoxide 
dismutase converts the superoxide in the 
free radical species H2O2, which in its turn 
is degraded into H2O and O2 by catalase 
and gluthatione peroxidase activity. In the 
presence of free iron that originates from 
hemoglobin, transferrin or ferretin, H2O2 
forms the highly reactive hydroxyl radicals 
(•OH) 53. The uncontrolled and excessive 
release of these free radicals causes lipid 
peroxidation in the cell membranes, which 
leads to impairment of the phospholipid 
dependent enzymes, disruption of ionic 
membrane gradients and eventually dis-
14
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ruption of the cell membrane 54. When a 
cell membrane is destroyed, the fatty ac-
ids that make up the cell membrane are 
released and form, when peroxidated, 
highly toxic compounds such as acrolein 
and 4-hydroxynonenal. These on their 
turn destroy cell membranes, releasing 
more fatty acids that undergo peroxida-
tion, resulting in an autocatalytic cell lysis 
process, which is typical for the second-
ary damage phase of SCI 55, 56.
3.2.3 Cellular events
The response of the immune system rep-
resents the ﬁrst cellular event that takes 
place in the secondary damage phase of 
SCI. Within 6 hrs after the primary injury, 
neutrophils enter the lesion site and start 
to remove tissue debris by phagocytosis 
57. Besides the restoration of tissue ho-
meostasis, neutrophils contribute to the 
progress of the secondary damage phase 
by releasing proteases and reactive oxy-
gen species. Microglia, the resident im-
mune cells in the CNS, respond quickly to 
the changes in the microenvironment and 
become activated 58. Activated microglia 
remove degenerated ﬁbers by phago-
cytes and function as antigen presenting 
cells to mediate the T-cell response. 59. 
Several days after the initial injury, blood 
born macrophages and lymphocytes in-
ﬁltrate the injured spinal cord tissue 57. 
The inﬁltration and prolonged activation 
of immune cells has been shown to have 
both beneﬁcial and deleterious effects on 
Table 1 Pathophysiological Events of the Secondary Injury that Occur After Acute Spinal 
Cord Injury
Vascular events
Post traumatic ischemia
Edema
Disruption of blood brain barrier
Biochemical alterations
Uncontrolled excitatory amino acid release
Ca2+ inﬂux into cells
Na+ inﬂux into mitochondria
Collapse of oxidative metabolism and ATP production
Cytochrome c release
Free radical overproduction 
Lipid peroxidation 
Cellular Events
Invasion of blood bound immune cells
Microglia activation
Reactive Astrogliosis
Wallerian degeneration 
Rupture of terminal clubs resulting in hydrolytic enzyme release
Apoptosis of glial cells
 Invasion of ﬁbroblast and Schwann cells
15
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the functional outcome after SCI. The 
release of pro-inﬂammatory cytokines 
such as tumor necrosis factor-alpha 
and inducible nitric oxide synthase, are 
thought to induce cellular degeneration 
in the secondary damage phase 60, 61. In 
a more chronic phase of the injury, acti-
vated immune cells produce growth fac-
tors that contribute to neuronal survival 
and tissue repair 62, 63. Furthermore, the 
clearance of myelin and axonal debris 
by immune cells may promote axonal 
regeneration considering that adult my-
elin contains potent axonal growth in-
hibitors 64.
CNS injury induces astroglial hypertro-
phy, process extension and moderate 
cell division. These so called reactive 
astroglial cells can be detected by the 
increased production of intermediate 
ﬁlament protein such as glial ﬁbrillary 
acidic protein (GFAP) and vimentin 65. 
Reactive astrocytes seal the injury site 
by producing a wide variety of extracel-
lular matrix (ECM) proteins. Reactive 
astrogliosis is often regarded as detri-
mental to functional outcome since they 
partly form the scar tissue surrounding 
the injury site, which is thought to act as 
a major obstacle for axon regeneration 
66, 67. Nevertheless, reactive atrocytes 
are essential for wound healing and 
blood–brain barrier repair. In addition, 
reactive astrocytes are able to restrict 
inﬂammation, protect neurons and oli-
godendrocytes, and preserve motor 
functions after mild or moderate SCI 68, 
69. Thus, reactive astroglia have an am-
bivalent role in the injured spinal cord, 
secreting factors, which inhibit axonal 
regeneration, on one hand, and stabiliz-
ing the injured tissue during the second-
ary damage phase on the other hand. 
Axonal breakdown takes place in the as-
cending ﬁber tracts above the lesion and 
descending ﬁber tracts below the lesion 
and is spatially associated with phago-
cytosis of tissue debris by activated mi-
croglia, a process which as also known 
as Wallerian degeneration 70. Abortive 
sprouting can be observed along the 
proximal part of lesioned CNS axons, 
which has already been described by 
Ramon y Cajal 1. As a result of continu-
ing proximodistal axonal transport, ter-
minal club structures are formed at the 
distal tip of lesioned axons. After rup-
ture of the terminal club, the hydrolytic 
enzymes that are enriched in the termi-
nal clubs are released, causing autolysis 
of the spinal cord tissue 71. 
The described vascular events, bio-
chemical alterations and responses of 
the immune system as part of the sec-
ondary damage phase also affect spinal 
cord cells that initially survived the inju-
ry. The programmed cell death machin-
ery becomes activated through death 
receptors, mitochondrial malfunction or 
caspases, ultimately leading to loss of 
glial and neuronal cells 72. The number 
of apoptotic cells is the highest close 
to the lesion epicenter. Apoptosis of oli-
godendroglia in the proximity of spared 
axons causes chronic demyelination, 
which often represents the morphologi-
cal correlate for the delayed sensory and 
motor dysfunction occuring after SCI 73. 
16
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4. CAUSES FOR THE POOR 
REGENERATIVE CAPACITY OF 
THE CENTRAL NERVOUS 
SYSTEM 
In contrast to the CNS, the peripheral 
nervous system (PNS) is capable of spon-
taneous recovery after axonal damage. 
Schwann cells, which are the resident 
PNS glial cells, play a crucial role in this 
regeneration process. When the distal part 
of a lesioned PNS axon degenerates, the 
Schwann cells that lose axonal contact 
start to proliferate and form a cell strand 
within the basal lamina tube, the so-called 
bands of Büngner 74. Furthermore, the 
Schwann cells in the denervated nerve 
stump express adhesion molecules and 
neurotrophic factors essential for axon 
regeneration. Severed axons sprout into 
the Schwann cell columns of the distal 
nerve segment, which ultimately can lead 
to reinnervation of the denervated target, 
in most cases the skeletal muscle 75. 
Although CNS axons are capable of long 
distance axonal sprouting into a periph-
eral nerve graft, injured CNS neurons 
react differently compared to PNS neu-
rons. However, in particular the inhospi-
table environment surrounding severed 
CNS axons determines their inability to 
regrow 2, 3. Substantial progress has been 
made revealing the biological bases of the 
A
B
C
D
myelinating
Schwann cell
non-myelinating
Schwann cell
macrophage
Figure 2: Axonal regeneration in the peripheral nervous system. (A) Peripheral axons (blue) are either 
ensheathed or myelinated by Schwann cells (grey). (B) As long as the perineurium is intact, lesioned peripheral 
axons are able to spontaneously regenerate over considerable distances. Therefore, resident Schwann cells 
that lose axonal contact start to proliferate and form axon-guiding structures, the so-called bands of Büngner. 
Schwann cells furthermore, produce neurotrophic factors and guidance molecules that enhance axonal 
regeneration. Inﬁltrated macrophages (red) remove the debris that originates from the degenerating distal 
part of the lesioned axons. (C) Regenerating axons become remyelinated by the resident Schwann cells. (D) 
Ultimately, the regenerating peripheral axons are capable of reinnervating their target organ.
17
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regeneration inhibiting properties of the 
CNS in comparison to the PNS. A number 
of factors have been identiﬁed: the pres-
ence of extrinsic axonal growth inhibiting 
factors, decreased intrinsic regenerative 
potential of CNS axons, the absence of 
remyelination and the development of a 
cystic tissue defect, which all are thought 
to play a signiﬁcant role for the poor re-
generative capacity after SCI.
4.1 Extrinsic axonal growth inhibiting 
factors
4.1.1 Glial scar 
Glial scar formation represents a major 
obstacle for axonal regeneration after 
SCI. The glial scar consists of reactive as-
trocytes and their ECM proteins. As soon 
as the surrounding dura mater gets dis-
rupted in more severe lesions, invading 
ﬁbroblasts will contribute to the glial scar. 
Subsequently, astrocytes start to up-reg-
ulate the expression of proteoglycans, a 
class of ECM molecules 76. Proteoglycans 
have been identiﬁed as potent inhibitors 
of CNS axon extension both in vitro and in 
vivo 6, 77-79. Ultrastucturally, growth cones 
of sprouting axons are not able to regen-
erate through the glial scar and form dys-
trophic endbulbs 66, 67. Remarkably, cellu-
lar sources of proteoglycans in the lesion 
site also produce axon growth permissive 
ECM components such as L1 and laminin. 
80. Both in vitro and in vivo, the balance 
between inhibitory and permissive ECM 
components substantially inﬂuences the 
ability of axons to regenerate 80, 81. There-
fore, the obstruction of neurite extension 
by inhibitory ECM components such as 
proteoglycans and the growth promoting 
capacity of permissive ECM components 
of the glial scar cannot be described as an 
“all or nothing” mechanism 80. Moreover, 
it is now clear that at least certain sub-
populations of dystrophic axons are able 
to return to an active growth state when 
they are given a proper stimulus, for in-
stance additional neurotrophic factor sup-
port82, 83.
In addition to proteoglycans, several other 
inhibitors for axonal regeneration are up-
regulated in the glial scar. The secreted 
protein semaphorin 3 is upregulated in in-
vading ﬁbroblasts and acts as a chemore-
pellent for neuropilin expressing neurons. 
84. Furthermore, Slit proteins along with 
their glypican 1 receptors, which are im-
portant inhibitors for axonal elongation 
during development, are upregulated in 
reactive astrocytes 85
The formation of the glial scar starts after 
disruption of the BBB and is most likely 
triggered by the inﬂux of molecules, nor-
mally absent in the CNS, and the invasion 
of activated microglia in the injured CNS 
parenchyma 86. The search for potential 
candidate molecules, which may promote 
reactive gliosis, is ongoing. However, 
there is clear evidence that both interleu-
kin-1 and transforming growth factor-beta 
(TGF-beta) produced by macrophages 
play a major role in the transformation of 
normal astrocytes into the reactive pheno-
type 87, 88. Furthermore, the secretion of the 
inﬂammatory cytokine interferon-gamma 
mediates glial scarring after brain injury 89. 
Additionally, signaling between B-ephrins 
and EphB receptors in response to injury 
18
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supports the ﬁbroglial scar formation initi-
ated by meningeal ﬁbroblasts, which in-
vade the injured spinal cord in the adult 
CNS 90.
4.1.2 Myelin associated inhibitors
Distinct from the already described growth 
cone dystrophy is the collapse of growth 
cones where mature regenerating CNS 
axons encounter mature oligdendrocytes 
or myelin. Growth cone collapse results in 
a shrunken growth cone in combination 
with a stalled forward progress that can 
restart over time, and has been described 
best in vitro 91. It is unclear whether growth 
cone collapse precedes growth cone dys-
trophy.
Three different classes of myelin-associat-
ed molecules have been described caus-
ing growth cone collapse and inhibition 
of neurite outgrowth: Nogo, Myelin-As-
sociated Glycoprotein (MAG) and Oligo-
dendrocyte Myelin Glycoprotein (OMGP). 
Nogo exists in three isoforms, Nogo-A, 
Nogo-B and Nogo-C and is mostly asso-
ciated with the endoplasmatic reticulum 
of oligodendrocytes, however, a propor-
tion can be detected on the cell surface. 
The three isoforms share the inhibitory 
Nogo-66 domain, Nogo-A has an addi-
tional inhibitory domain, amino-Nogo, at 
the N-terminus 92-94. MAG, a member of 
the immunoglobulin superfamily, is a sialic 
acid-binding protein and can be found in 
both CNS and PNS myelin 95, 96. OMGP is 
a glycosyl phosphatidylinositol-linked pro-
tein not only expressed by oligodendro-
cytes, but also in by Schwann cells, their 
counterparts in the PNS 97. Interestingly, 
all three classes of myelin inhibitors seem 
to act through the neuronal expressed 
Nogo-receptor (Ngr) 98-100. Ngr uses p75 
low afﬁnity NGF receptor (p75-LNGR) as 
a co-receptor to activate the small GTP-
ase Rho and its signal transduction path-
way to inhibit neurite outgrowth 101, 102.
The role of myelin inhibitors in growth 
cone collapse and inhibition of neurite 
outgrowth has been impressively dem-
onstrated in vitro, the exact role of myelin 
inhibition in vivo remains unclear. Inhibi-
tion of Nogo using speciﬁc neutralizing 
antibodies elicit an axonal response and 
improved functional outcome after SCI 103, 
104, presumably through the activation of 
collateral sprouting of uninjured axons 105. 
The inhibition of Ngr signaling after SCI 
through speciﬁc antibodies promotes lo-
cal sprouting, however, long range axon 
regeneration is minimal 7, 103. Animals lack-
ing either speciﬁc or all three Nogo vari-
ants allow only limited axonal regeneration 
at best 106-108. Furthermore, adult sensory 
neurons regrow in both intact and degen-
erating white matter tracts of adult mice 
79, 109. There is strong evidence suggesting 
that the geometrical organization of my-
elin is biologically relevant in vivo, which 
is based on the ﬁnding that white matter 
supports parallel axonal sprouting but 
inhibits nonparallel sprouting against the 
orientation of the white matter tracts 110. 
Therefore, it is likely that myelin associat-
ed inhibitory molecules could be essential 
for oriented and fascicled long distance 
axon growth 111. Myelin-associated inhibi-
tion is considered to be crucial to maintain 
the topography of highly speciﬁc nervous 
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system projections, which is supported by 
studies inducing aberrant sprouting of lo-
cal circuitry in the adult intact cerebellum 
after neutralizing Nogo 112. In other words, 
neutralizing myelin based inhibitors as a 
repair strategy for SCI could induce aber-
rant and dysfunctional sprouting of non-
injured systems.
4.1.3 Other inhibitors
Besides myelin-associated inhibitors, 
there are indications that at least some 
of the chemoattractant and repulsive ef-
fectors that play a role during develop-
ment also are present in the adult spinal 
cord. The highly conserved laminin-re-
lated molecule netrin system with its re-
ceptors DCC and Unc5 can function both 
as an attractant and repellent for growing 
axons, depending on the cAMP or cGMP 
level within the growth cone 113. In the in-
jured rat spinal cord, Netrin-1 is expressed 
throughout grey and white matter by oli-
godendrocyte precursors still undergoing 
division 114. Furthermore, grafts of netrin-1 
over-expressing ﬁbroblasts reduce axonal 
growth after adult spinal cord injury, which 
suggest a role for endogenous netrin-1 as 
an inhibitor of intra-spinal neuron derived 
axon regeneration 115.
4.2 Intrinsic regeneration limiting 
factors
4.2.1 Regeneration-associated genes
Besides the above described extrinsic 
factors that limit the regenerative capacity 
of CNS axons, differences in the intrinsic 
state of the lesioned neurons contributes 
signiﬁcantly to the poor regenerative ca-
pacity of the diseased CNS. Neurons re-
act upon axotomy by up-regulating the 
expression of regeneration-associated 
genes (RAG), including growth-associat-
ed proteins such as GAP-43 and CAP-23 
and adhesion molecules like L1, N-CAM. 
Most changes in RAG expression occur in 
response to axotomy of CNS neurons and 
are qualitatively and quantitatively differ-
ent from those that occur in the PNS. In 
general, up-regulation of RAG is weaker 
and more transient or even absent in CNS 
neurons compared to PNS neurons 116, 117. 
The expression level of RAG appears to 
correlate with the regenerative capacity of 
an axotomized neuron 118. Under certain 
conditions, the over-expression of mul-
tiple RAG is sufﬁcient to induce axonal 
regeneration, even in a CNS environment 
119. 
4.2.2 Trophic support
The differential expression of growth fac-
tors and their receptors after axotomy 
represents another signiﬁcant difference 
between PNS and CNS neurons. In con-
trast to PNS neurons, CNS neurons fail 
to induce sufﬁcient expression of trophic 
factors such as BDNF and NT-4/5 after 
axotomy, which results in signiﬁcant atro-
phy of ﬁber tracts such as the rubrospinal 
and the corticospinal tract 120. After ad-
ministration of BDNF and NT-3 in rodent 
models of SCI, structural and functional 
recovery has been reported 5, 121. Func-
tional improvements are most likely attrib-
utable to the reduced atrophy of axons 
and stimulation of injury-induced plastic-
ity of surviving axons, since long-distance 
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tract regeneration was not observed 5, 8, 121, 
122. These ﬁndings support the notion that 
the administration of neurotrophic factors 
is a promising strategy to induce axonal 
and functional recovery after SCI.
4.3 Demyelination
Loss of oligodendrocytes through pro-
grammed cell death contributes signiﬁ-
cantly to functional deﬁcits observed after 
SCI. The resulting demyelination slows 
down or even blocks completely appro-
priate nerve conduction in uninjured ax-
ons. In contrast to the PNS, the CNS ex-
hibits only a limited capacity to remyelin-
ate affected ﬁber tracts 123. Replacement 
of oligodendroglia and remyelination has 
been achieved by transplanting Schwann 
cells, olfactory ensheathing cells or oligo-
dendrocyte precursor cells 124-126. Either 
protection of intrinsic oligodendrocytes 
or their appropriate replacement to main-
tain myelination will result in signiﬁcant 
improvement in functional outcome after 
spinal cord injury. 
4.4 Cyst formation
Necrosis and apoptosis of spinal cord 
parenchyma results in a ﬂuid ﬁlled lesion 
cavity forming at the lesion epicenter. 
Subsequently, a disturbed cerebrospinal 
ﬂuid circulation along the central canal of-
ten supports the development of a ﬂuid 
ﬁlled cavity – so called syringomyelia. It 
is evident that cystic lesion cavities repre-
sent a major obstacle for the regeneration 
of severed axons. In the PNS, the resident 
Schwann cells react upon the injury by 
proliferation and cells migrate into the le-
sion site, providing a substrate for regen-
erating axons 75. Although some prolifera-
tion of astrocytes can be observed after 
SCI, the extent of cell renewal, even after 
the application of growth factors, does not 
allow to replace the cystic lesion cavity 4. 
Therefore, strategies need to be devel-
oped, which provide regrowth conducive 
substrates either through cell transplanta-
tion approaches or through implantation 
of appropriate acellular matrices.
5. INDUCING RECOVERY AFTER 
SPINAL CORD INJURY
Recovery after spinal cord injury can be 
described on both structural and func-
tional levels. Structural recovery can 
be observed in terms of tissue repair, 
axonal growth and elongation, remy-
elination and synapse formation and is 
measured using descriptive tests that 
determine the integrity of the injured 
system. Functional recovery describes 
improved function of the injured subject 
after therapeutical intervention. Func-
tional recovery can be determined using 
electrophysiology and speciﬁc behav-
ioral tests that describe the ability of the 
injured system to perform a certain task. 
Although the induction of structural re-
covery is the most compelling approach 
to induce functional recovery, it is not 
the only means that has the potential to 
improve the outcome after SCI.
5.1 Prevention of secondary damage 
The disruption of ascending and de-
scending axon pathways in the white 
matter represents the main structural 
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correlate for functional impairment 
caused by spinal cord trauma. Of note, 
a small percentage of spared axon pro-
jections is sufﬁcient to maintain a large 
degree of function 127. Pathophysiologi-
cal changes during the secondary injury 
phase are responsible to a signiﬁcant 
extent for the ultimate white matter 
damage occuring over time after the 
initial injury. Therefore, therapeutic in-
terventions need to be introduced be-
fore the cascade of secondary damage 
events starts, in order to promote white 
matter sparing and improved functional 
outcome. The inhibition of earlier de-
scribed effectors of secondary damage 
(for instance free radical cellular dam-
age, cytochrome C release and Na+ and 
Ca2+ inﬂux-related cell death) has been 
shown to induce tissue sparing and im-
provement of functional outcome after 
SCI in animal models 9, 128, 129. Most inter-
ventions to reduce secondary damage 
require either pre- or immediate post-
injury application in order to be effec-
tive, which of course is problematic to 
realize in a clinical setting 130. Moreover, 
the beneﬁts of the standard administra-
tion of a high dose methylprednisolone 
immediately after the spinal trauma in 
order to reduce secondary damage are 
still under dispute 15. No doubt, the in-
vestigation of approaches to attenuate 
sequelae of secondary injury events will 
be an important research topic in the fu-
ture. However, the translation into clini-
cally relevant strategies continues to be 
a challenging task. 
5.2 Induction of injury-induced 
plasticity
The success of a therapeutic intervention 
aiming for functional recovery depends on 
the ability to reestablish a critical number 
of connections between supraspinal and 
spinal neurons. The fact that 55% of the 
SCI patients have neurological incom-
plete lesions and that even a majority of 
the complete SCI patients exhibit spared 
rims of white matter at the lesion epicen-
ter suggests that enhancing the injury-in-
duced plasticity of spared axons repre-
sents a promising mechanism to induce 
functional recovery after SCI 23. Indeed, 
there have been several animal studies in 
which the enhancement of compensatory 
collateral sprouting after incomplete SCI 
can be induced by the administration of 
neurotrophic factors, GAP-43 up-regula-
tion or the neutralization of myelin-asso-
ciated inhibitors 13, 131, 132. The efﬁcacy of 
strategies enhancing the intrinsic plastic-
ity remains to be determined. However, 
this approach can only be applied for 
structural incomplete SCI. After denerva-
tion in complete SCI, only therapies that 
induce regeneration of severed axons and 
subsequently target reinnervation will be 
able to promote functional regeneration. 
5.3 Induction of axonal regeneration
Axonal growth can represent either plas-
ticity or regeneration. Therefore, it is im-
portant to strictly deﬁne the possible axo-
nal growth phenomena. First, the most re-
stricted form is reactive synaptogenesis, 
which depicts local ingrowth of otherwise 
non-injured afferents that terminate in the 
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close proximity of the denervated sites. 
Furthermore, new connections can be es-
tablished by ectopic ingrowth of sprouts 
from non-injured axons that originally 
project at remote locations, which is de-
ﬁned axonal sprouting. Alternatively when 
the axonal growth originates from the am-
putated axon itself, it is referred to as re-
generative sprouting. Axonal regeneration 
ﬁnally describes regenerative sprouting 
that leads to reconnection of lesioned 
axon with their original targets 133. The ul-
timate goal of SCI research is to induce 
axonal regeneration of disrupted ﬁber 
tracts, leading to regain of function, which 
further is referred to as functional axonal 
regeneration.
It is of utmost importance to keep in mind 
that if functional recovery is observed, this 
not necessarily has to be the direct cor-
relate of the elicited structural recovery. 
Since the majority of experimental SCI 
models employed represent incomplete 
injuries, a limited degree of regain of func-
tion after SCI most frequently can be ex-
plained by compensation of spared con-
nections. It therefore is very challenging 
to determine whether the observed func-
tional recovery can be attributed to true 
axonal regeneration or by plasticity phe-
nomena within spared axon projections. 
Before functional axonal regeneration 
can be claimed, each individual aspect of 
structural recovery, including cell surviv-
al, axon growth, synapse formation and 
remyelination must be described for the 
injured connection. Furthermore, it must 
be proven that the observed functional re-
covery can be attributed to the observed 
morphological changes, for instance by 
speciﬁcally targeting regenerates with 
pharmaceutical (e.g. by neurotransmitter 
antagonists) or surgical interventions (e.g. 
by retransection) to reverse functional im-
provement. Numerous studies report re-
generative sprouting in combination with 
behavioral recovery 4-13. Although these 
studies provide valuable insights into the 
regenerative mechanisms that play a role 
after SCI, most studies only provide data 
on a limited series of tests. The true sig-
niﬁcance of the described regeneration 
therefore remains subject of further inves-
tigations. 
The development of a therapeutic interven-
tion that enables regeneration of lesioned 
axons over long distances is often consid-
ered to be an essential aspect to induce 
functional axonal regeneration. Neverthe-
less, it remains to be determined in which 
degree long distance axonal regeneration 
is required in order to induce substantial 
functional recovery. It is possible that only 
bridging the lesion site is sufﬁcient to form 
a connective relay with spared axonal ﬁbers 
below the lesion. The functional recovery 
that can be observed after injury-induced 
plasticity indicates that the wiring of the 
adult spinal cord could be more plastic then 
expected 134. In this respect, it is an interest-
ing observation that the axonal reconnec-
tion in cold-blooded species that are ca-
pable of axonal regeneration after SCI pre-
dominantly occurs by regeneration of cells 
that are closely rostral to the injury site 135. 
Signiﬁcant axonal regeneration of lesioned 
CNS axons over long distances within the 
CNS has never been shown. 
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5.4 Cellular therapy as a multi-facet 
tool to enable functional axonal 
regeneration
In order to achieve the challenging 
goal of functional axonal regeneration, 
injured neurons must survive, extend 
axons through an adversive environ-
ment, ﬁnd appropriate target neurons 
and ultimately form functionally relevant 
synapses. It is evident that a multi-facet 
therapeutic intervention is needed in or-
der to accomplish these complex tasks. 
Moreover, if the regenerative failure of 
injured CNS axons is perceived as an im-
balance between the present stimulators 
and inhibitors of axonal regeneration, a 
combined therapy that both neutralizes 
inhibition and provides additional growth 
stimulation is most likely to be effective. 
Since the CNS is not able to intrinsically 
replace lost spinal cord parenchyma 
sufﬁciently, cellular replacement is con-
sidered to be a crucial prerequisite in 
a putative therapeutical approach. The 
regenerative properties of the PNS can 
be be transferred to a limited extent 
to the CNS by the transplantation of 
Schwann cells and olfactory ensheath-
ing cells. Schwann cells induce axonal 
regeneration by providing a growth sup-
portive substrate and by supplying tro-
phic support 136. Furthermore, Schwann 
cells are able to remyelinate CNS axo-
ns to restore proper nerve conduction. 
However, Schwann cells do not facili-
tate axonal regrowth beyond the graft 
to reenter the caudal host spinal cord 
137. Alternatively, olfactory ensheathing 
cells (OEC) are shown to be interesting 
candidates for the use in a cellular ther-
apy approach after SCI. OEC represent 
a “hybrid” between CNS (astroglia) and 
PNS glial cells (Schwann cells) that pro-
mote reentry of olfactory nerve endings 
from the PNS into the CNS throughout 
life. The olfactory system is unique in 
terms of its constant renewal of adult 
neuronal cells 138. OEC can be isolated 
from adult olfactory nerves. When OEC 
are grafted into the lesioned spinal cord, 
tissue repair, axonal regeneration, remy-
elination and functional recovery can be 
observed to a limited degree. Whether 
the observed functional recovery can be 
attributed to axonal regeneration of le-
sioned axons has not been shown yet 
139, 140.
Neural stem cells (NSC) as a source for 
cell-based therapies have the impor-
tant advantage to give rise to all three 
major cell types of the central nervous 
system (CNS): neurons, astrocytes and 
oligodendrocytes. Therefore, they can 
replace degenerated spinal cord paren-
chyma in an organotypcially appropriate 
manner. NSC have been isolated from 
both the developing and adult CNS and 
can be expanded in culture using epider-
mal growth factor and ﬁbroblast growth 
factor as mitogens 141, 142. Embryonic de-
rived NSC have been shown to promote 
partial functional recovery following spi-
nal cord injury 12, 143. Since ethical and 
logistic concerns restrict the large-scale 
use of embryonic derived stem cells, 
NSC derived from adult neural tissue 
are preferable. Furthermore, adult NSC 
could be isolated from the patient’s own 
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neural tissue, thus avoiding the need of 
life long immunosuppression in trans-
planted subjects to avoid graft rejection. 
The potential of adult derived NSC to in-
duce axonal regeneration remains to be 
determined.
6. INTRODUCTION TO THE USED 
SPINAL CORD INJURY MODELS
6.1 Animal models of spinal cord 
injury
In animal models of SCI, both structural 
and functional regeneration can be inves-
tigated. Unfortunately, the conclusions ob-
tained from animal models of SCI can be 
transferred to the human situation only to 
a limited extent. On both the structural and 
functional level, the human spinal cord dif-
fers signiﬁcantly with the animal situation. 
Already the sheer difference in size means 
that axons need to regenerate over tens of 
centimeters in humans instead of only a 
few centimeters in animals, particularly in 
rodents. Furthermore, the cytoarchitecture 
of the human spinal cord is signiﬁcantly dif-
ferent when compared to the rat, which is 
the most frequently used laboratory animal 
in SCI research. In this respect, the most 
prominent example is the signiﬁcance of 
the rubrospinal and corticospinal tract, 
which are the major descending axon 
pathways that project to the spinal cord. 
During phylogenetic development, the abil-
ity to make precise movements became 
more and more advantageous, which re-
quired increasingly complex motor control 
systems. Therefore, the red nucleus in the 
brain stem and its rubrospinal tract that 
represents the major somatic motor sys-
tem in phylogenetic more primitive verte-
brates was copied to the motor cortex and 
its corticospinal tract in phylogenetically 
more advanced mammals. The additional 
space for projection neurons and supra-
spinal input in the cortex as compared to 
the brainstem is paralleled with a much 
more reﬁned somatopy of the motor cor-
tex when compared to the red nucleus, 
which has lead to an increased capacity 
to perform complicated motor tasks. Ad-
ditionally, the rubrospinal tract consists of 
considerably less descending ﬁbers in hu-
mans than in rats 144. As a consequence, 
the rubropsinal tract has only very lim-
ited signiﬁcance for the motor abilities of 
humans, whereas in rats, the rubrospinal 
tract is crucial for skilled locomotion 145. It 
therefore is not surprising that the compar-
ison of function between humans and ani-
mal models of SCI is problematic. This is 
further explained by the fact that humans 
are the only obligatory bipedal animals. To 
a great extent, the unique gait of humans 
is controlled by supraspinal control 146. This 
is in contrast to the locomotion of four-
legged animals in which the motor activity 
of stepping and gait is predominantly con-
trolled by specialized reﬂex circuits, known 
as the central pattern generators (CPGs) 
147. Since interneurons only are lost at the 
injured segment, reﬂexes remain intact 
above and below the lesion. Therefore, it is 
not surprising that even after a severe SCI, 
locomotion is preserved signiﬁcantly in 
four-legged animals as long as the CPG is 
not affected directly. There are signiﬁcant 
differences in the control of locomotion be-
tween humans and animals, e.g. the role of 
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Figure 3: Schematic graph showing the consequences of SCI on spinal cord projections. Decisive for 
the functional outcome after SCI is the damage to the long axonal connections in the spinal cord white 
matter. Mechanical and functional disruption of descending and ascending connections prevents voluntary 
motor and conscious sensory control, leading to the compartmentalization of the body in a functional and a 
dysfunctional part. Interneurons only are lost in the injured segments, leaving spinal reﬂexes intact above and 
below the injured segments. The blue projection represents the sensory afferent, black the interneuron and 
grey the lower motor neuron. The corticospinal tract projection is schematized in red. 
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the CPG in humans has yet to be clariﬁed 
148. Nevertheless, assessment of locomo-
tor ability is the most frequently employed 
functional parameter in animal models of 
SCI 149, 150. It therefore is important to evalu-
ate whether observed functional recovery 
of locomotion in SCI animals can be ex-
plained by hyperactive reﬂex responses 
rather than by reestablishment of function-
al connections. 
The outcome parameters of interest de-
termine the choice for the appropriate SCI 
animal model. SCI models ideal for the in-
vestigation of axonal regeneration may be 
less suitable for the assessment of func-
tion and vice versa. In transection models 
of SCI for instance, the selective disruption 
of ﬁber tracts enables the reliable assess-
ment of the regenerative response of the 
injured axons. The functional outcome of 
transection injuries however is less clini-
cally relevant since most SCI represent 
contusion injuries. Experimental contu-
sion injuries on the other hand are the 
most relevant in terms of their proximity to 
pathomechanisms in human SCI 151, but 
are less reproducible when compared to 
transection models. Furthermore, the dif-
fuse axonal damage in contusion injuries 
makes it almost impossible to recognize 
functional axonal regeneration, since the 
eventually observed structural and func-
tional recovery cannot be reliably attrib-
uted to the regeneration of speciﬁc ﬁber 
tracts. Alternatively, many alternative mod-
els of SCI have been described, including 
chemical agent induced and aspiration in-
juries 152-154.
6.2 Cervical dorsal column 
transection using a tungsten 
wire knife device
In this thesis, a lesion model for SCI was 
used in which the cervical dorsal column 
of rats is speciﬁcally transected using a 
tungsten wire knife device. The stereotac-
tic guidance of the wire knife device al-
lows reproducible transection of the dor-
sal columns without causing unnecessary 
damage to the spinal cord grey matter. 
Unlike suggested by the terminology “wire 
knife”, the tungsten wire induces a rather 
blunt transection, causing the formation of 
a restricted cystic cavity at the lesion site. 
Because of the minimal disruption of the 
meninges and surrounding vasculature, a 
wire knife lesion causes very little vascu-
lar disruption (hemorrhage, ischemia) and 
major invasion of meningeal ﬁbroblasts 
into the lesion is avoided. The preserva-
tion of meningeal sheats allows inject-
ing cell suspension grafts with almost no 
leaking of cells out of the graft site. 
The employed dorsal column transection 
model is speciﬁcally developed to com-
pletely lesion the crossed dorsal compo-
nent of the CST, which represents approx-
imately 95% of all CST axons 155, 156. The 
CST plays an important role in the control 
of ﬁne coordinated movement through its 
terminations in the ventral horn 157. How-
ever, permanent functional deﬁcits in ﬁne 
motor tasks such as forelimb reaching are 
only found when a cervical dorsal column 
transection injury is combined with a ven-
tral transection of the uncrossed ventral 
component of the CST 31. Thus, the isolat-
ed transection of the dorsal CST, as used 
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here, only allows to determine morphologi-
cal changes, in particular regeneration of 
corticospinal axons31. To a limited extend, 
ascending proprioceptive axon projections 
in the dorsal columns will be transected as 
well. Obvious behavioral alterations have 
not been observed. The precise functional 
impact of proprioceptive axon disruption 
has yet to be determined. 
6.3 Contusive spinal cord injury 
using the Inﬁnitive Horizon 
Impactor device
In addition, a contusion injury model was 
used in which a blunt spinal cord trauma 
in adult rats is induced at thoracal level by 
employing the computer-controlled Inﬁnite 
Horizon (IH) spinal cord injury device (Pre-
cision Systems & Instrumentation, Lexing-
ton, USA). The IH impactor allows the ex-
ecution of a deﬁned force on the exposed 
surface of the spinal cord that leads to a 
reproducible and well-deﬁned contusion 
injury 158. Unlike the used wire-knife lesion 
model, a severe contusion injury at thora-
cal level induces lasting behavioral deﬁcits 
and thus allows the assessment of behav-
ioral data such as the locomotor ability 
150. Furthermore, the more clinical relevant 
nature of the contusion injury allows the 
pathomorphological comparison between 
the animal model and injured patients. 
Reproducibility is often problematic with 
contusion injury models. However, since 
the IH impactor is equipped with a force-
feedback impounder and uses a deﬁned 
force rather than displacement to deﬁne 
the severity of the contusion injury, highly 
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Figure 4: Schematic representation of the used cervical dorsal column transection model. (A) In rats, the 
corticospinal tract axons (red) project in the spinal cord through a crossed dorsal component that contains 
95% of the axons and an ipsilateral ventral component containing less than 5% of all CST axons.  Additionally, 
there exists a minor dorsolateral component of the CST, containing less than 2% of CST axons. Strikingly, the 
main part of crossed portion of the CST ﬁbers in humans is located in the dorsolateral component of the CST. 
The other ﬁbers in the dorsal column (Blue) represent ascending collaterals of the primary sensory afferents 
and ascending projections of spinal neurons projecting to other segments to the spinal cord. (B) In the used 
SCI model, a small dural incision is made and the wire knife device is stereotactically lowered into the spinal 
cord parenchyma. At the correct depth, the tungsten wire is extruded, forming a wire arch below the dorsal 
CST. (C) Subsequently, the wire knife device with the extruded wire is raised until the tip of the wire is visible, 
transecting a large part of the dorsal columns, while leaving the dura intact. (D) Directly following the lesion, 
cellular grafts can be injected into the lesion defect through a pulled glass capillary. 
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reproducible injuries can be induced using 
this device 158. 
7. AIM OF THIS THESIS
The aim of this thesis was to investigate 
the capacity of grafts of adult derived neu-
ral progenitor cells (NPC) to induce struc-
tural regeneration and contact-mediated 
axon guidance in the injured spinal cord. 
Therefore, the properties of NPC grafts 
were carefully studied in small animal 
models of SCI. Furthermore, the isolation 
of autologous cell material and the ability 
to genetically modify NPC using viral vec-
tors was investigated. Finally, non-invasive 
imaging in small animal models of SCI 
was investigated in order to facilitate fu-
ture studies in which the potential of NPC 
grafts to induce functional regeneration in 
the injured spinal cord is tested.
In Chapter 2, we describe the isolation of 
NPC, survival, differentiation and tissue 
replacement capacity after transplantation 
into the acutely lesioned spinal cord. After 
having determined that NPC grafts require 
a supporting matrix to replace cystic lesion 
defects, we developed a co-transplanta-
tion protocol using NPC and syngenic skin 
ﬁbroblasts, which is described in chapter 
3. Subsequently, Schwann cells, which 
not only replace cystic lesion defects, but 
also have intrinsic regeneration promoting 
capabilities, were studied. In chapter 4a, 
we describe a fast and efﬁcient method to 
purify adult Schwann cell from peripheral 
nerve homogenates for autologous cell 
therapy. Co-transplantation of NPC with 
Schwann cells is described in chapter 4b. 
The overexpression of ectopic genes using 
ex vivo gene therapy has been shown to 
represent a promising tool to augment the 
regenerative potential of grafted cells in a 
cellular therapy approach, e.g. by overex-
pressing growth factors. Experiments in-
vestigating the applicability of ex vivo gene 
therapy using adult derived NPC are de-
scribed in chapter 5. In order to enable the 
monitoring of NPC induced regeneration in 
future studies, non-invasive imaging tech-
niques need to be developed that allow in 
vivo imaging of neuropathological changes 
in small animal models of SCI. Therefore, 
high-resolution magnetic resonance imag-
ing of spinal cord injured rats was studied 
in chapter 6. Finally, in chapter 7, the pre-
sented studies are discussed in respect to 
their potential to promote functional axonal 
regeneration after SCI.
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Adult neural progenitor cell grafts survive after 
acute spinal cord injury and integrate along 
axonal pathways
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1. INTRODUCTION
The traumatic lesion of the mammalian 
spinal cord is followed by the degenera-
tion of spinal cord speciﬁc cells such as 
astroglia, oligodendroglia and neurons 
in and around the lesion site. Ultimately 
a cystic lesion defect will persist, which, 
besides the lack of growth promoting 
molecules and the upregulation of growth 
inhibitory components 1-4, represents a 
key factor impeding the regeneration of 
injured axons. The extent of intrinsic cell 
renewal alone 5, even after application 
of mitogenic agents such as epidermal 
growth factor (EGF) and ﬁbroblast growth 
factor 2 (FGF-2) 6, 7, is not sufﬁcient to al-
low substantial recovery following spinal 
cord injury 8. Therefore, exogenous cell 
replacement strategies have to be con-
sidered.
Ideally, cellular candidates for trans-
plantation should be able to replace the 
function of astrocytes, which build the 
cellular scaffold of the spinal cord paren-
chyma and may provide guidance cues 
for regenerating axons, and oligoden-
drocytes, which myelinate axons, thus 
allowing proper nerve conduction. The 
replacement of neurons is negligible in 
spinal cord injury, since only neurons at 
the injured segmental level are lost and 
therefore contribute only minimally to the 
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functional deﬁcits observed after spinal 
cord injury. The use of cellular grafts as 
vehicles to locally deliver growth promot-
ing molecules is desirable. Various cell 
types such as ﬁbroblasts, Schwann cells 
and olfactory ensheathing cells have been 
analyzed for their regenerative capacity 
after transplantation into the injured spinal 
cord 9-14. Cell based therapies were able 
to substitute for the loss of glial cells to 
some degree and to mediate the applica-
tion of growth promoting factors, howev-
er, structural and functional recovery was 
moderate at best.
Organotypic cell replacement can be 
achieved with neural progenitor cells 
(NPC). NPC from embryonic as well as 
adult central nervous system (CNS) tissue 
have the capacity for self-renewal and 
multipotency 15, 16. After delayed trans-
plantation of embryonic derived NPC 
into the injured rat spinal cord differen-
tiation into glial and neuronal lineages as 
well as modest functional improvement 
have been reported 17-19. However, ethi-
cal concerns and the limited availability 
restrict the large-scale use of embryonic 
derived NPC. To prevent rejection of al-
logenic embryonic cells after transplanta-
tion, suppression of the host immune sys-
tem is required, which represents another 
major disadvantage of embryonic derived 
neural cell grafts. In contrast, the patients’ 
own cells could be utilized to obtain adult 
NPC, thus avoiding issues regarding 
chronic immunosuppression and ethical 
concerns, as they would apply for embry-
onic cell sources. Transplantation of adult 
NPC into the intact spinal cord of adult 
rats revealed that grafted cells survived, 
migrated over considerable distances 
within the spinal cord and differentiated 
into astroglial and oligodendroglial cells 
20. Subventricular zone derived adult NPC 
survived after delayed transplantation (at 
least 7 days after the injury) into the spinal 
cord parenchyma surrounding the spinal 
cord injury site 21. Grafted adult NPC dif-
ferentiated into astroglial lineages; oligo-
dendroglial and neuronal differentiation 
was not observed in the lesion condition. 
The aim of the present study was to de-
termine whether adult spinal cord derived 
NPC will survive transplantation directly 
into the acutely injured spinal cord lesion 
site, replace degenerated spinal cord pa-
renchyma and promote regeneration of 
selectively disrupted corticospinal tract 
(CST) axons.
2. MATERIALS AND METHODS
2.1 Animal subjects
 Adult female Fischer 344 rats weighing 
160-180 g were used as donors for the 
isolation of NPC and for the transplanta-
tion experiments. All experiments were 
carried out in accordance with the Eu-
ropean Communities Council Directive 
(86/609/EEC) and institutional guidelines. 
All efforts were made to minimize the num-
ber of animals used and their suffering. 
2.2 Preparation of adult NPC
Rats were deeply anesthetized using a 
cocktail of ketamine (62.5 mg/kg; WDT, 
Garbsen, Germany), xylazine (3.175 
mg/kg; WDT, Garbsen, Germany) and 
acepromazine  (0.625 mg/kg, Sanoﬁ-
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Ceva, Düsseldorf, Germany) in 0.9% ster-
ile saline solution and killed by decapita-
tion. The region of the complete cervical 
enlargement (spinal cord level C3 through 
T1) was dissected out. After removal of 
the dura, the tissue was minced, washed 
in sterile Dulbecco’s phosphate buffered 
saline/D-glucose (4.5 g/l; PAA Labora-
tories, Linz, Austria) and digested in a 
solution of papain (0.01%; Worthington 
Biochemicals, Lakewood, USA), neu-
tral protease (0.1%; Roche, Mannheim, 
Germany), DNase I (0.01%; Worthington 
Biochemicals) and 12.4 mM MgSO4, dis-
solved in Hank’s balanced salt solution 
(HBSS; PAA Laboratories, Linz, Austria) 
for 30 min at 37°C. The digested tissue 
was centrifuged at 120 x g for 5 min at 4°C 
and washed three times in DMEM-HAMS 
F12 (Pan Biotech, Aidenbach, Germany), 
supplemented with 10% fetal calf serum 
(FCS; Pan Biotech, Aidenbach, Germany). 
The cells were transferred to culture dish-
es containing serum-free growth medium, 
which consists of Neurobasal medium 
with B27 supplement (both Gibco, Karl-
sruhe, Germany) and 20 ng/ml recombi-
nant human FGF-2 (R&D System, Wies-
baden, Germany). Neurobasal medium 
with B27 supplement has been shown to 
substantially increase the proliferation rate 
of NPC in vitro 22 as compared to stan-
dard proliferation medium consisting of 
DMEM/F12 and N2 supplement 23, 24. Cells 
were either grown as neurospheres in un-
coated cell culture ﬂasks or as adherent 
monolayers in culture ﬂasks, which were 
coated as follows: ﬂasks were incubated 
with 20 µg/cm2 poly-l-ornithine (Sigma) in 
distilled H2O for 2 h at 37°C, rinsed and 
incubated with 0.4µg/cm2 laminin (Sigma) 
in PBS for 2 h at 37°C. The cell culture 
medium was changed twice per week. In 
neurosphere cultures, the medium was 
replaced by centrifuging the medium con-
taining neurospheres at 120 x g for 5min 
at 4°C, removing the supernatant and re-
suspending the cells in fresh growth me-
dium. Cell cultures were passaged in 2 
week intervals. Monolayer cultures were 
detached by incubation with 40 ml/cm2 
Acccutase  (Innovative Cell Tech, San 
Diego, USA) for 5min at 37°C. Finally, the 
cells were centrifuged at 120 x g for 5min 
at 4°C and resuspended in fresh growth 
medium. Passaging of neurospheres was 
performed as follows: the medium con-
taining the neurospheres was collected in 
a 15 ml centrifuge tube and centrifuged 
at 120 x g for 5min at 4°C. The pellet was 
resuspended in 1 ml of Accutase™ and 
incubated at 37°C for 10 min. The neuro-
spheres were resuspended in growth me-
dium, triturated and centrifuged at 120 x g 
for 5 min at 4°C. After counting an aliquot 
of the resulting single cell suspensions in 
a hemocytometer, 3000 cells/cm2 were 
plated in fresh growth medium.
2.3 Retroviral transduction of adult 
NPC
Adult NPC were genetically modiﬁed to 
express the reporter gene green-ﬂuo-
rescent protein (GFP) as previously de-
scribed for Schwann cells and ﬁbroblasts 
13, 25. The coding sequence for GFP was 
cloned into the multiple cloning site of the 
Moloney leukemia virus-derived retroviral 
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vector pLXSN (Clontech, Heidelberg, Ger-
many). The 293T cell line based Phoenix 
amphotrophic producer cells (Gary Nolan, 
Stanford, USA) were grown in DMEM me-
dium supplemented with 10% FCS and 
transfected with the retroviral construct. 
After two days, the virus-containing me-
dium was collected, ﬁltered through a 
0.45 µm syringe ﬁlter and stored at -80°C. 
The resulting virus contained the neomy-
cin resistance gene under control of the 
SV40 promoter and the GFP transgene 
under control of the constitutively active 
Moloney murine sarcoma virus-derived 5’ 
LTR promoter sequences. 
Adult NPC taken from passage number 
6 neurospheres were split 1:3 one day 
before transduction. The cells were in-
cubated for 8 h on two consecutive days 
with retrovirus containing growth medium 
supplemented with 1 µg/ml Polybrene 
(Sigma). To select for cells, which integrat-
ed the retroviral vector, G418 (500 µg/ml; 
Gibco Karlsruhe, Germany) was added to 
the growth medium. Successful incorpo-
ration of the transgene was conﬁrmed by 
detection of GFP using an inverted ﬂuo-
rescence microscope (Olympus IX 70). 
2.4 In Vitro immunocytochemistry 
To obtain monolayer cultures, neuro-
spheres of established cultures were dis-
sociated using Accutase (Innovative Cell 
Tech, San Diego, USA) and plated on 
poly-l-ornithine/laminin (P-Orn/Lam, Sig-
ma) coated glass coverslips. To induce 
differentiation, the cells were incubated 
for 7 days in medium, in which FGF-2 was 
replaced by 1% FCS (Pan Biotech, Aiden-
bach, Germany). 
The following antibodies were used to 
analyze the differentiation pattern of adult 
NPC in vitro: mouse-anti-nestin for pro-
genitor/stem cells (Pharmingen, Heidel-
berg, Germany; at 1/1000), mouse-anti-
GFAP for astroglia (Chemicon, Hofheim, 
Germany; at 1/600), mouse-anti-GalC 
for oligodendroglia (Chemicon, Hofheim, 
Germany; at 1/500) and mouse-anti-beta-
III-tubulin for neurons (clone TUJ1; Babco, 
Richmond, USA; at 1/500).  
Cells were washed three times with tris-
buffered saline (TBS) after ﬁxation with 4% 
paraformaldehyde in PBS, blocked with 
TBS containing 3% donkey serum/0,1% 
Triton-X (Sigma) and incubated overnight 
with the primary antibody in TBS + 3% 
donkey serum + 0.1% Triton-X at 4°C. 
The following day, cells were washed 
with TBS and incubated with rhodamine-
X linked secondary donkey-anti-mouse 
antibodies (Jackson, Hamburg, Germany; 
at 1/1000) in TBS + 3% donkey serum + 
0.1% Triton-X for 2h. Finally, nuclei were 
counterstained with Hoechst 33342 (2 µg/
ml in TBS; Sigma). The coverslips were 
mounted onto glass slides using Prolong-
Antifade (Molecular Probes, Leiden, Neth-
erlands). For the immunocytochemical 
analysis, 8 bit monochrome pictures were 
taken at 20x magniﬁcation on a ﬂuorescent 
microscope (Leica DMR) equipped with a 
Spot CCD camera model 2.2.1 (Diagnos-
tic Instruments, Sterling Heights, USA). 
Three independently performed immu-
nocytochemical stains were analyzed in 
expansion and differentiation conditions. 
Immunoreactive cells were determined in 
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5 random ﬁelds per immunocytochemical 
stain in relation to all cells present within 
the ﬁeld (= number of Hoechst counter-
stained nuclei). 
2.5 Preparation of adult NPC for 
transplantation
Adult NPC, either retrovirally transduced 
to express the reporter gene GFP as 
described above (NPC-GFP) or incu-
bated 48h before transplantation with a 
1µM solution of the proliferation marker 
bromodeoxyuridine (BrdU; Sigma) in the 
growth medium (NPC-BrdU), were trans-
planted. To control for the stable expres-
sion of the GFP reporter gene, a subgroup 
of adult GFP expressing NPC was prela-
beled with BrdU (NPC-GFP/BrdU). The 
respective cells, kept as neurospheres in 
uncoated cell culture ﬂasks, were cut into 
fragments (average size 200µm) using a 
McIlwain Tissue Chopper (Mickle Engi-
neering, Gomshall, United Kingdom) 26. To 
estimate the number of adult NPC, three 
samples (100µl each) from uncoated cell 
culture ﬂasks containing the neurosphere 
fragments were taken and dissociated 
with Accutase (Innovative Cell Tech, San 
Diego, USA). The resulting single cell sus-
pension was stained with Trypan Blue 
(Sigma) and counted using a Neubauer 
hemocytometer. The remaining neuro-
sphere fragments were washed twice and 
resuspended in PBS to yield the ﬁnal con-
centration of 1.6-1.8 x 105 cells/µl ready 
for transplantation. 
2.6 Surgical procedures
Animals were anesthetized using a cock-
tail of ketamine, xylazine and aceproma-
zine as described above. Spinal cord dor-
sal column transections at cervical level 
C3 and anterograde labeling of the CST 
were performed as previously described 
27, 28. 
After a stereotactically guided transection 
of the dorsal CST with a tungsten wire 
knife (David Kopf Instruments, Tujuna, 
USA) at cervical level C3, a total volume 
of 3 µl cell suspension containing 4.8-5.4 
x 105 cells (n=8 NPC-BrdU; n=8 NPC-
GFP; n=4 NPC-GFP/BrdU) was inject-
ed directly into the lesion site through a 
pulled glass micropipette (200µm internal 
diameter) using a Picospritzer II (General 
Valve, Fairﬁeld, USA). Animals receiving 
spinal cord lesions without cell transplan-
tation (n=6) served as controls. Superna-
tant from the last washing step after BrdU 
incubation was injected into 2 animals 
Table 1: Immunohistochemical Markers for Adult NPC Differentiation
Neural progenitor cells Nestin (Pharmingen)
Glial precursor cells NG2 (B. Stallcup)
Radial glia BLBP (N. Heintz)
Astroglia GFAP (DAKO)
Oligodendroglia GalC (Chemicon), APC (Oncogene)*
Neurons Beta-III-tubulin, (Babco, Promega)
GalC was used for detection of oligodendroglial differentiation in vitro only. In vivo only cells, which were 
APC positive and at the same time GFAP negative, were classiﬁed as oligodendroglia.
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(3µl per animal) to control for extracellular 
BrdU contamination in the cell suspen-
sion, which would produce unspeciﬁc la-
beling of proliferating host cells. 
For anterograde tracing of the CST pro-
jections, 300 nl of a 10% solution of bioti-
nylated dextran-amine (BDA; 10.000 MW, 
Molecular Probes, Leiden, Netherlands) 
was injected through pulled glass micro-
pipettes (40 µm internal diameter) into 
each of 18 sites per hemisphere spanning 
the rostrocaudal extent of the rat forelimb 
and hindlimb sensorimotor cortex using 
a PicoSpritzer II 27 1 week post lesioning/
grafting. 
2.7 Morphological analysis
At 3 weeks post lesioning/grafting, ani-
mals were transcardially perfused with 
a 0.9% saline solution followed by 4% 
paraformaldehyde in PBS. Sagittal 35µm 
cryostat sections were processed for vi-
sualization of the BDA-labeled CST and 
for immunohistochemistry.  Every seventh 
section was taken for Nissl staining to de-
termine the cystic lesion size. 
Double/triple labeling immunoﬂuores-
cence techniques were performed to as-
sess cell survival, differentiation pattern 
and interaction of grafted adult NPC with 
injured CST axons. The following primary 
antibodies were used:  rabbit-anti-BLBP 
(for radial glia; generous gift N. Heintz, 
Rockefeller University, New York, USA; at 
1/1000), rabbit-anti-GFAP (for astrocytes; 
DAKO, Glostrup, Denmark; at 1/200), 
mouse-anti-APC (for oligodendrocytes, 
Oncogene, Darmstadt, Germany; at 
1/1000), mouse-anti-beta-III-tubulin (for 
neurons; Promega, Mannheim, Germany; 
at 1/100) and rabbit-anti-NG2 (for glial re-
stricted precursor cells; generous gift B. 
Stallcup, Burnham Institute, La Jolla, USA; 
at 1/500), all visualized using rhodamine-
X linked donkey secondary antibodies 
(Jackson, Hamburg, Germany; at 1/1000). 
BrdU-prelabeled grafted cells were identi-
ﬁed with a rat-anti-BrdU antibody (Harlan 
SeraLab, Loughborough, UK; at 1/500) vi-
sualized using ﬂuorescein linked donkey 
secondary antibodies (Jackson, Ham-
burg, Germany; at 1/1000). GFP express-
ing grafted NPC were visualized by using 
a rabbit-anti-GFP antibody (Molecular 
Probes, Leiden, Netherlands; at 1/750). 
To assess the number of dividing grafted 
NPC double immunoﬂuorescence label-
ing was performed with the proliferation 
marker mouse-anti-Ki-67 (Dianova, Ham-
burg, Germany; at 1/50). 
Sections were rinsed in TBS (0.1M), in-
cubated in TBS + 3% donkey serum + 
0.1% Triton-X for 1h, then transferred into 
the ﬁrst primary antibody and incubated 
overnight at 4°C on a rotating platform. 
For visualization of BrdU-prelabeled adult 
NPC the staining protocol was modiﬁed 
as follows: after rinsing in TBS, sections 
were incubated for 1h in 50% formamide/
2xSSC (0.3 M NaCl, 0.03M sodium citrate) 
at 65ºC. Sections were rinsed in 2xSSC, 
incubated for 30min in 2 N HCl at 37ºC, 
and rinsed for 10min in 0.1 M boric acid 
pH 8.5.  After rinsing in TBS, the proto-
col continued with the incubation in TBS 
+ 3% donkey serum + 0.1% Triton-X as 
described above. The following day, sec-
tions were rinsed and incubated with ﬂuo-
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rescence (rhodamine-X, ﬂuorescein, Cy5) 
conjugated secondary donkey antibodies 
(Jackson, Hamburg, Germany; at 1/1000) 
for 2.5 h. BDA-labeled CST axons were 
visualized by incubation with Cy5-conju-
gated streptavidin (Jackson, Hamburg, 
Germany; at 1/1000).  After a ﬁnal rins-
ing step in TBS, sections were mounted 
onto glass slides and coverslipped with 
ProLong Antifade Kit (Molecular Probes, 
Leiden, Netherlands). Immunohistochemi-
cal analysis was performed with a confocal 
ﬂuorescence microscope (Leica TCS-NT). 
Co-localization of BrdU prelabeled NPC 
with the individual differentiation marker 
was determined by analyzing between 
15-20 optical sections through the z-axis 
of a 35 µm thick section. Co-localization 
was conﬁrmed, once the differentiation 
marker was spatially associated to BrdU 
nuclear labeling through subsequent opti-
cal sections in the z-axis. For brightﬁeld 
microscopic immunohistochemical analy-
sis of BDA-labeled CST axons, sections 
were incubated overnight with avidin bio-
tinylated peroxidase complex (Vector Elite 
Kit, Vector Laboratories, Wertheim, Ger-
many; at 1/1000) with TBS, followed by 
treatment for 5min with a 0.05% solution 
of 3,38-diaminobenzidine, 0.01% H2O2, 
and 0.04% nickel chloride in TBS (brown-
black reaction product). 
The cystic lesion size was assessed on 
serial sagittal Nissl stained sections in 210 
µm intervals. Images containing the cystic 
lesion area were captured at 5x magniﬁ-
cation on a Leica DMR microscope with 
a Spot CCD camera model 2.2.1 (Diag-
nostic Instruments, Michigan, USA). The 
lesion area was determined by measuring 
the number of pixels within cystic lesion 
areas using NIH Image software (version 
1.62), which was converted into mm2. Re-
generative responses of CST axons were 
determined by looking for BDA-labeled 
and DAB visualized axonal proﬁles reach-
ing into the cystic lesion center or ven-
trally around it using a LEICA DMR micro-
scope at 40x magniﬁcation in one sagittal 
section per animal going through the main 
part of the dorsal CST.
3. RESULTS
3.1 In vitro characterization of adult 
NPC 
The aim of the in vitro analysis in the pres-
ent study was to validate the differentiation 
pattern in comparison to previous studies 
20, 23, and to determine whether retroviral 
gene transfer may cause a shift in the dif-
ferentiation pattern of FGF-2 responsive 
adult NPC. Cells, which were isolated 
from the adult rat spinal cord at cervical 
level and plated as monolayers on P-Orn/
Lam coated glass coverslips, appear as 
typical uniform small cells with thin pro-
cesses (Fig. 1A). Cells maintained in un-
coated culture ﬂasks form three-dimen-
sional cell conglomerates (neurospheres) 
(Fig. 1B). After introducing the reporter 
gene GFP into NPC using a retroviral vec-
tor, which drives GFP expression by a 5’ 
long terminal repeat promoter, transgene 
expression is detectable in vitro over at 
least 6 passages and a 2 months period 
(Fig. 1C). 
In proliferation conditions using FGF-2, 
NPC primarily express nestin (19.9% ± 
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6.7) indicating the presence of undifferen-
tiated cells, and the early neuronal marker 
beta-III-tubulin (18.1% ± 1.7). No cells are 
found with antigenic properties of astro-
glia (GFAP expression) or oligodendroglia 
(GalC expression) (Fig. 2, 3A). After incu-
bation of NPC with 1% FCS instead of 
FGF-2 (differentiation condition) for one 
week, nestin immunoreactive cells disap-
pear completely, whereas cells immuno-
reactive for the oligodendroglial marker 
GalC increase signiﬁcantly (15.0% ± 6.5), 
indicating a shift from undifferentiated to-
wards differentiated cells. The detection 
of early neuronal antigenicity (beta-III-tu-
bulin) is unchanged in differentiation me-
dium (21.2% ± 3.1). The yield of GFAP ex-
pressing cells indicating astroglial differ-
entiation remains low (0.8% ± 0.2), even 
in differentiation medium (Fig. 2, 3B). 
Quantitative analysis of cell differentiation 
after the introduction of the reporter gene 
GFP through a retroviral vector diluted in 
serum-containing supernatant reveals no 
signiﬁcant changes compared to unmodi-
ﬁed NPC in both, proliferation and differ-
entiation conditions. There is a tendency 
for decreased neuronal antigenicity in 
GFP transgenic NPC (beta-III-tubulin ex-
pression 10.4% ± 3.3), which is not signif-
icantly different compared to unmodiﬁed 
NPC (p=0.073) (Fig. 3). 
3.2 Survival, proliferation, transgene 
expression and differentiation of 
adult NPC in vivo
Adult NPC, either prelabeled with BrdU 
in vitro or genetically modiﬁed to express 
the reporter gene GFP, were transplanted 
as small neurosphere suspensions right 
after a cervical wire knife dorsal column 
transection directly into the injury site. At 3 
weeks post injury/transplantation, detailed 
morphological analysis was performed. 
NPC readily survive following transplanta-
tion into the acutely injured spinal cord as 
Figure 1: Isolation and genetic modiﬁcation of adult NPC in vitro. NPC isolated from the adult cervical 
spinal cord were grown (A) as monolayers attached to P-Orn/Lam coated surfaces or (B) as free-ﬂoating 
neurospheres. Phase contrast micrograph. (C) Fluorescence microscopic analysis of the same neurosphere 
conﬁrms a high transduction efﬁcacy of adult NPC, which have been genetically modiﬁed to express GFP 
using a retroviral vector. Scale bar A 50µm, B, C 75µm.
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Figure 2: Differentiation pattern of adult NPC in vitro. The typical immunocytochemical appearance of adult 
NPC in vitro is exempliﬁed for nestin and beta-III-tubulin in proliferation conditions (FGF-2 added) (A-F), 
whereas cells expressing GFAP or GalC are shown in differentiation conditions (1% FCS added) (G-L). (A-
C) Nestin for neural stem/progenitor cells, (D-F) beta-III-tubulin (clone TUJ1) for neurons, (G-I) GFAP for 
astroglial cells and (J-L) GalC for oligodendroglia. All differentiation markers are shown in red. Merging of the 
differentiation markers and GFP (shown in green) conﬁrm the transgene expression in undifferentiated (C) and 
differentiated cells (F, I, L). Hoechst 33342 as nuclear counterstain (shown in blue). Scale bar A-L 20 µm. 
47
Chapter 2
indicated by the widespread detection of 
BrdU-prelabeled cells. NPC are found pre-
dominantly in a dense rim surrounding the 
cystic lesion and along the central canal 
(Fig. 4A). NPC detection decreases cau-
dally and rostrally to the lesion site. Cells 
are found up to 3mm away from the lesion 
site in the rostral-caudal direction, con-
ﬁrming their migratory capacity. Almost 
no cells are found ventral to the grafting 
site in the dorsal column suggesting that 
migration in the dorso-ventral direction is 
restricted. BrdU contamination of the NPC 
containing medium can be excluded, be-
cause no BrdU immunoreactivity around 
the injection site is detectable in control 
animals receiving injections of superna-
tant from the last washing step after BrdU 
incubation into the spinal cord (data not 
shown). Injection of neural precursor cells, 
which were killed prior to transplantation 
by freeze-thaw cycles, did not reveal any 
unspeciﬁc BrdU immunoreactivity in host 
cells by means of BrdU washed out from 
dying grafted cells 29. Another concern 
is the uncontrolled proliferation of trans-
planted NPC leading to tumor formation. 
However, there are no signs of swelling 
or change of shape of the spinal cord at 
the transplantation site macroscopically. 
The low proliferation rate of grafted NPC 
is conﬁrmed on the molecular level, since 
very few of the BrdU prelabeled cells are 
found to co-localize with the proliferation 
marker Ki-67 3 weeks after the transplan-
tation (Fig. 4A). 
A control group of animals, which re-
ceived GFP expressing and at the same 
time BrdU-prelabeled NPC (NPC-GFP/
BrdU), allowed to assess the stable trans-
gene expression in adult NPC in vivo as a 
prerequisite for the introduction of thera-
peutic transgenes in subsequent studies. 
After 3 weeks post transplantation, GFP 
expression is dramatically downregulated 
as indicated by the low number of GFP 
positive cells in contrast to the abundance 
of BrdU prelabeled transplanted NPC 
(Fig.4B). The detection of BrdU prelabeled 
NPC excludes the possibility that a lack 
Figure 3: Quantitative analysis of the differentiation pattern of adult NPC in vitro. (A) Adult NPC maintained 
in proliferation conditions with FGF-2 or (B) differentiation conditions with 1% FCS. The error bars reﬂect the 
standard error of the mean. 
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of cell survival is responsible for the poor 
expression of GFP in vivo.
Grafted NPC display antigenic properties 
of glial precursor cells (NG2), radial glial 
cells (BLBP), astroglia (GFAP) and oligo-
dendroglia (APC) as conﬁrmed by co-lo-
calization with BrdU prelabeled grafted 
NPC (Fig. 5A-L). None of the grafted NPC 
are identiﬁed to display antigenic proper-
ties of neurons (Fig. 5M-O), even though 
beta-III-tubulin expressing NPC are found 
frequently in vitro. 
Most of the differentiation markers used, 
which are either cytoplasmatic (GFAP, 
BLBP, APC, beta-III-tubulin) or extracellu-
lar (NG2), become upregulated in the host 
spinal cord displaying a dense immunore-
activity around the injury site. Combined 
with the fact that BrdU represents a nu-
clear marker to identify grafted cells, it is 
impossible to discriminate in all regions 
unequivocally between co-localization of 
differentiation markers with grafted NPC 
versus resident spinal cord cells, which 
prohibits a thorough quantitative analysis. 
However as a general observation, the 
majority of grafted NPC express antigenic 
properties of radial glia or astroglia, fewer 
cells show immunoreactivity for oligoden-
droglial or glial precursor markers. 
3.3 Replacement of the cystic lesion 
defect
One goal of cellular therapy following 
spinal cord injury is to replace the cystic 
lesion defect, which represents a typical 
Figure 4: Survival, proliferation and transgene expression of grafted NPC in vivo. (A) The majority of 
grafted BrdU prelabeled adult NPC (shown in red) is detected in a rim surrounding the spinal cord lesion 
site. Grafted cells can be detected in decreasing quantities rostral and caudal up to 2 mm away from the 
transplantation site. After 3 weeks post transplantation, almost none of the grafted NPC are co-localized with 
the proliferation marker Ki-67 (shown in green) indicating that the proliferation rate of NPC is rather low after 
mitogen withdrawal and transplantation (arrowheads highlight the central canal). (B) Almost all grafted BrdU 
prelabeled NPC (shown in red) lack GFP expression (shown in green) indicating silencing of the transgene in 
adult NPC 3 weeks after transplantation. Scale bar A 150µm, B 30µm. 
49
Chapter 2
Figure 5: NPC differentiation in vivo. The differentiation pattern of grafted NPC was assessed by determining 
the co-localization of individual glial/neuronal markers (shown in green) and BrdU prelabeling (shown 
in red). Grafted NPC are co-localized with NG2 immunoreactivity representing glial precursor cells (A-C), 
BLBP immunoreactivity for radial glial cells (D-F), GFAP immunoreactivity for astroglial cells (G-I) and APC 
immunoreactivity indicating oligodendroglial differentiation (J-L). APC immunoreactive cells do not co-
express GFAP (shown in blue) conﬁrming the oligodendroglial differentiation. Adult NPC displaying antigenic 
properties of neurons (beta-III-tubulin immunoreactivity) are not identiﬁable (M-O). Confocal ﬂuorescence 
micrographs, scale bar A-C 5µm, D-O 10µm.
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morphological sequel following CNS in-
jury and impedes axonal regeneration. To 
assess whether grafts of adult NPC would 
at least partially reduce the lesion area, 
the cystic lesion compartments were 
quantiﬁed in serial sagittal sections of ani-
mals with lesions only versus animals with 
lesions followed by NPC transplantation. 
The typical triangular to round shape of a 
wire knife dorsal column transection does 
not differ between non-grafted and NPC 
grafted spinal cord injured animals (Fig. 
6A, B). The quantiﬁcation of the cystic 
lesion area in consecutive Nissl sections 
conﬁrmed that, no matter whether ani-
mals receive grafts or not, the cystic le-
sion remains unchanged (Fig. 6C; lesion + 
NPC graft 0.278mm2 ± 0.099; lesion only 
0.281mm2 ± 0.135). 
3.4 Adult NPC grafts and axonal 
regeneration
In the present study, we performed an 
incomplete spinal cord injury lesioning 
speciﬁcally the main dorsal CST at cer-
vical level C3. The immunohistochemical 
analysis of neuroﬁlament expression as 
an unspeciﬁc axonal marker and the vi-
sualization of anterogradely BDA-labeled 
CST axons were employed to determine 
the spatial association of grafted NPC 
and injured axons. After 3 weeks of trans-
plantation, processes from GFP express-
ing NPC are aligned along neuroﬁlament 
expressing axons adjacent to the cystic 
lesion area (Fig. 7A). NPC are also iden-
tiﬁed in between BDA-labeled axonal 
proﬁles, with their GFP positive process-
es appearing to be in contact with CST 
axons (Fig. 7B). Whether axons regener-
ate along grafted NPC or whether grafted 
cells migrate towards these axons and 
align along them, cannot be determined. 
Immunohistochemical markers could not 
further specify the phenotype of these 
cells, however, morphologically they ap-
pear as either astroglia or oligodendroglia. 
Compared to animals with lesion only, no 
enhanced regrowth responses of disrupt-
ed CST axons in or around the lesion site 
Figure 6: Lesion size after transplantation of adult 
NPC. Serial sagittal Nissl stained sections through 
the spinal cord injury site do not reveal a decrease 
of the cystic lesion defect after NPC transplantation. 
(A) Animal with lesions only, (B) animal with a spinal 
cord lesion followed by NPC transplantation. (C) 
Quantitative analysis of the cystic lesion size in mm2 
(error bars represent standard error of the mean). 
Scale bar A, B 500µm.
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are observed following NPC transplanta-
tion (Fig. 7C, D). 
4. DISCUSSION
This study demonstrates that syngenic 
adult neural progenitors cells survive 
transplantation into the acutely injured 
spinal cord, differentiate into oligoden-
droglia and astroglia and integrate along 
injured axonal pathways surrounding the 
lesion defect. 
Thus far, studies reported survival of adult 
NPC only after transplantation into the in-
tact spinal cord 20 or after delayed trans-
plantation into the injured spinal cord 21, 
30. Probably the most inhospitable CNS 
environment for any cell graft to survive in 
is an acutely injured area, which is char-
acterized by the initiation of inﬂammatory 
cascades, upregulation of mediators of 
cell death/degeneration and secondary 
ischemic events 31. Whether transplanta-
tion of NPC as small neurosphere frag-
ments instead of single cell suspensions 
contributed to the observed graft survival, 
remains to be determined. Within neuro-
spheres, cell cell contacts remain intact 
and detrimental effects by dissociation 
methods to generate single cell suspen-
sions can be avoided 32. Whether poor 
cell survival in the ﬂuid-ﬁlled lesion cav-
ity or the lack of an extracellular scaffold 
prevented the cyst replacement cannot 
be answered in the present study. Find-
Figure 7: Grafted NPC and axon regeneration. GFP expressing NPC (shown in green) are located in between 
neuroﬁlament expressing axons (shown in red) adjacent to the lesion and appear to align along them (A). 
Similarly, adult NPC are identiﬁed to integrate in between BDA labeled CST axons (shown in red) immediately 
rostral to the lesion site (B). Compared to animals with lesions only (C), animals with lesions and NPC grafts do 
not reveal an increased regenerative response of interrupted CST axons (D). A,B Confocal immunoﬂuorescence 
micrographs, C,D brightﬁeld micrographs. Scale bar A 55mm, B 20mm, C and D 200µm
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ings from studies analyzing the regenera-
tive capacity of embryonic derived neural 
stem cells, which completely ﬁll out the 
cystic spinal cord contusion site 18, sug-
gest that adult NPC may indeed produce 
insufﬁcient extracellular matrix to maintain 
themselves within the lesion cyst (person-
al communication, J.W. McDonald). 
This study provides important insights 
into the regenerative potential of adult 
NPC grafts. Very promising is the obser-
vation that adult NPC migrate and align 
along injured axon pathways caudal and 
rostral to the lesion site. This ﬁnding sug-
gests that they are not sealed off by the 
surrounding host spinal cord, in contrast 
to other cell types used for transplantation 
such as ﬁbroblasts or Schwann cells 9, 13. 
Thus, adult NPC may have the capacity to 
build a continuum between the host and 
the actual graft. In the present study, there 
may have been axon sprouting responses 
around the lesion supported by grafted 
NPC. However, these effects would have 
been marginal at best, since thorough 
qualitative analysis of CST projections 
did not reveal any differences between 
lesioned only and NPC grafted animals. 
Whether adult NPC may provide a cellular 
scaffold for regenerating axons within the 
lesion center, and which glial subpopu-
lation may serve as a cellular scaffold to 
guide growing axons after injury, remains 
to be determined. 
Withdrawal of the mitogen and addition 
of serum resulted primarily in early neuro-
nal (beta-III-tubulin) and oligodendroglial 
(GalC) differentiation in vitro, in contrast to 
very few cells expressing astroglial mark-
ers (GFAP). The already high proportion of 
neuronal antigenicity in proliferation condi-
tions remains unchanged in differentiation 
conditions. It is difﬁcult to validate these 
data by comparing them with previous 
studies 20, 23, 24 since differences in cell cul-
ture conditions (passage number, density 
of plated cells in differentiation assays, se-
rum contents) and immunocytochemical 
analysis make any detailed comparison 
unreliable. The overall differentiation pat-
tern replicates previous ﬁndings, however, 
we detect a higher proportion of neuronal 
antigenicity, which might be attributable 
to the use of Neurobasal medium with 
B27 supplement 22. A systematic analy-
sis of different media and supplements 
inﬂuencing the differentiation pattern of 
subventricular zone derived adult NPC 
in vitro revealed that replacement of B27 
supplement by N2 reduces the neuronal 
antigenicity from 22% to 10%. In line with 
previous studies describing the differen-
tiation pattern of adult NPC in vitro 20, 22, 
only around one third of NPC display glial 
or neuronal immunoreactivity. One has to 
consider that a major proportion of cells 
has not yet fully differentiated to express 
marker of mature cells such as GFAP or 
GalC. This notion is supported by a sub-
sequent experiment, which demonstrates 
that around 50% of adult NPC in vitro 
represent glial precursor cells expressing 
A2B5, both in proliferation and differentia-
tion conditions (M. Vroemen, unpublished 
observation). What becomes clear is that 
the differentiation pattern in vitro has only 
a very limited predictive value for the dif-
ferentiation in vivo. There, NPC differen-
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tiate primarily into astroglial cells, fewer 
into oligodendroglia, none into neurons 
3 weeks after transplantation into the in-
jured spinal cord. As demonstrated by 
others, molecular cues by the host spinal 
cord override the differentiation pattern of 
adult NPC before transplantation 20, 21, 33, 
34. In contrast, embryonic derived neural 
stem cells, predifferentiated in vitro or not, 
display antigenic properties of glial cells 
and neurons following transplantation 
into the spinal cord 17. It is conceivable 
that embryonic and adult derived neural 
stem/progenitor cells show a differential 
response to instructive cues of the graft 
environment. 
This study reports for the ﬁrst time oli-
godendroglial differentiation after trans-
plantation of adult NPC into the injured 
spinal cord. Apparently, adult spinal cord 
derived NPC retain the multipotency to 
differentiate into oligodendroglia and are 
able to recognize respective instructive 
signals by the host spinal cord. Oligoden-
droglial differentiation after transplanta-
tion of adult NPC has been shown previ-
ously, however, cells were grafted into the 
intact spinal cord 20. The only other pub-
lished study, examining the regenerative 
capacity of adult heterotopic subventricu-
lar zone derived NPC after delayed trans-
plantation into the injured spinal cord, did 
not observe oligodendroglial differentia-
tion 21. Differences regarding the region of 
progenitor cell isolation (spinal cord ver-
sus subventricular zone), the propagating 
conditions in vitro (different culture me-
dium or supplements), the timing of trans-
plantation (delayed versus immediately 
after injury) and the analyzing methods 
(different antibodies for oligodendroglial 
differentiation) may all have accounted for 
the observed differences. The presence 
of astroglial differentiation and the lack of 
neuronal differentiation are in accordance 
with previous studies 20, 21. 
The downregulation of transgene expres-
sion in transplanted NPC prohibits not 
only optimal tracking of grafted NPC, 
but in addition, approaches to introduce 
therapeutic genes into NPC need to be 
reconsidered. The phenomenon of down-
regulation or silencing of transgenes in 
undifferentiated cells introduced by retro-
viral vectors has been observed by others 
35. The presence of retroviral silencer ele-
ments, cytosine methylation of CpG sites 
and insufﬁcient promoters are thought 
to contribute to transgene silencing 35, 36. 
More promising approaches to success-
fully genetically modify adult NPC point to 
the use of modiﬁed promoters or different 
viral vectors 36-39. 
Results from the present study demon-
strating, that adult NPC survive trans-
plantation into the acutely injured spinal 
cord, integrate into the host spinal cord 
in close spatial association with injured 
and non-injured CNS axons and differ-
entiate into oligodendroglia and astroglia, 
are very promising. However, investiga-
tions have to be continued before any 
conclusions regarding the regenerative 
capacity of adult NPC in spinal cord in-
jury can be drawn. Adult NPC need to ﬁll 
out the lesion defect to assess their axon 
growth promoting properties. If there is a 
regeneration promoting effect, the ideal 
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cell type, which may provide a scaffold 
for regenerating axons, has to be identi-
ﬁed and speciﬁed. The remyelination by 
grafted adult NPC differentiating into oli-
godendroglial cells has to be assessed. 
Strategies need to be developed to en-
rich favorable glial subpopulations in vi-
tro, which maintain their differentiation 
pattern after transplantation. And ﬁnally, 
considering autologous transplantation 
of adult neural stem cells as a potential 
treatment strategy for spinal cord injured 
individuals, it has to be demonstrated 
that adult NPC can be harvested from the 
individual’s own CNS, expanded and en-
riched in culture and re-implanted into the 
spinal cord lesion site. 
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Adult neural progenitor cells provide a permissive 
guiding substrate for corticospinal axon growth 
following spinal cord injury
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1. INTRODUCTION
Cell-based therapies in the injured spinal 
cord are intended to ﬁll lesion cavities, 
which typically develop at an injury site, 
and to provide a cellular growth condu-
cive substrate for re-growing axons. Vari-
ous cell types such as ﬁbroblasts, olfac-
tory ensheathing cells, Schwann cells and 
neural stem/progenitor cells have been 
used to replace injured spinal cord paren-
chyma, and to elicit axonal regeneration 
1-6. Neural stem/progenitor cells repre-
sent a particularly attractive cell type for 
CNS transplantation, because they al-
low organotypic cellular replacement, 
and may have the capacity to establish 
growth promoting guidance structures, 
thus recapitulating cell-based axon guid-
ance in the developing CNS.  Indeed, time 
course studies in the early postnatal rat 
spinal cord demonstrate that immature 
astrocytes expressing vimentin and GFAP 
might promote the longitudinal outgrowth 
of corticospinal axons 7, 8. In the injured 
peripheral nervous system, cellular guid-
ance plays a key role in promoting axo-
nal regeneration. Schwann cells build a 
longitudinally aligned cellular path, guide 
regenerating axons along their processes, 
and express cell adhesion molecules and 
growth factors in appropriate spatial and 
temporal sequences 9. 
ABSTRACT
Adult neural progenitor cells (NPC) are an attractive source for cell transplantation and 
neural tissue replacement after central nervous system (CNS) injury. Following trans-
plantation of NPC cell suspensions into the acutely injured rat spinal cord NPC survive, 
however, they migrate away from the lesion site and are unable to replace the injury in-
duced lesion cavity. In the present study we examined 1) whether NPC can be retained 
within the lesion site after co-transplantation with primary ﬁbroblasts, and 2) whether 
NPC promote axonal regeneration following spinal cord injury. Co-cultivation of NPC 
with ﬁbroblasts demonstrated that NPC adhere to ﬁbroblasts and the extracellular 
matrix produced by ﬁbroblasts. In the presence of ﬁbroblasts, the differentiation pat-
tern of co-cultivated NPC was shifted towards glial differentiation. Three weeks after 
transplantation of adult spinal cord derived NPC with primary ﬁbroblasts as mixed cell 
suspensions into the acutely injured cervical spinal cord in adult rats, the lesion cavity 
was completely replaced. NPC survived throughout the graft and differentiated exclu-
sively into glial cells. Quantiﬁcation of neuroﬁlament labeled axons and anterogradely 
labeled corticospinal axons indicated that NPC co-grafted with ﬁbroblasts signiﬁcantly 
enhanced axonal regeneration. Both, neuroﬁlament labeled axons and corticospinal 
axons aligned longitudinally along GFAP expressing NPC derived cells, which dis-
played a bipolar morphology reminiscent of immature astroglia. Thus, grafted astroglial 
differentiated NPC promote axon regrowth following spinal cord injury by means of 
cellular guidance. 
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Adult neural progenitor cells (NPC), iso-
lated from the subventricular zone or spi-
nal cord, have been shown to self-renew, 
and to be multipotent in vitro and after 
transplantation into the CNS 10, 11. Follow-
ing transplantation of adult NPC into the 
intact and injured spinal cord, only astro-
glial and oligodendroglial differentiation 
is observed 12-14. Even after transplanta-
tion into the acutely injured spinal cord 
lesion site, adult NPC survive. However, 
grafted NPC migrate completely into the 
surrounding host parenchyma, thus pre-
venting the replacement of the lesion cav-
ity 14. Therefore, studies investigating the 
transplantation of NPC in the injured CNS 
have not been able to determine whether 
adult NPC promote axonal regeneration 
across cystic lesion defects caused by 
spinal cord injury. 
Recently, it has been demonstrated in an 
ischemia model that an additional sup-
porting scaffold such as an artiﬁcial bio-
degradable polymer is required to retain 
transplanted neural stem cells within le-
sion cavities developing after ischemia 
15. Fibroblasts naturally provide a cellular 
and acellular (extracellular matrix produc-
tion) supporting scaffold in various tis-
sues. Following transplantation into the 
injured spinal cord, ﬁbroblasts replace 
cystic lesion defects, however, ﬁbroblasts 
alone are not sufﬁcient to provide a cel-
lular guiding path for injured CNS axon 
pathways such as the corticospinal tract 
(CST) 16-18.
We therefore aimed to investigate if the 
combination of NPC and ﬁbroblasts can 
retain NPC in the lesion site and augment 
axonal growth. Results of the present 
study indicate that NPC grafted togeth-
er with primary ﬁbroblasts to the injured 
spinal cord provide a cellular guiding 
substrate across the lesion cavity and 
enhance the growth of lesioned cortico-
spinal axons.
2. MATERIALS AND METHODS
2.1 Animals
Adult female Fischer 344 rats (160-180 
g) were used for the isolation of NPC and 
ﬁbroblasts. All experiments were carried 
out in accordance with the European 
Communities Council Directive (86/609/
EEC) and institutional guidelines. All ef-
forts were made to minimize the number 
of animals used and their suffering. Ani-
mals had ad libidum access to food and 
water throughout the study. All surgical 
procedures were performed under an-
esthesia with a combination of ketamine 
(62.5 mg/kg; WDT, Garbsen, Germany), 
xylazine (3.175 mg/kg; WDT, Garbsen, 
Germany) and acepromazine (0.625 mg/
kg, Sanoﬁ-Ceva, Düsseldorf, Germany) in 
0.9% sterile saline solution. 
2.2 Preparation of Adult NPC and 
ﬁbroblasts
Rats were deeply anesthetized as de-
scribed above and killed by decapitation. 
The cervical enlargement (spinal cord lev-
el C3 through T1) was dissected and the 
dura removed. The tissue was minced, 
washed in sterile Dulbecco’s phosphate 
buffered saline/D-glucose (4.5g/l; PAA 
Laboratories, Linz, Austria) and digested in 
a solution of papain (0.01%; Worthington 
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Biochemicals, Lakewood, USA), neutral 
protease (0.1%; Roche, Mannheim, Ger-
many), DNase I (0.01%; Worthington Bio-
chemicals) and 12.4mM MgSO4, dissolved 
in Hank’s balanced salt solution (HBSS; 
PAA Laboratories, Linz, Austria) for 30 min 
at 37°C. The tissue was centrifuged at 
120 x g for 5 min at 4°C and washed three 
times in DMEM-HAMS F12 (Pan Biotech, 
Aidenbach, Germany) supplemented with 
10% fetal calf serum (FCS; Pan Biotech, 
Aidenbach, Germany). The cells were 
transferred to culture dishes containing 
serum-free growth medium, consisting of 
Neurobasal medium with B27 supplement 
(Gibco, Karlsruhe, Germany) and 20 ng/ml 
recombinant human FGF-2 (R&D System, 
Wiesbaden, Germany). Cells were grown 
ﬁrst as neurospheres for 2-3 passages in 
uncoated culture ﬂasks. The medium was 
replaced by centrifuging the medium con-
taining neurospheres at 120 x g for 5 min 
at 4°C, removing the supernatant and re-
suspending the cells in fresh growth me-
dium. For passaging of neurospheres, the 
medium containing the neurospheres was 
collected in a 15 ml centrifuge tube and 
centrifuged at 120 x g for 5 min at 4°C. 
The pellet was resuspended in 1 ml of Ac-
cutase and incubated at 37°C for 10 min. 
The neurospheres were resuspended in 
growth medium, triturated and centrifuged 
at 120 x g for 5 min at 4°C. The resulting 
single cell suspensions were seeded at a 
density of 3000 cells/cm2 in fresh growth 
medium. Cells were passaged every sec-
ond week. For the consecutive 2-3 pas-
sages, NPC were grown as monolayers in 
culture ﬂasks coated with poly-l-ornithine 
(20µg/cm2; Sigma) and laminin (0.4µg/
cm2; Sigma). The cell culture medium was 
changed twice per week. Monolayer cul-
tures were detached by incubation with 
40 ml/cm2 Acccutase (Innovative Cell 
Tech, San Diego, USA) for 5 min at 37°C. 
Finally, the cells were centrifuged at 120 
x g for 5 min at 4°C and resuspended in 
fresh growth medium. 
For the identiﬁcation of NPC co-cultured 
with primary ﬁbroblasts in vitro (see be-
low), NPC were genetically modiﬁed to 
express the reporter gene green-ﬂuores-
cent protein (GFP) using a retroviral vector 
as previously described 14. 
Primary cultures of adult Fischer 344 ﬁ-
broblasts were generated from skin biop-
sies and cultivated under standard culture 
conditions as previously described 5. 
2.3 Preparation of adult NPC for 
transplantation
Adult NPC were incubated with 1 µM bro-
modeoxyuridine (BrdU; Sigma) in growth 
medium for 48 h just before transplanta-
tion. A sample of single cell suspensions 
was stained with Trypan Blue (Sigma) and 
counted using a Neubauer hemocytom-
eter. The remaining single cell suspension 
was washed twice and resuspended in 
PBS to yield a ﬁnal concentration of 0.8 x 
105 cells/µl for co-transplantation of NPC 
and ﬁbroblasts (NPC-FF). Fibroblasts 
were trypsinized and counted in a Neu-
bauer hemocytometer. Cells were washed 
twice and resuspended in PBS to yield 
the ﬁnal concentration of 0.2 x 105 cells/
µl. Fibroblast and NPC suspensions were 
mixed before transplantation. For pure 
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ﬁbroblast grafts (FF), ﬁbroblasts were re-
suspended at a concentration of 0.4 x 105 
cells/µl. Due to the larger cell size of ﬁbro-
blasts this suspension was approximately 
equally dense as the mixed cell grafts. 
2.4 In vitro co-cultures of adult NPC 
and ﬁbroblasts
To study the adhesion behavior of adult 
NPC in the presence of ﬁbroblasts, GFP 
expressing NPC were either kept as neu-
rospheres in T25 ﬂasks in proliferation 
medium either without (pure NPC condi-
tion) or with primary ﬁbroblasts (NPC-FF 
condition). Daily for 7 days after the start 
of co-culturing, the adhesion behavior of 
NPC was monitored using an inverted 
phase contrast and ﬂuorescence micro-
scope (Olympus).  
To analyze the in vitro differentiation of 
NPC, neurospheres of established NPC 
cultures were dissociated using Accutase 
(Innovative Cell Tech, San Diego, USA) 
and seeded on poly-l-ornithine/laminin 
(P-Orn/Lam, Sigma) coated cover slips 
either alone (NPC proliferation condition) 
or together with primary rat ﬁbroblasts at 
a ratio of 1:2 (NPC-FF proliferation con-
dition) for 4 days in serum-free medium 
(Neurobasal medium with B27 supple-
ment and FGF-2 as described above).  In 
parallel, cultures of NPC alone (NPC dif-
ferentiation condition) were incubated in 
medium, consisting of Neurobasal medi-
um, B27 supplement and 1% fetal calf se-
rum (Pan Biotech, Aidenbach, Germany). 
Cells were subsequently ﬁxed with 4% 
paraformaldehyde in PBS and immuno-
labeled using the following antibodies: 
mouse-anti-nestin for progenitor/stem 
cells (Pharmingen, Heidelberg, Germany; 
at 1/1000), mouse-anti-GFAP for astro-
glia (Chemicon, Hofheim, Germany; at 
1/600), mouse-anti-A2B5 for glial precur-
sor cells (Chemicon, Hofheim, Germany; 
at 1/100), mouse-anti-Gal-C for oligoden-
droglia (Chemicon, Hofheim, Germany; at 
1/500) and mouse-anti-beta-III-tubulin for 
neurons (clone TUJ1; Babco, Richmond, 
USA; at 1/500). 
Cells were washed 3 times with tris-
buffered saline (TBS) after ﬁxation, 
blocked with TBS containing 3% donkey 
serum/0.1% Triton-X (Sigma) and incu-
bated overnight with the primary antibody 
in TBS + 3% donkey serum + 0.1% Tri-
ton-X at 4˚C. The following day, cells were 
washed with TBS and incubated with rho-
damine-X linked secondary donkey-anti-
mouse antibodies (Jackson, Hamburg, 
Germany; at 1/1000) in TBS + 3% don-
key serum + 0.1% Triton-X for 2h. Finally, 
nuclei were counterstained with Hoechst 
33342 (2 µg/ml in TBS; Sigma). The cover-
slips were mounted onto glass slides us-
ing Prolong-Antifade (Molecular Probes, 
Leiden, Netherlands). For the immunocy-
tochemical analysis, 8 bit monochrome 
pictures were taken at 20x magniﬁcation 
on a ﬂuorescent microscope (Leica DMR) 
equipped with a Spot CCD camera model 
2.2.1 (Diagnostic Instruments, Sterling 
Heights, USA). The number of speciﬁ-
cally immunolabeled cells and the total 
cell number (number of Hoechst counter-
stained nuclei) were determined in 5 ran-
dom ﬁelds for each differentiation marker 
to determine the percentage of cells ex-
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pressing the respective differentiation 
marker. Three independently performed 
immunocytochemical stains were ana-
lyzed under expansion and differentiation 
conditions.
2.5 Surgical procedures
Spinal cord lesions, cell transplantation 
and anterograde labeling of the CST were 
performed as previously described 14, 19, 20. 
Cells were grafted immediately post-injury 
to maximize the potential growth respons-
es of corticospinal axons and to ensure 
that the injured tips of corticospinal axons 
are in close proximity to the graft site.
Brieﬂy, the dorsal columns containing the 
dorsal CST were transected at cervical 
level C3 using a tungsten wire knife (David 
Kopf Instruments Tujuna, USA) leaving the 
surrounding dura intact. A total volume of 
3 µl of a cell suspension containing either 
2.4 x 105 NPC (prelabeled with BrdU) com-
bined with 0.6 x 105 ﬁbroblasts (NPC-FF; 
n=8) or 1.2 x 105 ﬁbroblasts only (FF; n=8) 
was injected directly into the lesion site 
through a pulled glass micropipette (100 
µm internal diameter) using a Picospritzer 
II (General Valve, Fairﬁeld, USA). Animals 
receiving spinal cord lesions without cell 
transplantation (LESION; n=6) served as 
controls. 
For anterograde tracing of the CST pro-
jections, 300 nl of a 10% solution of bioti-
nylated dextran-amine (BDA; 10.000 MW, 
Molecular Probes, Leiden, Netherlands) 
was injected through pulled glass micro-
pipettes (40 µm internal diameter) into 
each of 18 sites per hemisphere spanning 
the rostrocaudal extent of the rat forelimb 
and hindlimb sensorimotor cortex using 
a PicoSpritzer II 19 1 week post lesioning/
grafting. 
2.6 Morphological analysis
At 3 weeks post lesioning/grafting, ani-
mals were transcardially perfused with a 
0.9% saline solution in 0.1 M phosphate 
buffer followed by 4% paraformaldehyde 
in 0.1 M phosphate buffer. Sagittal 35 µm 
cryostat sections were processed for vi-
sualization of the BDA labeled CST and 
for immunohistochemistry. Every seventh 
section was mounted for Nissl staining to 
determine the lesion size. 
Double/triple labeling immunoﬂuorescence 
techniques were performed with free ﬂoat-
ing sections to assess cell survival, in vivo 
differentiation pattern, and interaction of 
grafted adult NPC with injured axons. The 
following primary antibodies were used: 
rabbit-anti-BLBP (for radial glia; gener-
ous gift N. Heintz, Rockefeller University, 
New York, USA; at 1/1000), mouse-anti-
GFAP (for astrocytes; DAKO, Glostrup, 
Denmark; at 1/200), mouse-anti-APC (for 
oligodendrocytes, Oncogene, Darmstadt, 
Germany; at 1/1000), rabbit-anti-200 kDa 
neuroﬁlament (axonal marker; Boehringer 
Mannheim, Germany; at 1/250). Immu-
nolabeling was visualized using ﬂuores-
cein linked donkey secondary antibodies 
(Jackson, Hamburg, Germany; at 1/1000). 
BrdU-prelabeled cells were identiﬁed with 
a rat-anti-BrdU antibody (Harlan SeraLab, 
Loughborough, UK; at 1/500) visualized 
using rhodamine X- linked donkey sec-
ondary antibodies (Jackson, Hamburg, 
Germany; at 1/1000). 
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Sections were rinsed in 0.1 M Tris buff-
ered saline (TBS), incubated in TBS + 
3% donkey serum + 0.1% Triton-X for 
1h, then transferred into the ﬁrst primary 
antibody and incubated overnight at 4°C 
on a rotating platform. For visualization of 
BrdU-prelabeled adult NPC the staining 
protocol was modiﬁed as follows: after 
rinsing in TBS, sections were incubated 
for 1h in 50% formamide/2xSSC (0.3 M 
NaCl, 0.03M sodium citrate) at 65ºC. Sec-
tions were rinsed in 2xSSC, incubated for 
30 min in 2 N HCl at 37ºC, and rinsed for 
10 min in 0.1 M boric acid pH 8.5. After 
rinsing in TBS, sections were incubated in 
TBS + 3% donkey serum + 0.1% Triton-
X as described above. The following day, 
sections were rinsed and incubated with 
ﬂuorophor (rhodamine-X, ﬂuorescein, Cy5) 
conjugated secondary donkey antibodies 
(Jackson, Hamburg, Germany; at 1/1000) 
for 2.5 h. BDA labeled CST axons were 
visualized by incubation with Cy5-conju-
gated streptavidin (Jackson, Hamburg, 
Germany; at 1/1000). After a ﬁnal rins-
ing step in TBS, sections were mounted 
onto glass slides and coverslipped with 
ProLong Antifade Kit (Molecular Probes, 
Leiden, Netherlands). 
For brightﬁeld immunohistochemical 
analysis of axon regeneration rabbit-
anti-200-kDa neuroﬁlament (Boehringer 
Mannheim, Germany; at 1/250) was used 
as axonal marker.
Brightﬁeld immunohistochemical analysis 
was performed by incubating free-ﬂoating 
sections for 24 h in primary antibody solu-
tion in TBS containing 5% blocking serum 
and 0.25% Triton X-100; incubation for 1 
h with biotinylated donkey IgG (Dianova, 
Germany; at 1/1000) in TBS containing 
5% blocking serum; 1 h incubation with 
avidin biotinylated peroxidase complex 
(Vector Elite kit; Wertheim, Germany; at 
1/1000) with TBS containing 5% block-
ing serum; development for 3–15 min in 
a 0.05% solution of 3,38-diaminoben-
zidine (DAB), 0.01% H2O2, and 0.04% 
nickel chloride in TBS. For brightﬁeld 
microscopic immunohistochemical analy-
sis of BDA labeled CST axons, sections 
were incubated overnight with avidin bio-
tinylated peroxidase complex (Vector Elite 
Kit, Vector Laboratories, Wertheim, Ger-
many; at 1/1000) with TBS, followed by 
treatment for 5 min with a 0.05% solution 
of DAB, 0.01% H2O2, and 0.04% nickel 
chloride in TBS (brown-black reaction 
product). Tissue sections were mounted 
onto gelatin-coated glass slides, air dried, 
dehydrated and coverslipped with Neo 
Mount (Merck).
Brightﬁeld imaging was conducted on a 
Leica DMR microscope with a Spot CCD 
camera model 2.2.1 (Diagnostic Instru-
ments, Michigan, USA). Confocal im-
munoﬂuorescence microscopy was per-
formed using a Leica TCS-NT system.
2.7 Quantiﬁcation of NPC 
differentiation in vivo
The in vivo differentiation pattern of NPC 
was analyzed by confocal ﬂuorescence 
microscopy (Leica TCS-NT). Co-localiza-
tion of BrdU labeled NPC with differen-
tiation markers was analyzed using 15-20 
optical sections along the z-axis of 35 
µm thick sections at 400x magniﬁcation. 
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Differentiation markers were considered 
co-localized, if they surrounded the nu-
clear BrdU labeling through subsequent 
optical sections in the z-axis. The in vivo 
differentiation pattern was quantiﬁed in 
one section for each differentiation mark-
er by analyzing 2 scans within the graft at 
400x magniﬁcation. The total number of 
BrdU positive cells within each scan was 
counted and correlated to the number of 
BrdU positive cells co-localizing with the 
respective differentiation marker (GFAP, 
BLBP, APC). 
2.8 Quantiﬁcation of axonal 
regeneration
For quantiﬁcation of axon (neuroﬁlament 
labeling) and CST axon proﬁles (BDA la-
beling) within the graft, every eighth sec-
tion out of all sagittal sections per animal 
was processed for the visualization of 
BDA or neuroﬁlament, respectively. Out of 
these sections, the section containing the 
center of the graft was selected for quan-
tiﬁcation of neuroﬁlament labeling, the 
section covering the main portion of the 
dorsal CST was chosen for quantiﬁcation 
of CST regeneration. Digital brightﬁeld im-
ages of neuroﬁlament-DAB or BDA-DAB 
visualized sections were captured using a 
Spot CCD camera, model 2.2.1 (Diagnos-
tic Instruments, Michigan, USA) attached 
to a Leica DMR microscope at 200x mag-
niﬁcation. For the quantiﬁcation of axon 
proﬁles, neuroﬁlament-DAB or BDA-DAB 
positive structures were highlighted by 
marking them in NIH Image 1.62 with a 
digital pen, while going through the z-axis 
of the section, to detect complete label-
ing of neuroﬁlament/BDA positive axons 
throughout the depth of the section. The 
number of pixels representing the marked 
lines was assessed using NIH Image 1.62 
software. To determine the maximum dis-
tance of CST axon regeneration into the 
graft (axon length), the distance between 
the graft host interface and the longest 
axon ending was measured using NIH 
Image 1.62. The graft host interface was 
determined after inserting the transmitted 
light condenser, which allows to discrimi-
nate between the orderly tissue architec-
ture of the host and the randomly orga-
nized cell graft. An observer blinded to 
group identity rated the degree of axonal 
regeneration of each animal.
2.9 Statistical analysis
All data are expressed as mean ± SEM. 
Comparisons between NPC-FF, and FF 
grafted animals were made by nonpara-
metric Mann-Whitney U tests and P<0.05 
was considered signiﬁcant. 
3. RESULTS
3.1 Adhesion and differentiation 
pattern of adult NPC co-cultured 
with ﬁbroblasts.
Previously, we have shown that the trans-
plantation of NPC suspensions is not suf-
ﬁcient to replace the lesion cavity, which 
forms after spinal cord injury 14. To deter-
mine if ﬁbroblasts might be able to pro-
vide a supporting scaffold for NPC in the 
injured spinal cord, we ﬁrst investigated 
the inﬂuences of primary ﬁbroblasts on 
NPC adhesion and differentiation in vi-
tro. Co-cultures of adult GFP expressing 
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NPC and skin-derived ﬁbroblasts were 
prepared on uncoated standard plastic 
culture ﬂasks and compared to pure NPC 
cultures. Consistent with previous reports, 
adult NPC formed free ﬂoating cell con-
glomerates (neurospheres), which did not 
attach to the surface of the plastic culture 
dish (Fig. 1A,B) 14. In contrast, NPC co-
cultured with primary ﬁbroblasts adhered 
to the uncoated plastic surface within 24 
hours (Fig. 1C,D). NPC survived in the 
presence of ﬁbroblasts, were frequently in 
direct contact with ﬁbroblasts and formed 
processes along the ﬁbroblast surface. 
Although NPC/ﬁbroblast co-cultures were 
maintained in serum-free FGF-2-contain-
ing proliferation medium, NPC differenti-
ated into GFAP (31.4% ± 2.7) or Gal-C 
(5.9% ± 0.5) expressing glial cells with the 
respective astroglial and oligodendroglial 
morphology, and beta-III-tubulin (48.9% ± 
1.7) expressing neurons (Fig. 2C-E,H). The 
ﬁnding that the sum of individual differen-
tiation markers exceeds 100% is likely 
due to an overlap between GFAP and 
A2B5 in astroglial/glial precursor cells as 
previously described 21. In contrast, adult 
NPC maintained as pure NPC cultures 
displayed antigenicity and morphology 
of stem/progenitor cells (nestin; 19.2% 
± 0.9), glial precursor cells (A2B5; 41.8% 
± 1.2) and early neurons (beta-III-tubulin; 
22.2% ± 1.8) only (Fig. 2A,B,F). After in-
duction of differentiation in pure NPC cul-
tures by adding FCS instead of FGF-2 for 
4 days (Fig. 2G), nestin expressing cells 
Figure 1: Adherence of NPC co-cultured with primary ﬁbroblasts: (A) Adult NPC spontaneously form free-
ﬂoating neurospheres in uncoated culture ﬂasks. Cells do not adhere to the plastic surface. (B) View of the 
same ﬁeld as (A) under ﬂuorescent illumination demonstrates GFP expression by NPC. (C) Co-cultivation 
of NPC with ﬁbroblasts leads to the adherence of NPC to the plastic surface already after 24 hours either 
independently of surrounding ﬁbroblasts (arrowheads) or directly attached to ﬁbroblasts (arrows). (D) 
Expression of GFP (arrowheads and arrows corresponding to C) identiﬁes the adhering cells as NPC. (A, C) 
phase-contrast microscopy, B, D ﬂuorescence microscopy. Scale bar 64 µm
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disappeared completely and glial precur-
sor cells expressing A2B5 were reduced 
(29.5% ± 1.8). The number of beta-III-tu-
bulin expressing cells increased to 45.9% 
(± 1.4). In contrast to previous studies us-
ing comparable cell culture conditions, 
GFAP and Gal-C expressing cells were 
still absent in differentiation conditions 13, 
14. However, in these studies a longer in-
cubation period in differentiation medium 
(7 days versus 4 days in the present differ-
entiation assay) was chosen. It has been 
suggested that the neuronal marker beta-
III-tubulin is expressed in astroglial cells 
22. However, in a previous experiment we 
did not detect any co-localization in adult 
NPC in vitro in a double immunoﬂuores-
cent analysis with beta-III-tubulin and 
GFAP (unpublished observation). 
Taken together, ﬁbroblasts and extracel-
lular matrix molecules secreted by ﬁbro-
blasts provided a supporting scaffold for 
NPC to adhere to in culture. The presence 
of ﬁbroblasts shifted the differentiation 
pattern of FGF-2 responsive adult NPC 
towards glial phenotypes.
3.2 Cyst replacement, survival and 
cell differentiation 
Pure NPC (4.8-5.4 x 105 cells per graft) 
grafted immediately after a cervical dor-
sal column transection 14 or delayed 1-2 
weeks later (unpublished observation) 
were not sufﬁcient to replace or even 
Figure 2: Differentiation of NPC co-cultivated with ﬁbroblasts: Morphology and immunocytochemical labeling 
of adult NPC in (A, B) pure NPC cultures and (C-E) NPC/FF co-culture conditions in FGF-2-containing 
proliferation medium.  Cells display immunoreactivity for (A) the stem/progenitor marker nestin, (B) the glial 
precursor marker A2B5, (C) the astroglial marker GFAP, (D) the oligodendroglial marker Gal-C, and (E) the 
early neuronal marker beta-III-tubulin (clone TUJ1). All differentiation markers are shown in red, Hoechst 
33342 nuclear counterstaining is shown in blue.  (F-H) Quantiﬁcation of the differentiation pattern of adult 
NPC in vitro 4 days after plating on P-Orn/Lam coated plates:  (F) pure NPC cultures in FGF-2 containing 
proliferation medium, (G) pure NPC cultures in FCS containing differentiation medium and (H) FF-NPC co-
cultures in FGF-2 containing proliferation medium. Scale bar A 5.7 µm, B 6.1 µm, C 8.2 µm, D 10.9 µm, E 
8.2 µm. 
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reduce the cystic lesion defect. To de-
termine whether ﬁbroblasts are able to 
maintain NPC within the lesion site, NPC 
and ﬁbroblasts were co-grafted as mixed 
cell suspension (NPC-FF) directly into 
the lesion site following an acute cervi-
cal wire knife lesion in adult rats. Animals 
receiving lesions without grafting (LE-
SION) or pure ﬁbroblast grafts (FF) served 
as controls. Three weeks post-lesioning, 
animals without transplants developed le-
sion cavities in the dorsal half of the spi-
nal cord.  In contrast, lesion cavities were 
completely replaced in all animals with 
NPC-FF and FF grafts (Fig. 3). Grafts in-
tegrated well into the host parenchyma. 
There were no signs of uncontrolled graft 
proliferation or tumor formation in NPC-
FF and FF grafted animals. Three weeks 
after NPC-FF transplantation, adult NPC 
survived throughout the graft as indicat-
ed by the presence of BrdU labeled NPC 
within the graft (Fig. 4A,C-E), in contrast 
to the absence of BrdU immunoreactiv-
ity in FF grafts (controls) (Fig. 4B). NPC 
were found primarily within the graft, only 
few BrdU labeled NPC were identiﬁable in 
the host parenchyma adjacent to the graft 
(Fig. 4A). NPC were not evenly distributed 
in all NPC-FF co-grafts. In some animals, 
NPC were found in clusters in the center 
of the graft (Fig.4A), in others they were 
found predominantly along the graft-host 
border, but still within the graft (Fig.4C-
E).
BrdU labeled NPC co-grafted with ﬁbro-
blasts displayed antigenic properties of 
astroglial (GFAP positive; 43.5% ± 2.3), 
radial glial (BLBP positive; 44.2% ± 3.5) 
and oligodendroglial cells (APC positive, 
GFAP negative; 17.8% ± 3.1) (Fig. 5). The 
percentage of the individual differentia-
tion markers adds up to more than 100% 
(exactly 105.5%), which is likely due to an 
overlap between GFAP and BLBP in as-
troglial cells as previously described 23. 
Figure 3: Cystic lesion replacement: (A) Three 
weeks following a cervical wire knife dorsal column 
transection a typical triangular shaped cystic lesion 
defect develops in animals without transplantation. 
(B) NPC-FF co-grafts completely replace the cystic 
lesion cavity and integrate into the host spinal 
cord. (C) FF grafts also reduce the lesion defect 
completely. A-C sagittal Nissl stained sections; 
rostral left, dorsal top; scale bar A-C 196 µm.
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The majority of GFAP positive NPC dis-
played bipolar processes rather than mul-
tipolar/stellate processes typically found 
in mature or reactive astrocytes (Fig.5A-
C, 6D-G). Consistent with previous stud-
ies 13, 14, none of the BrdU prelabeled cells 
differentiated into a neuronal phenotype 
as indicated by the lack of beta-III-tubulin 
– BrdU colocalization (data not shown). 
3.3 Axonal regeneration
The maintenance of adult NPC within the 
lesion cavity of NPC-FF co-transplant re-
cipients allowed us for the ﬁrst time to in-
vestigate the capacity of NPC to promote 
axon regeneration into the graft. Axonal 
Figure 4: NPC survival and distribution: (A) Immunohistochemical detection of BrdU prelabeled NPC 
(rhodamine labeled; red) throughout the graft illustrates that NPC co-grafted together with primary ﬁbroblasts 
into the acutely injured spinal cord survive. A signiﬁcant proportion of grafted NPC can be co-localized 
(arrowheads) with GFAP antigenicity (ﬂuorescein labeled; green) indicating glial differentiation. (B) As control, 
BrdU is not detectable within FF grafts, GFAP expression is restricted to the surrounding host spinal cord. 
GFAP expressing processes reach into the ﬁbroblast graft only for a very limited distance. (C-E) The graft-host 
interface is shown at higher magniﬁcation in another NPC-FF grafted animal. (C) GFAP immunolabeled cells, 
(D) BrdU labeled grafted NPC and (E) merged micrograph of (C) and (D). Arrowheads highlight BrdU/GFAP 
co-localizing grafted NPC. Orientation in all micrographs: dorsal is at the top, rostral to the left. Dashed lines 
delineate the graft/host transition. Confocal ﬂuorescence micrograph; scale bar A, B 81,5 µm, C-E 49 µm.
71
Chapter 3
Figure 5: Confocal analysis of NPC differentiation in NPC-FF co-grafts: (A-C) BrdU prelabeled NPC co-
localize with GFAP immunoreactivity (arrowheads). GFAP expressing cells frequently display bipolar elongated 
processes reminiscent of immature or radial glial cells in the developing CNS.  (D-F) NPC are also co-localized 
with BLBP (arrowheads), which is typically expressed in radial glial cells. (G-I) NPC immunoreactive for 
APC and at the same time negative for GFAP (Cy5 labeled; blue) indicate oligodendroglial differentiation 
(arrowheads). The BrdU labeled NPC, co-localized with APC in the center of the ﬁeld, is also co-localized with 
GFAP suggesting astroglial rather oligodendroglial differentiation. (C, F, I) Merged images of the rhodamine, 
ﬂuorescein and Cy5 channels. (J) Quantiﬁcation of BrdU prelabeled NPC co-localized with BLBP, GFAP or 
APC. Scale bar A-C, 27.4 µm, D-F 24.4 µm, G-I 15.9 µm.
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Figure 6: Axonal growth into ﬁbroblast (FF) and NPC/ﬁbroblast grafts (NPC-FF): Representative micrographs 
of neuroﬁlament expressing axonal proﬁles within (A) NPC-FF and (B) FF grafts. Dashed lines delineate the 
graft/host interface. (C) Quantiﬁcation of neuroﬁlament labeling reveals signiﬁcantly more axonal growth 
into co-grafts (p<0.05). Error bars represent SEM. (D) Neuroﬁlament (NF) expressing axons within the graft 
are longitudinally oriented along (E) GFAP labeled cells (highlighted by arrowheads in D, E and G), which 
are colocalized with (F) BrdU prelabeled NPC (highlighted by arrow in G). (G) Merged image of (D-G). (A, 
B) Immunohistochemical brightﬁeld images, (D-G) confocal immunoﬂuorescence images. Orientation in all 
images: rostral to the left, dorsal at the top. Scale bar A, B 85.7 µm, D-G 14.8 µm. 
growth into NPC-FF co-grafts was com-
pared to FF grafts by quantifying the num-
ber of neuroﬁlament labeled axonal proﬁles. 
Axonal growth was observed into both, FF 
grafts and NPC-FF co-grafts. However, the 
number of axonal proﬁles was signiﬁcantly 
increased by 47 % into NPC-FF co-grafts 
(7809 ± 1120 pixels/graft) versus ﬁbroblast 
grafts (5299 ± 618 pixels/graft; p < 0.05) 
(Fig. 6A-C). Neuroﬁlament labeled axons 
within NPC-FF co-grafts were frequently 
oriented longitudinally along GFAP labeled 
cellular processes (Fig. 6D-G), which co-
localized with BrdU labeled nuclei.  GFAP 
expressing cells in the graft typically dis-
played a bipolar, immature morphology.  
The cervical wire knife lesion completely 
disrupts the main portion of the CST de-
scending in the dorsal columns of the spi-
nal cord. Therefore, the presence of antero-
gradely BDA labeled axonal proﬁles tra-
versing from the main dorsal pathway into 
the graft indicates regrowth of transected 
CST axons rather than sprouting respons-
es of uninjured ventral corticospinal axons. 
In analogy to neuroﬁlament labeled axons, 
signiﬁcantly more CST axons regenerated 
into NPC-FF co-grafts (2774 pixels ± 384) 
in comparison to FF grafts (1027 pixels ± 
356; p<0.05) (Fig. 7A-C). In addition, the 
distance of CST axon regrowth into the 
graft measuring the longest distance of 
BDA labeled CST axon endings from the 
graft-host interface into the graft was sig-
niﬁcantly enhanced by 69% in NPC-FF 
co-grafts (316 mm ± 40) versus FF grafts 
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(187 mm ± 35; p<0.05) (Fig. 7D). Similar to 
neuroﬁlament labeled axons, BDA labeled 
CST axons were aligned along GFAP 
positive processes in the graft (Fig. 7E-
G). BDA labeled CST axon endings dis-
played morphological features of growth 
cones, strongly suggesting an ongoing 
process of axonal regrowth along cellular 
processes rather than grafted cells align-
ing their processes along axons within 
the grafts. GFAP positive cells showed a 
bipolar morphology with long processes 
and co-localized with BrdU labeled nu-
clei, identifying them as NPC derived cells 
(Fig. 7H). These data indicate that grafted 
NPC-derived GFAP expressing cells have 
the capacity to build a physical guiding 
structure for regenerating CST axons. 
4. DISCUSSION
Findings of the present study indicate that 
grafted adult neural progenitor cell (NPC) 
derived glial cells enhance regeneration 
of CNS axons following spinal cord injury. 
NPC grafts facilitate axonal regeneration 
by providing a growth permissive guid-
ing substrate mimicking axonal outgrowth 
pattern in the developing CNS. 
Studies in lower vertebrates indicate 
that glial cells play an important role 
as guidance cues for axon growth and 
regeneration during development and after 
injury 24, 25. The role of direct cellular guid-
ance in axonal growth during development 
Figure 7: Corticospinal axon regeneration: Representative micrographs of BDA labeled corticospinal axons 
within (A) NPC-FF and (B) FF grafts. Dashed lines delineate the graft/host transition. (C) Quantiﬁcation of 
BDA labeling reveals signiﬁcantly more axonal growth into NPC-FF grafts (p<0.05). (D) The distance of CST 
axon growth into the graft is signiﬁcantly higher in NPC-FF grafts compared to FF grafts (p<0.05). Error bars 
represent SEM. (E) BDA labeled CST axons are longitudinally aligned along (F) GFAP expressing cells, which 
are colocalized with (G) BrdU prelabeled nuclei of grafted NPC (highlighted by arrows in F- H). (H) Merged 
images of (E-G). Axon endings with morphological features of growth cones (arrowheads) are oriented along 
GFAP positive processes, indicating that axons use GFAP expressing cells as a guiding scaffold. (A, B) 
Immunohistochemical brightﬁeld micrographs, (E-H) confocal immunoﬂuorescence micrograph. Orientation 
in all images: rostral to the left, dorsal at the top. Scale bar A, B 36.4 µm, E-H 25.5 µm.
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and after injury is much less deﬁned in 
the mammalian CNS. Axonal pathﬁnding 
in the corpus callosum of developing rats 
has been associated with cellular guid-
ance cues provided by astroglial cells 26, 27. 
Time course studies in the postnatal mam-
malian spinal cord demonstrate that cor-
ticospinal axons growing throughout the 
spinal cord between postnatal day 0 and 
10 are in close spatial and temporal as-
sociation with processes of vimentin and 
GFAP expressing glial cells 7. In vitro stud-
ies have shown that astroglial cells directly 
guide neurite outgrowth only at a distinct 
immature developmental stage 28, 29. There, 
growth promoting astroglial cells display a 
bipolar morphology with long processes 28. 
This bipolar morphology can be found in 
grafted GFAP expressing NPC in our study 
indicating that these cells represent an im-
mature glial cell type rather than mature 
astrocytes. Therefore, the axonal growth 
observed in our experiments likely recapit-
ulates cell guided axon outgrowth during 
development. 
Co-cultivation of NPC with ﬁbroblasts 
signiﬁcantly increased the percentage of 
cells differentiating into a glial GFAP ex-
pressing phenotype in our in vitro experi-
ments. Previous in vitro studies also dem-
onstrated that mesenchymal cells such 
as meningeal cells or corneal ﬁbroblasts 
promote glial differentiation in fetal cortex 
derived cell cultures or postnatal cerebellar 
slice cultures 30, 31. Interestingly, meningeal 
cells also induced a bipolar morphology 
in GFAP expressing cells 31 similar to the 
glial morphology of NPC co-grafted with 
ﬁbroblasts. Whether these effects are me-
diated through direct cell-cell interactions 
or through soluble factors remains to be 
determined. Further evidence supporting 
the concept that ﬁbroblasts might promote 
a more bipolar glial phenotype resembling 
immature astroglial cells, is provided by 
previous observations 14. After transplanta-
tion of pure NPC, isolated and cultivated 
under the same conditions as in the pres-
ent study, GFAP immunolabeled cells fre-
quently displayed a mature, stellate ap-
pearance.
We observed an increase in axonal sprout-
ing into NPC-FF grafts compared to control 
ﬁbroblast grafts despite the presence of 
putative inhibitory extracellular matrix mol-
ecules such as chondroitin sulfate proteo-
glycans, which have been detected within 
and around ﬁbroblast containing grafts fol-
lowing spinal cord injury 18. It is possible 
that NPC inﬂuence the local expression 
or degradation of inhibitory extracellular 
matrix molecules to an extent that cannot 
be determined by immunohistochemistry. 
This notion is supported by recent ﬁndings 
demonstrating that immature glial cells are 
capable to overcome the growth-inhibitory 
barrier by digesting speciﬁcally the CSPG 
aggrecan in in vitro outgrowth assays 32. 
Alternatively, axon growth promoting glial 
cells could express growth permissive 
signals, which outweigh inhibitory signals 
from various extracellular matrix molecules 
present within the graft 18. In this context, 
it is interesting to note that growth permis-
sive signals such as the cell adhesion mol-
ecules NCAM and L1 have been identiﬁed 
on growth promoting immature astroglia, 
however, not on mature astroglia 29.
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It becomes evident from this study that 
any restorative strategy employing neural 
stem cells for transplantation without a 
supporting scaffold following spinal cord 
injury is not sufﬁcient to replace extensive 
lesion defects developing in the course of 
a traumatic spinal cord lesion, and there-
fore cannot provide a bridge for axons to 
regenerate on. The necessity to admin-
ister a supporting scaffold together with 
neural stem cells has already been dem-
onstrated following transplantation into an 
ischemia induced CNS lesion 15. However, 
in the present study naturally occurring ﬁ-
broblasts and/or extracellular matrix mol-
ecules released by ﬁbroblasts as opposed 
to previously used artiﬁcially manufactured 
polymers were able to maintain adult NPC 
within the cystic lesion defect. Some ex-
tracellular matrix molecules secreted by 
ﬁbroblasts such as laminin or ﬁbronectin 
have been found to enhance cell motility, 
and thereby might accelerate the migra-
tion of adult NPC away from the graft into 
the surrounding host spinal cord. However, 
other extracellular matrix molecules such 
as CSPG, which are expressed in ﬁbro-
blast containing grafts 18, actually inhibit 
NPC migration 33. Thus, CSPG might be 
an important component to prevent signiﬁ-
cant migration of NPC away from the le-
sion site and to maintain NPC within the 
lesion cavity. 
In terms of a putative clinical application, 
the question remains whether adult NPC 
are a cell population superior to ﬁbroblasts 
alone or to fetal spinal cord tissue contain-
ing immature neural cells, which are already 
placed in a predeﬁned tissue architecture 
before grafting. Both strategies have been 
shown to replace cystic lesion defects and 
to promote partial functional recovery fol-
lowing acute and chronic spinal cord injury 
17, 34-40. In particular, ﬁbroblasts genetically 
modiﬁed to secrete regrowth promoting 
neurotrophic factors such as neurotroph-
in-3 (NT-3) or brain derived neurotrophic 
factor (BDNF) elicit regeneration of supra-
spinal projections into the graft, however, 
axons are unable to reenter the host spi-
nal cord 35, 39. Thus, ﬁbroblasts represent a 
powerful cellular vehicle to locally deliver 
growth promoting molecules, however, 
they do not have the capacity to serve as a 
“bridge” reconnecting injured rostral axons 
with targets located distally or vice versa. 
Fetal spinal cord tissue has been demon-
strated to elicit functional recovery, but the 
exact structural mechanisms remain to be 
determined 34, 38, 41. Ethical concerns and 
the limited availability of fetal transplants 
further restrict their clinical applicability. 
Adult NPC represent a highly promising 
source for regenerative cell based-strat-
egies following spinal cord injury. How-
ever, at the time point investigated axon 
growth is still limited. Axons do not regen-
erate beyond a limited distance within the 
transplant and do not re-enter the caudal 
host spinal cord. Future studies need to 
investigate axonal regeneration over lon-
ger periods of time. The exact character-
istics of growth promoting glial cells need 
to be speciﬁcally identiﬁed and these cell 
populations need to be enriched to aug-
ment structural and potentially functional 
recovery. Increasing the ratio of NPC to 
ﬁbroblasts, overexpressing neurotrophic 
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factors such as NT-3 17, and stimulating the 
neuronal cell body with cyclic nucleotides 
42 might be other means to enhance the re-
generative capacity of axons into and be-
yond NPC containing grafts. Studies in the 
chronically injured spinal cord are needed 
to determine whether NPC survival/dif-
ferentiation and corticospinal growth re-
sponses are similar in chronic spinal cord 
injuries compared to acute injuries investi-
gated in the present study.
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1. INTRODUCTION
After limited injury to the peripheral ner-
vous system (PNS), endogenous Schwann 
cells are recruited to form a scaffold for re-
generating axons to grow along, produce 
growth conducive extracellular matrix 
components, secrete neurotrophic fac-
tors and remyelinate regenerating axons 
in a phenotypical appropriate manner, 
which ultimately leads to reinnervation of 
the target and functional recovery 1.
By transplanting Schwann cells, these 
favorable properties have been success-
fully transferred to more severe periph-
eral nerve injuries and even central ner-
vous system (CNS) lesions. After severe 
peripheral nerve injuries endogenous 
recruitment of Schwann cells is not suf-
ﬁcient to promote morphological and 
functional restoration. The availability of 
peripheral nerve autograft material, which 
represents the standard therapy in these 
cases, is limited. Allografts on the other 
hand, are subject to graft rejection 2. Ar-
tiﬁcially produced guidance channels 
seeded with autologous Schwann cells 
could overcome these limitations. Syn-
genic Schwann cells seeded into guid-
ance channels have been successfully 
employed to support regeneration in ani-
mal models of peripheral nerve injury 3, 4.
In the CNS, transplanted Schwann cells 
can regenerate and remyelinate axons, 
which have been completely interrupted 
ABSTRACT
The intrinsic capacity of Schwann cells to promote regeneration after limited peripheral 
nerve lesions has been successfully transferred to extensive peripheral nerve injuries 
and central nervous system lesions by autologous transplantation strategies. However, 
both the intrinsic ability of axotomized neurons to regenerate and the permissiveness of 
the parenchyma surrounding the acute injury site diminish over time. Therefore, the au-
tologous transplantation mode requires a fast and effective method to isolate Schwann 
cells from peripheral nerve biopsies. Here, we report a method to purify p75 low afﬁnity 
nerve growth factor receptor (p75LNGFr) expressing Schwann cells from peripheral 
nerve biopsies in adult rats using magnetic-activated cell separation (MACS). After 
one week of nerve degeneration in culture, nerve fragments were dissociated result-
ing in mixed cultures containing Schwann cells and ﬁbroblasts. After incubation with 
speciﬁc anti-p75LNGFr antibodies and secondary magnetic bead conjugated antibod-
ies followed by one cycle of MACS, 95% pure Schwann cell cultures were generated 
as conﬁrmed by ﬂow-cytometry and immunocytochemistry. In contrast to established 
methods, MACS separation of p75LNGFr expressing cells allows the reliable puriﬁca-
tion of Schwann cells within 9 days after biopsy employing direct selection of Schwann 
cells rather than ﬁbroblast depletion assays. Therefore, this method represents an ef-
fective and fast means to generate autologous Schwann cells for clinical transplanta-
tion strategies aiming for axon repair and remyelination.
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5-8, or have been demyelinated by toxins 
or irradiation 9-12. Furthermore, the regen-
erative capacity of Schwann cells can be 
enhanced by ex vivo genetic modiﬁcation 
to overexpress neurotrophic factors 13-15. 
Ideally, Schwann cells are transplanted 
in an autologous fashion to avoid graft 
immune rejection. The disadvantage is 
that autologous Schwann cells will not 
be available immediately after a nerve le-
sion. The generation of sufﬁcient quanti-
ties of Schwann cells for transplantation 
from the patient’s own peripheral nerve 
biopsy requires at least three to six weeks 
according to established protocols 16-18. 
However, the regeneration supportive 
capacity in the PNS and CNS decreases 
over time due to events such as cellular 
degeneration, scar formation and down-
regulation of growth promoting molecules 
19, 20. 
The separation of Schwann cells from 
rapidly dividing ﬁbroblasts, which build 
the protecting layers (epi-, perineurium) 
surrounding bundles of nerve ﬁbers, 
represents the major time consuming fac-
tor 21, 22. Thus far, established methods for 
Schwann cell puriﬁcation from peripheral 
nerve fragments are based on ﬁbroblast 
depletion as opposed to direct selection 
of Schwann cells. As an initial step to 
separate Schwann cells from ﬁbroblasts, 
nerve fragments are maintained under cell 
culture conditions on an adhesive sub-
strate such as laminin for several weeks. 
This procedure allows ﬁbroblasts to mi-
grate out, while Schwann cells remain 
in the nerve fragment. Each consecutive 
transfer of these nerve fragments reduces 
the number of ﬁbroblasts 17. The number 
of rapidly dividing ﬁbroblasts can be re-
duced by adding antimitotic drugs such 
as cytosine arabinoside (Ara-C) to the cell 
culture medium or by maintaining serum-
free primary cultures 23, 24. The yield of en-
riched Schwann cells can be further en-
hanced by predegeneration of peripheral 
nerves in vivo before biopsy 16, 25. Besides 
the time required to enrich Schwann cells, 
these puriﬁcation methods are rather 
unspeciﬁc 18. More speciﬁc puriﬁcation 
methods, such as ﬁbroblasts depletion 
using speciﬁc antibodies against the cell-
surface antigen Thy-1 coupled to either 
complement activation or immunopan-
ning, have only been reported for neona-
tal peripheral nerves 26, 27. 
Magnetic-activated cell separation 
(MACS) represents a highly effective and 
fast method to select individual cell popu-
lations from a mixed cell population. Cell 
type speciﬁc cell surface antigens are la-
beled with magnetic bead conjugated an-
tibodies followed by separation on a high 
gradient magnetic column 28. A suitable cell 
surface antigen to select Schwann cells is 
the p75 low afﬁnity nerve growth factor 
receptor (p75LNGFr), which is widely ex-
pressed on Schwann cells in vitro, but not 
on ﬁbroblasts 29. A similar approach using 
magnetic Dynabeads to enrich p75LNGFr 
expressing olfactory ensheathing cells has 
been described recently 30. Vice versa, the 
cell surface antigen Thy-1 is expressed on 
ﬁbroblasts, but not on Schwann cells, and 
thus can be used to enrich Schwann cells 
by depleting Thy-1 expressing ﬁbroblasts 
31. 
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In the present experiment, we investigated 
the efﬁcacy of MACS to purify Schwann 
cells from adult sciatic nerve biopsies by 
using either speciﬁc antibodies (1) against 
p75LNGFr to select Schwann cells or (2) 
against Thy-1 to deplete ﬁbroblasts. Re-
sults from this study indicate that only 
MACS selection of p75LNGFr express-
ing Schwann cells represents a highly 
effective procedure to establish primary 
Schwann cell cultures for autologous 
transplantation strategies in the PNS and 
CNS. 
2. MATERIALS AND METHODS
2.1 Schwann cell isolation
Sciatic nerve fragments with a length of 
approximately 35mm were taken bilater-
ally from deeply anesthetized (0.5 ml of 
a combination of ketamine (50 mg/kg), 
xylazine (2.6 mg/kg) and acepromazine 
(0.5 mg/kg)) adult Fischer 344 rats (aver-
age weight 160-180 g). The sciatic nerves 
were washed with ice-cold Hank’s bal-
anced salt solution (HBSS, PAA Labora-
tories, Austria) and the epineurium was 
stripped off with a ﬁne forceps. Each sci-
atic nerve fragment weighed on average 
29.6 mg ± 1.7.  Nerves were cut into 1mm 
pieces and plated on collagen type-I (5 
mg/cm2, Pan Biotech, Germany) coated 
culture dishes in standard medium, which 
consists of Dulbecco’s modiﬁed essential 
medium (DMEM) supplemented with 10% 
fetal calf serum (FCS; Pan Biotech, Ger-
many) and Penicillin/Streptomycin (100 
U of penicillin, 100 mg/ml Streptomy-
cin; Pan Biotech, Germany). The culture 
dishes with the sciatic nerve pieces were 
kept in a cell culture incubator at 37°C in 
a humidiﬁed atmosphere containing 5% 
CO2. After 7 days in culture, the sciatic 
nerve fragments were transferred into 24 
well plates containing 500 µl HBSS with 
3% trypsin, 1% collagenase and 1% hy-
aluronidase (all Sigma, Germany) per well. 
After two hours of incubation at 37°C, tis-
sue fragments were dissociated by tritura-
tion through a glass Pasteur-pipette and a 
20-gauge sterile needle. The suspension 
was centrifuged at 120 x g for 10 min at 
room temperature. After resuspension in 
standard medium, trituration through a 
22-gauge hypodermic needle followed. 
The resulting cell suspension was cultured 
in standard medium for two days on poly-
l-ornithin/laminin (P-Orn/Lam; both Sig-
ma, Germany) culture ﬂasks, which were 
coated as follows: ﬂasks were incubated 
with 20mg/cm2 poly-l-ornithin in distilled 
H2O for 2 hours at 37°C, rinsed with dis-
tilled H2O and incubated with 0.4 mg/cm
2 
laminin in PBS for 2 hours at 37°C. After 
2 days in culture, the number of viable 
cells total before MACS and ﬂow-cytom-
etry/immunocytochemistry analysis was 
determined by counting the Trypan blue 
excluding cells using a hemocytometer.
2.2 Schwann cell puriﬁcation
Each puriﬁcation run using MACS was 
conducted with nerve biopsies pooled 
from 3-4 rats (6-8 nerve explants). The 
MACS procedure was performed accord-
ing to the manufacturer’s instructions 
(Miltenyi Biotec, Germany). The ﬂask con-
taining the unpuriﬁed cells was washed 
with Dulbecco’s phosphate buffered saline 
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(PBS) and incubated with 40 µl/cm2 Ac-
cutase (Innovative Cell Tech, San Diego, 
USA) for 5 minutes to detach the cells. 
Accutase, which is a mixture of collage-
nases, proteases and EDTA, was used 
instead of trypsin to protect trypsin sensi-
tive cell surface markers. The cells were 
collected in DMEM containing 10% FCS 
and were centrifuged at 300 x g for 5 min 
at 4°C, washed with PBS supplemented 
with 2mM EDTA (PE) and counted using 
a hemocytometer (= number of unpuri-
ﬁed cells). A sample of unpuriﬁed cells (2 
x.105) was seeded on P-Orn/Lam coated 
culture ﬂask for further analysis.
For MACS Schwann cell selection, the re-
maining unpuriﬁed cells were incubated 
with 5 µl (equals 0.25 mg IgG1) of the anti-
p75LNGFr monoclonal antibodies (Chem-
icon, Germany) in 95 µl Dulbecco’s PBS, 
2mM EDTA, 0.5% BSA (PEB) for 10 min 
at room temperature. At the end of the in-
cubation, 5ml of PE was added and the 
cells were centrifuged (300 x g for 5 min 
at 4°C). After one wash with PE, the cells 
were incubated with 20 µl of the micro-
bead-linked rat anti-mouse IgG1 (at 1:5; 
Miltenyi Biotec, Germany) in 80 µl PEB for 
15 min at 4°C. After 2 rinsing steps with 
PE, a MS column (Miltenyi Biotec, Germa-
ny) was placed in the MiniMACS magnet 
(Miltenyi Biotec, Germany) and ﬂushed 
with PEB. A maximum of 5 x 106 cells was 
resuspended in 500 µl PEB and applied 
onto the MS+ column. Three rinses with 
500 µl PEB followed to wash out unbound 
cells, which represented the p75LNGFr 
negative fraction. After removal from the 
magnet, the column was ﬂushed with 2 
ml PE, which allowed the collection of the 
p75LNGFr positive cell fraction. 
For MACS ﬁbroblast depletion, cell sus-
pensions were incubated with a mouse 
monoclonal anti-Thy-1 IgG1 (at 1:100; 
Harlan Sera Lab, Germany) and micro-
bead-linked rat anti-mouse IgG1 antibod-
ies as described. The MS column was 
loaded with a maximum of 5 x 106 labeled 
cells. Cells not binding to the column at-
tached to the magnet represented the 
Thy-1 negative cell fraction. Flushing of 
the column after removal of the magnet 
allowed the collection of the Thy-1 posi-
tive cell fraction.  
Figure 1: Time line from peripheral nerve biopsy (day 0) through immunocytochemical/ﬂow-cytometry 
analysis of MACS selected cells (day 11). 
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The number of viable cells in the various 
fractions was determined by counting 
the Trypan blue excluding cells using 
a hemocytometer. For ﬂow-cytometry 
analysis 2 days later, a sample of puri-
ﬁed cells (2 x 105) was plated on P-Orn/
Lam coated culture ﬂasks and standard 
medium was added. The remaining 
Schwann cells were expanded in stan-
dard medium supplemented with 2 µM 
forskolin (Sigma, Germany) and 0.2% 
bovine pituitary extract (Clonetics, Ger-
many).
2.3 Flow-cytometry analysis of 
MACS selected cells 
A sample of unpuriﬁed cells or cells (2 x 
105 cells each) puriﬁed by either p75LNGFr 
selection or Thy-1 depletion was harvest-
ed within 48 hours after MACS using Ac-
cutase, washed with PE and immunola-
beled with the anti-Thy-1 mouse antibody 
(at 1:100 in PEB) used for the ﬁbroblast 
depletion assay. The cells were washed 
with PE, stained with a secondary ﬂuo-
rescein-conjugated donkey anti mouse 
IgG antibody (at 1:1000 in PEB; Jackson 
Immunoresearch, Germany) and washed 
with PE. The total number of 10,000 
events was analyzed on a FACSCalibur 
ﬂow-cytometer (Becton-Dickinson, Ger-
many) directly after the staining proce-
dure. Data were processed with the Win-
MDI 2.8 software (J. Trotter, USA). The 
percentage of ﬁbroblasts in the various 
samples was determined by measuring 
the fraction of Thy-1 positive cells in the 
ﬂuorescence intensity dotplot compared 
to the total amount of intact cells. 
2.4 Immunocytochemistry
Cells from each sampling fraction were 
plated in standard medium on P-Orn/Lam 
coated Permanox Chamber Slides (Nunc, 
Germany) for 2 days. The cells were ﬁxed 
with ice-cold 4% paraformaldehyde in 
PBS for 30 minutes, rinsed 3 times with 
Tris-buffered saline (TBS), blocked with 
TBS containing 3% donkey blocking se-
rum (Pan Biotech, Germany) and incu-
bated overnight with the primary antibody 
in TBS containing 3% blocking serum at 
4°C. The following primary antibodies were 
used: anti-p75 low afﬁnity NGF receptor 
(rabbit polyclonal; Chemicon, Germany; 
at 1:2000), anti-27C7 (mouse monoclonal; 
generous gift from K. Wewetzer, Univer-
sity of Hannover, Germany; at 1:200) and 
mouse anti-Thy-1 (mouse monoclonal; 
Harlan Sera Lab, Germany; at 1:2000). 
Cells were rinsed twice with TBS and in-
cubated for 2 hours with the correspond-
ing secondary ﬂuorescein or rhodamine-
X linked donkey anti-mouse/rabbit IgG 
antibodies (Jackson Immunoresearch, 
Germany; at 1:1000) in TBS containing 
3% donkey blocking serum. After 5 rinses 
with TBS, incubation with Hoechst 33342 
(2 mg/ml; Sigma) as a nuclear counter-
stain followed. The chambers were re-
moved from the slides and coverslipped 
using Prolong Antifade (Molecular Probes, 
Netherlands) as mounting medium. 
Phase contrast images of unﬁxed cell cul-
tures were taken on an inverted Olympus 
IX70 phase contrast microscope (Olym-
pus, Germany), equipped with a Color 
View 12 digital camera (Soft Imaging 
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System, Germany). Immunocytochemis-
try samples were analyzed using a Leica 
DMR ﬂuorescence microscope (Leica, 
Germany). At every individual ﬁlter set-
ting, 8 bit monochrome pictures were tak-
en using a Spot CCD camera model 2.2.1 
(Diagnostic Instruments, Michigan USA). 
3. RESULTS
3.1 Schwann cell isolation
After obtaining sciatic nerve biopsies from 
adult rats, nerve fragments were kept in 
culture for 7 days before dissociation (Fig. 
1). After 7 days of in vitro degeneration, 
dissociation of peripheral nerve frag-
ments and 2 days in culture, 0.86 x 106 
cells ± 0.09 x 106 (n=6) total viable cells 
per animal were counted, which corre-
sponds to 1.5 x 104 cells per mg nerve tis-
sue. Out of all dissociated cells less than 
5% were non-viable cells. Dissociation 
before day 7 post biopsy resulted in a low 
yield of Schwann cells (data not shown). 
Peripheral nerve homogenates plated on 
Table 1: Flow-cytometry analysis of Thy-1 expressing ﬁbroblasts after MACS p75LNGFr Schwann cell 
selection.
unpuriﬁed
fraction
MACS
p75LNGFr positive fraction 
MACS
p75LNGFr negative fraction 
Exp. # (Thy-1 expressing cells in percent (%))
1 18.56 4.92 91.37
2 63.36 5.20 98.40
3 35.58 1.98 59.25
4 60.33 10.26 95.04
5 64.58 5.76 94.61
6 77.72 1.79 98.06
Mean 53.4 5.0 89.5
SD 21.9 3.1 15.0
Table 2: Flow-cytometry analysis of Thy-1 expressing ﬁbroblasts after MACS Thy-1 ﬁbroblast depletion
unpuriﬁed
fraction
MACS
Thy-1 positive fraction 
MACS
Thy-1 negative fraction 
Exp. # (Thy-1 expressing cells in percent (%))
1 23.10 88.98 14.63
2 18.56 85.09 3.08
3 63.36 93.41 63.86
4 39.63 91.72 26.80
5 35.58 77.60 2.65
6 60.33 95.16 59.48
7 64.58 80.62 42.27
8 77.72 88.42 76.76
Mean 47.9 87.6 36.2
SD 21.6 6.2 28.7
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Figure 2: Immunocytochemical analysis before and after MACS p75LNGFr Schwann cell selection from 
peripheral nerve biopsies. A-D show unpuriﬁed cultures right after peripheral nerve dissociation, E-H illustrate 
the p75LNGFr positive and I-L the p75LNGFr negative fraction (A, E, I phase-contrast micrographs; all others 
immunoﬂuorescent micrographs). (A) Peripheral nerve homogenates in culture consist of bipolar Schwann 
cells with small cigar-shaped nuclei and ﬂattened ﬁbroblasts with prominent oval nuclei, which is mirrored 
by (B) p75LNGFr expressing Schwann cells and (C) Thy-1 expressing ﬁbroblasts. (D) Overlay of C and D. 
Of note, the Hoechst 33342 nuclear counterstain is always co-localized with either Thy-1 or p75LNGFr. (E) 
Following MACS p75LNGFr selection, cells are found almost exclusively with the typical bipolar Schwann 
cell morphology in the p75LNGFr positive fraction. (F) These cells express p75LNGFr, (G) but not Thy-1. (H) 
Overlay of F and G. (I) In contrast, the p75LNGFr negative fraction contains cells with ﬁbroblast morphology. 
This is paralleled by (J) the lack of p75LNGFr and (K) abundance of Thy-1 immunoreactivity. (L) Overlay of J 
and K. Thy-1 immunoreactivity (ﬂuorescein; green), p75LNGFr immunoreactivity (rhodamine; red), Hoechst 
33342 nuclear counterstain (blue).  Scale bar A, E, I 75µm;  B-D, F-H, J-L, 100mm.
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P-Orn/Lam coated culture ﬂasks after 
dissociation, contained both, typical fu-
siforme bipolar Schwann cells with small 
cigar-shaped nuclei and ﬂattened ﬁbro-
blasts with prominent oval nuclei (Fig. 2A). 
The immunocytochemical analysis con-
ﬁrmed the presence of Schwann cells by 
p75LNGFr expression and of ﬁbroblasts 
by Thy-1 expression (Fig. 2B-D). The 
typical phase-contrast appearance was 
less prominent in immunocytochemically 
stained cells due to paraformaldehyde 
ﬁxation induced alterations of Schwann 
cell and ﬁbroblast morphology. Flow-cy-
tometry analysis of the primary cultures 
within 48 hours after enzymatic digestion 
revealed that 53.4% ± 21.9  (n=6) were 
Thy-1 expressing ﬁbroblasts (Table 1; Fig. 
4A). 
3.2 Schwann cell puriﬁcation by 
positive selection
Nine days after the sciatic nerve biopsy 
(Fig. 1), dissociated sciatic nerve frag-
ments were puriﬁed by MACS using 
p75LNGFr antibodies to select Schwann 
cells. This procedure was repeated for 6 
different nerve biopsies (Table 1). Two days 
later, p75LNGFr selected cells revealed 
the typical Schwann cell morphology on 
coated culture ﬂasks (Fig 2E). Immunore-
activity for p75LNGFr and the absence of 
Thy-1 expression conﬁrmed the Schwann 
cell identity (Fig. 2F-H). In contrast, cells 
obtained from the p75LNGFr negative 
fraction appeared as large, ﬂattened cells 
with prominent nuclei resembling the 
typical ﬁbroblast morphology in phase-
contrast (Fig. 2I). These cells expressed 
Thy-1, which identiﬁes ﬁbroblasts, but not 
p75LNGFr (Fig. 2J-L). Finally, co-localiza-
tion of p75LNGFr and 27C7 expression, a 
marker for non-myelinating Schwann cells 
32, reconﬁrms the Schwann cell identity of 
p75LNGFr expressing cells (Fig. 3). Cells, 
neither expressing p75LNGFr or Thy-1, 
were not found (Fig. 2D). 
Qualitative morphological data from 
MACS p75LNGFr selected cells were par-
alleled by quantitative analysis of Thy-1 
Figure 3: p75LNGFr expressing cells are Schwann cells. (A) Immunocytochemical analysis with the Schwann 
cell speciﬁc antibody 27C7, which recognizes non-myelinating Schwann cells, conﬁrms the Schwann cell 
phenotype of (B) p75LNGFr expressing cells. (C) Overlay of A and B. 27C7 immunoreactivity (ﬂuorescein; 
green), p75LNGFr immunoreactivity (rhodamine; red), Hoechst 33342 nuclear counterstain (blue). Scale bar 
A-C 100mm. 
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positive cells as determined by ﬂow-cy-
tometry two days after MACS (Table 1; 
Fig. 4). Cultures derived from one cycle 
of MACS p75LNGFr selection contained 
5.0% ± 3.1 (n=6) Thy-1 positive ﬁbro-
blasts, compared to 53.4% before MACS, 
indicating a high speciﬁcity (95.0%) for 
Schwann cells. As a parameter for the 
sensitivity of this method, cultures from 
the MACS p75LNGFr negative fraction 
contained only 10.5% Thy-1 negative 
cells. This fraction most likely represents 
Schwann cells not captured by the col-
umn. The absolute number of cells re-
trieved in the p75LNGFr positive fraction 
further conﬁrms the high sensitivity. From 
1.37 x 106 unpuriﬁed cells (sample from 
pooled cells, counted before MACS), 0.58 
x 106 cells in the MACS p75LNGFr positive 
fraction were identiﬁed as Thy-1 negative 
by ﬂow-cytometry, thus representing the 
yield of Schwann cells after one cycle of 
p75LNGFr MACS selection. Considering 
that our unpuriﬁed biopsy homogenates 
contain on average 46.6% Schwann 
cells (= 0.64 x106 cells; ﬂow-cytometry 
Thy-1 negative unpuriﬁed cells), 91.0 
% of all Schwann cells present in the 
peripheral nerve biopsies following dis-
sociation can be retrieved. This means, 
transferred to the total numbers of cells 
obtainable from one single rat, that out 
of 0.86 x 106 cells 0.40 x 106 represent 
Schwann cells, from which 0.37 x 106 
cells can be retrieved. 
After adding the mitogens forskolin and 
bovine pituitary extract to the medium, 
the Schwann cells could be expanded 
with a cell doubling time of 5 days over 
at least 4 passages, without observing 
ﬁbroblasts overgrowing them (data not 
shown). 
Figure 4: Flow-cytometry analysis of MACS p75LNGFr separated cells. Dot plots were obtained by ﬂow-
cytometry analysis of Thy-1 expressing cells, showing the side scatter signal versus the ﬂuorescence signal 
intensity in arbitrary units (AU). The dot plots were gated to select the viable cells from the cell population. 
The boxed areas labeled R2 contain the Thy-1 positive ﬁbroblasts. (A) The unpuriﬁed peripheral nerve 
homogenates almost equally consist of Thy-1 positive (R2 labeled box) and Thy-1 negative cells. (B) The 
majority of cells of the MACS p75LNGFr positive fraction is located outside of the boxed area indicating that 
they do not express Thy-1 . (C) Almost all cells from the MACS p75LNGFr negative fraction express Thy-1 
(inside boxed area), which identiﬁes them as ﬁbroblasts
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3.3 Schwann cell puriﬁcation by 
ﬁbroblast depletion
Identical to the MACS p75LNGFr selec-
tion protocol, sciatic nerve fragments were 
dissociated 7 days after the nerve biopsy 
was taken and were puriﬁed by MACS 
Thy-1 depletion two days later. The sepa-
ration procedure was repeated in 8 differ-
ent experiments (Table 2). In contrast to 
the described MACS p75LNGFr selection 
assay, Schwann cell puriﬁcation by MACS 
depletion of Thy-1 expressing ﬁbroblasts 
did not prove to be effective in this ex-
periment. The MACS column was able to 
bind Thy-1 expressing ﬁbroblasts, since 
the Thy-1 positive fraction had a higher 
percentage of Thy-1 positive ﬁbroblasts 
compared to unpuriﬁed cells after one cy-
cle of MACS Thy-1 depletion as assessed 
by ﬂow-cytometry (Table 2). However, the 
Thy-1 negative fraction still contained 
36.2% ± 28.7 (n=8) Thy-1 positive cells 
indicating a low sensitivity to detect Thy-1 
expressing ﬁbroblasts. The speciﬁcity of 
MACS for Thy-1 expressing ﬁbroblasts 
was only 87.6% ± 6.2 (n=8), suggesting 
that unlabeled cells were captured by 
MACS Thy-1 selection. The quantitative 
ﬂow-cytometry results were conﬁrmed by 
phase-contrast and immunocytochemical 
analysis of the MACS Thy-1 depletion as-
say (data not shown). 
4. DISCUSSION
The results of the present study demon-
strate that Schwann cells can be puriﬁed 
by MACS from adult peripheral nerve bi-
opsies using the expression of the cell 
surface antigen p75LNGFr for selection. 
This method allows the fast and reliable 
puriﬁcation of adult Schwann cells direct-
ly through positive selection rather than 
indirectly through depletion of ﬁbroblasts. 
MACS depletion of Thy-1 expressing ﬁ-
broblasts lacks the sensitivity and speci-
ﬁcity to establish Schwann cell cultures 
from adult peripheral nerve biopsies.
The main advantage of MACS p75LNGFr 
Schwann cell selection is the fast estab-
lishment of primary Schwann cell cul-
tures from adult peripheral nerve biopsies 
within 9 days after biopsy. This time factor 
becomes particularly relevant for autolo-
gous transplantation strategies, since the 
intrinsic ability of axotomized neurons to 
regenerate and the permissiveness of the 
parenchyma surrounding the acute injury 
site diminish over time 19, 20. Routinely used 
methods to enrich Schwann cells from 
peripheral nerve biopsies such as the re-
petitive transfer of peripheral nerve frag-
ments in culture, the treatment of cultures 
with cytotoxic agents to eliminate prolifer-
ating ﬁbroblasts, and the predegeneration 
of peripheral nerve before biopsy, require 
at least three to six weeks to achieve suf-
ﬁcient puriﬁcation of Schwann cells 16, 
17. These time requirements may already 
be beyond the time point, where optimal 
axonal regeneration can be achieved. 
Enriching Schwann cells by dissociation 
of peripheral nerve biopsies earlier than 
7 days after biopsy was not possible. 
As conﬁrmed by others, immediate dis-
sociation of peripheral nerve fragments 
causes substantial damage to Schwann 
cells resulting in poor cell yields 17. Periph-
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eral nerve fragments require a minimum 
of time to degenerate, which will allow 
Schwann cells to retract their processes 
from the surrounding cells and to loosen 
junctions with extracellular matrix compo-
nents within the peripheral nerve 22. 
The MACS p75LNGFr selection protocol 
as described allows a high degree of pu-
riﬁcation without losing signiﬁcant quan-
tities of Schwann cells. Puriﬁcation by 
MACS selection requires a balance be-
tween the speciﬁcity of Schwann cell se-
lection and an optimal cell yield. Increas-
ing the number of rinses before eluting 
the column in the positive selection as-
say would enhance the speciﬁcity but at 
the same time the overall cell yield would 
decrease. A more efﬁcient means to in-
crease the speciﬁcity without decreasing 
the cell yield is to purify cell homogenates 
repeatedly on fresh columns. In the pres-
ent experiment, the degree of Schwann 
cell enrichment after one cycle of MACS 
p75LNGFr selection was sufﬁcient for 
several passages of Schwann cell cultures 
without observing ﬁbroblast expansion. 
The total cell yield of 0.86 x 106 cells per 
animal or 1.5 x 104 cells per mg nerve tis-
sue obtainable with the described MACS 
puriﬁcation protocol lies within the range 
of previously published data 17, 18, 33. 
A concern about MACS cell selection is 
that microbeads still bound to the cell 
surface would inﬂuence viability or ad-
herence of the  puriﬁed cells. However, 
none of these effects were observed in 
the present study. The small size of the 
microbeads (ca. 50 nm) prevents the ste-
ric interference or mechanical stress on 
the cells, which occurs when cells are 
bound to larger magnetic particles like 
Dynabeads 34. Because of the small size 
and the biodegradable constitution, the 
bound microbeads are removed by the 
normal membrane turnover.
In contrast, established puriﬁcation meth-
ods using cytotoxic agents such as Ara-
C to eliminate ﬁbroblasts from peripheral 
nerve biopsies have to accept consider-
able side effects. Cytotoxic agents unspe-
ciﬁcally eradicate proliferating cells and 
therefore proliferating Schwann cells will 
be eliminated as well 35. The overall cell 
yield of Schwann cells will decrease and 
the time required to generate sufﬁcient 
quantities of Schwann cells will increase. 
In addition, Ara-C can induce DNA dam-
age 36 and interfere with the overall protein 
synthesis 37. Thus, long-term effects on 
surviving Schwann cells are likely, which 
raises safety concerns regarding the ap-
plication of puriﬁed Schwann cells for 
transplantation in humans.
In analogy to previous studies, which 
used the expression of Thy-1 as a marker 
to select ﬁbroblasts either through im-
munopanning 27 or complement activa-
tion induced lysis 26, peripheral nerve ho-
mogenates were processed using MACS 
depletion of Thy-1 expressing ﬁbroblasts. 
This approach did not prove  to be effec-
tive, since it showed a very low sensitivity 
to detect ﬁbroblasts. These data are in line 
with previous experiments, in which we 
were not able to purify Schwann cells suf-
ﬁciently from adult peripheral nerve tissue 
using the complement activation induced 
lysis with Thy-1 as the selection antigen 
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(N.W., unpublished observation). Thus far, 
Thy-1 antibody labeling and subsequent 
complement activated lysis to deplete 
ﬁbroblasts have only been applied suc-
cessfully to neonatal peripheral nerve tis-
sue 26, 27. The difference between neonatal 
and adult peripheral nerve tissue can be 
attributed to the fact that peri- and epi-
neurium, which represent the main ﬁbro-
blast containing layers within the periph-
eral nerve, are just starting to develop in 
neonatal as compared to adult peripheral 
nerves. This makes ﬁbroblast depletion 
methods much more efﬁcient for neonatal 
nerve tissue 21. 
MACS selection of p75LNGFr express-
ing Schwann cells from adult peripheral 
nerve biopsies represents a fast, effec-
tive and safe means to enrich Schwann 
cells in culture for clinical transplantation 
strategies. MACS is already an approved 
method for the puriﬁcation of CD34 posi-
tive cells from the autologous peripheral 
blood for clinical applications 38. The ﬁrst 
clinical phase-I trail using autologous 
Schwann cells to remyelinate inﬂamma-
tory lesions within the central nervous 
system caused by multiple sclerosis (per-
sonal communication, Jeffery Kocsis) em-
phasizes the clinical relevance of Schwann 
cell transplantation paradigms. Of course, 
MACS selection of p75LNGFr expressing 
Schwann cells has to be validated in the 
human system, before this method can be 
applied to clinically relevant regenerative 
strategies aiming for axon repair and re-
myelination. 
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Schwann cells fail to replace ﬁbroblasts as 
supporting cells for adult neural progenitor cell 
grafts in the acutely injured spinal cord
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1. INTRODUCTION
The development of a cystic lesion cavity 
represents a typical sequel of spinal cord 
injury preventing axonal regrowth and 
functional recovery. In particular, following 
complete spinal cord injury the introduc-
tion of a permissive substrate as replace-
ment for the lesion cavity is required to 
promote axonal regeneration across the 
injury site and ultimately reinnervation of 
target neurons. 
Recently, we have demonstrated that adult 
neural progenitor cells (NPC) not only sur-
vive and allow organotypic cell replace-
ment after transplantation into the acutely 
injured spinal cord, but also replace cystic 
lesion defects and promote cell-contact 
mediated regeneration of the corticospi-
nal tract (CST) after co-grafting with pri-
mary ﬁbroblasts 1, 2. Fibroblasts were re-
quired to provide a supporting scaffold to 
maintain adult NPC within the lesion cav-
ity. If one considers NPC transplantation 
for clinical use, ﬁbroblasts need to be re-
placed by a more suitable cellular or non-
cellular supporting scaffold, since there 
are major concerns that ﬁbroblasts and 
extracellular matrix molecules released by 
ﬁbroblasts represent potent inhibitors of 
axonal regrowth in the mammalian cen-
ABSTRACT
Adult neural progenitor cells (NPC) co-grafted with ﬁbroblasts replace cystic lesion 
defects and promote cell-contact mediated axonal regeneration in the acutely injured 
spinal cord. Fibroblasts are required as a platform to maintain NPC within the lesion, 
however, they are suspected to create an inhospitable milieu for regenerating CNS 
axons. Therefore, we thought to replace ﬁbroblasts by primary Schwann cells, which 
might serve as a superior scaffold to maintain NPC within the lesion and might further 
enhance axon regrowth and remyelination following spinal cord injury. Adult rats under-
went a cervical dorsal column transection immediately followed by transplantation of 
either NPC/Schwann cell or NPC/Schwann cell/ﬁbroblast co-grafts. Animals receiving 
Schwann cell or ﬁbroblast grafts alone, or Schwann cell/ﬁbroblast co-grafts served as 
controls. At three weeks after injury/transplantation, histological analysis revealed that 
only ﬁbroblast containing grafts were able to replace the cystic lesion defect. In both, 
co-cultures and co-grafts, Schwann cells and NPC were segregated. Almost all NPC 
migrated out of the graft into the adjacent host spinal cord. As a consequence, only 
peripheral type myelin, but no CNS type myelin, was detected within NPC/Schwann 
cell containing co-grafts. Corticospinal axon regeneration into Schwann cell containing 
co-grafts was massively diminished. Taken together, Schwann cells within NPC grafts 
contribute to remyelination. However, Schwann cells fail as a supporting platform to 
maintain NPC within the graft and Schwann cells impair CNS axon regeneration, which 
makes them an unfavorable candidate to support/augment NPC grafts following spinal 
cord injury. 
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tral nervous system (CNS) 3, 4. 
Schwann cells might represent an ideal 
cell population to be combined with NPC 
instead of ﬁbroblasts for transplantation. 
Schwann cells are the key factor to sup-
port spontaneous axonal regeneration 
following peripheral nerve injury 5. Even 
after transplantation into the injured 
spinal cord, Schwann cells have been 
shown to promote axon regrowth and 
remyelination 6-8. Furthermore, Schwann 
cells intrinsically produce favorable ex-
tracellular matrix molecules such as 
laminin 9, which might be suitable as a 
supporting scaffold for co-grafted adult 
NPC. Schwann cells intrinsically secrete 
growth promoting neurotrophic factors 
and, as opposed to NPC 10, Schwann 
cells can be easily genetically modiﬁed 
to overexpress therapeutic transgenes 
11-13. 
In the present study we thought to elu-
cidate whether Schwann cells instead of 
ﬁbroblasts might provide a more favor-
able cell-based supporting scaffold for 
co-grafted adult NPC, which would al-
low superior structural repair as prereq-
uisite for substantial functional recov-
ery. Schwann cells were co-grafted with 
adult NPC into acute cervical dorsal col-
umn transections in adult rats. Results 
demonstrate that Schwann cells alone 
are not sufﬁcient to maintain co-grafted 
adult NPC in the lesion cavity. Only the 
addition of ﬁbroblasts to Schwann cell 
containing grafts allows cyst replace-
ment. However, Schwann cell contain-
ing grafts dramatically impair CNS axon 
regeneration. 
2. MATERIALS AND METHODS
2.1 Animals
Adult female Fischer 344 rats (160-180g) 
were used. All experiments were carried 
out in accordance with the institutional 
guidelines for animal care. All efforts were 
made to minimize the number of animals 
used. Animals had ad libitum access to 
food and water throughout the study. 
All surgical procedures were performed 
under anesthesia with a combination of 
ketamine (62.5mg/kg body weight; WDT, 
Garbsen, Germany), xylazine (3.175mg/
kg body weight; WDT) and acepromazine 
(0.625mg/kg body weight, Sanoﬁ-Ceva, 
Düsseldorf, Germany) in 0.9% sterile sa-
line solution. 
2.2 Cell preparation
For the isolation of NPC, ﬁbroblasts and 
Schwann cells, adult female Fischer 344 
rats were deeply anesthetized as de-
scribed above and killed by decapitation. 
NPC were isolated from the cervical spi-
nal cord as described before 1. Brieﬂy, the 
cervical spinal cord (spinal cord level C3 
through T1) was dissected out, minced 
and washed in sterile Dulbecco’s phos-
phate buffered saline/D-glucose (PBS, 
4.5g/l; PAA Laboratories, Linz, Austria). 
Subsequently, the tissue was digested in 
a solution of papain (0.01%; Worthington 
Biochemicals, Lakewood, USA), neutral 
protease (0.1%; Roche, Mannheim, Ger-
many), DNase I (0.01%; Worthington Bio-
chemicals) and 12.4mM MgSO4, dissolved 
in Hank’s balanced salt solution (HBSS; 
PAA Laboratories) for 30 min at 37°C. The 
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resulting cell suspension was washed 
and plated on culture dishes containing 
serum-free growth medium, consisting 
of Neurobasal medium with B27 supple-
ment (Gibco) and 20 ng/ml recombinant 
human FGF-2 (R&D System, Wiesbaden, 
Germany). Cells were expanded either as 
neurospheres in uncoated culture ﬂasks 
or as adherent monolayer in culture ﬂasks 
coated with poly-l-ornithine (20µg/cm2; 
Sigma) and laminin (0.4µg/cm2; Sigma) as 
described before 1. 
Primary ﬁbroblasts were isolated from 
adult Fischer 344 rat skin biopsies and 
cultured in DMEM medium (Pan Biotech, 
Aidenbach, Germany) supplemented with 
10% of FCS as described before 14. 
Schwann cells were isolated from adult 
sciatic nerve biopsies employing mag-
net-activated cell separation (MACS) of 
p75 low afﬁnity NGF receptor expressing 
Schwann cells according to established 
protocols 15. The purity of Schwann cells, 
which was assessed by comparing the 
number of Hoechst stained nuclei with 
p75 low afﬁnity NGF receptor expressing 
cells, was >99%. Puriﬁed Schwann cell 
cultures were expanded in DMEM medium 
supplemented with 10% FCS, 2 mM for-
skolin (Sigma) and 0.2% bovine pituitary 
extract (Clonetics, Oldendorf, Germany).
For the identiﬁcation of co-cultured NPC 
in vitro and co-grafted Schwann cells in 
vivo, the respective cell populations were 
genetically modiﬁed to express the re-
porter gene green-ﬂuorescent protein 
(GFP) using a MLV-based retroviral vec-
tor pCLE-GFP containing the internal EF-
1alpha promoter 1, 10. NPC or Schwann 
cells (passage 3-5) were plated in sub-
conﬂuent densities and were exposed 
on two consecutive days with retrovi-
rus containing growth medium supple-
mented with 1 µg/ml Polybrene (Sigma). 
G418 (500µg/ml; Gibco) was added to 
the growth medium for the selection 
of cells, which integrated the retroviral 
vector. Successful incorporation of the 
transgene was conﬁrmed by detection 
of GFP using an inverted ﬂuorescence 
microscope (Olympus IX 70). 
2.3 Co-cultures of adult NPC and 
Schwann cells 
For the analysis of NPC differentiation in 
vitro, GFP expressing NPC maintained 
as neurospheres were dissociated us-
ing Accutase (Innovative Cell Tech, San 
Diego, USA) and incubated in NB me-
dium with B27 supplemented with 5% 
FCS for 7 days after seeding onto poly-
l-ornithine/laminin (Sigma) coated cover 
slips (Pan Biotech). For the analysis of 
NPC differentiation co-cultured with 
Schwann cells, GFP expressing NPC 
were seeded onto a conﬂuent layer of 
Schwann cells. Co-cultures were incu-
bated for 7 days in NB medium with B27 
supplemented with 5% FCS. Cells were 
ﬁxed with 4% paraformaldehyde in PBS 
and immunolabeled using the following 
antibodies: mouse-anti-nestin for pro-
genitor/stem cells (Pharmingen, Heidel-
berg, Germany; at 1/1000), mouse-anti-
GFAP for astroglia (Chemicon, Hofheim, 
Germany; at 1/600), mouse-anti-A2B5 
for glial precursor cells (Chemicon; at 
1/100), mouse-anti-RIP for oligoden-
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droglia (Chemicon; at 1/500), mouse-
anti-beta-III-tubulin for neurons (Pro-
mega; at 1/500) and rabbit-anti-GFP for 
GFP expressing cells (Molecular Probes, 
Leiden, The Netherlands; at 1/1000). 
Cells were washed three times with 
tris-buffered saline (TBS) after ﬁxation, 
blocked with TBS containing 3% don-
key serum/0.1% Triton-X (Sigma) and 
incubated overnight with the primary 
antibody in TBS + 3% donkey serum + 
0.1% Triton-X at 4°C. The following day, 
cells were washed with TBS and incu-
bated with Alexa-568 linked secondary 
goat-anti-mouse (Molecular Probes; 
at 1/1000) and Alexa-488 linked goat-
anti-rabbit secondary antibodies (Mo-
lecular Probes; at 1/1000) in TBS + 3% 
donkey serum + 0.1% Triton-X for 2h. 
Finally, nuclei were counterstained with 
Hoechst 33342 (2 µg/ml in TBS; Sigma). 
The coverslips were mounted onto glass 
slides using Prolong-Antifade (Molecu-
lar Probes). For the immunocytochemi-
cal analysis, 8 bit monochrome pictures 
were taken at 20x magniﬁcation on a 
ﬂuorescent microscope (Leica DMR) 
equipped with a Spot CCD camera 
model 2.2.1 (Diagnostic Instruments, 
Sterling Heights, USA). The number of 
speciﬁcally immunolabeled cells and the 
total cell number (number of Hoechst 
counterstained nuclei) were determined 
in 5 random ﬁelds for each differentia-
tion marker to determine the percentage 
of cells expressing the respective differ-
entiation marker. Three independently 
performed immunocytochemical stains 
were analyzed under each condition. 
2.4 Preparation of cells for 
transplantation 
For the identiﬁcation after transplanta-
tion, NPC were prelabeled with the thy-
midine analogue bromodeoxyuridine 
(BrdU; Sigma) 48h before transplantation 
as described 1. Expression of the reporter 
gene GFP allowed to identify Schwann 
cell grafts in vivo. Immediately before 
transplantation, respective cells were har-
vested and washed three times in PBS. 
A sample of the resulting single cell sus-
pensions was stained with Trypan Blue 
(Sigma) and counted using a Neubauer 
hemocytometer. NPC, Schwann cell and 
ﬁbroblast suspensions were mixed and 
diluted in PBS to yield the appropriate cell 
densities in the different grafting para-
digms (Table 1). Due to the larger cell size 
of ﬁbroblasts in comparison to Schwann 
cells and NPC, the cell concentration in 
different grafting conditions was adapted 
to yield equally dense suspensions. 
2.5 Surgical procedures 
Spinal cord lesions, cell transplantation 
and anterograde labeling of the CST were 
performed as previously described 1, 2. 
Brieﬂy, the dorsal columns containing the 
dorsal CST were transected at cervical 
level C3 using a tungsten wire knife (Da-
vid Kopf Instruments Tujuna, USA) leaving 
the surrounding dura intact. A total vol-
ume of 2.5 µl cell suspension (for differ-
ent grafting conditions and experimental 
groups see Table 1) was injected directly 
into the lesion site through a pulled glass 
micropipette (100 µm internal diameter) 
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using a Picospritzer II (General Valve, 
Fairﬁeld, USA). Animals receiving a dorsal 
column transection without cell transplan-
tation served as control (Lesion; n=6). 
For anterograde tracing of the CST, 300 
nl of a 10% solution of biotinylated dex-
tran-amine (BDA; 10.000 MW, Molecular 
Probes) was injected through pulled glass 
micropipettes (40 µm internal diameter) 
into each of 18 sites per hemisphere 
spanning the rostrocaudal extent of the 
rat forelimb and hindlimb sensorimotor 
cortex using a PicoSpritzer II (General 
Valve) 1 week post lesioning/grafting.
2.6 Morphological analysis 
At 3 weeks post lesioning/grafting, ani-
mals were transcardially perfused with a 
0.9% saline solution in 0.1 M phosphate 
buffer followed by 4% paraformaldehyde 
in 0.1 M phosphate buffer. Sagittal 35 µm 
cryostat sections were processed for vi-
sualization of the BDA labeled CST and 
for immunohistochemistry. Every seventh 
section was mounted for Nissl staining to 
determine the lesion size. Double/triple 
labeling immunoﬂuorescence techniques 
were performed with free ﬂoating sections 
to assess cell survival and in vivo differ-
entiation pattern. The following primary 
antibodies were used: mouse-anti-GFAP 
for astrocytes (DAKO; at 1/200), mouse-
anti-APC for oligodendrocytes (Onco-
gene, Darmstadt, Germany; at 1/1000), 
rabbit-anti-NG2 for glial precursor cells 
(Chemicon; at 1/200), goat-anti-double-
cortin for neuronal precursor cells (Santa 
Cruz Laboratories, Santa Cruz, USA; at 
1/500), rabbit-anti-200 kDa neuroﬁlament 
as general axonal marker (Boehringer 
Mannheim, Germany; at 1/250), mouse-
anti-P0 for peripheral myelin (generous 
gift from J. Archelos, University of Dues-
seldorf, Germany; at 1/500), mouse-anti-
myelin oligodendrocyte-speciﬁc protein 
(MOSP) for CNS myelin (Chemicon; at 
1/5000), rat-anti-BrdU for BrdU-prela-
beled cells (Harlan SeraLab, Loughbor-
ough, UK; at 1/500) and rabbit-anti-GFP 
for GFP expressing cells (Molecular 
Probes; at 1/1000). Immunolabeling with 
primary antibodies was visualized us-
ing Alexa-488, Alexa-568 or Alexa-660 
linked donkey secondary antibodies (Mo-
lecular Probes; at 1/1000). Sections were 
rinsed in 0.1 M Tris buffered saline (TBS), 
incubated in TBS + 3% donkey serum + 
0.1% Triton-X for 1h, then transferred into 
the ﬁrst primary antibody and incubated 
overnight at 4°C on a rotating platform. 
For visualization of BrdU-prelabeled adult 
NPC the staining protocol was modiﬁed 
as follows: after rinsing in TBS, sections 
were incubated for 1h in 50% formamide/
Table 1: Cell concentration in different grafting conditions:
Experimental group Fibroblasts Schwann cells Neural progenitor cells
FF  (n=10) 1.5 x 105/µl -- --
SC  (n=8) -- 3 x 105/µl --
NPC/SC  (n=7) -- 1.25 x 105/µl 2.5 x 105/µl
SC/FF  (n=6) 1.5 x 104/µl 3 x 105/µl --
NPC/SC/FF  (n=6) 6.3 x 103/µl 1.25 x 105/µl 2.5 x 105/µl
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2xSSC (0.3 M NaCl, 0.03M sodium citrate) 
at 65ºC. Sections were rinsed in 2xSSC, 
incubated for 30 min in 2 N HCl at 37ºC, 
and rinsed for 10 min in 0.1 M boric acid 
pH 8.5. After rinsing in TBS, sections were 
incubated in TBS + 3% donkey serum + 
0.1% Triton-X as described above. The 
following day, sections were rinsed and 
incubated with ﬂuorophore (Alexa-488/-
568/-660) conjugated secondary donkey 
antibodies (Molecular Probes; at 1/1000) 
for 2.5 h. BDA labeled CST axons were 
visualized by incubation with Cy5-conju-
gated streptavidin (Jackson; at 1/1000). 
After a ﬁnal rinsing step in TBS, sections 
were mounted onto glass slides and cov-
erslipped with ProLong Antifade Kit (Mo-
lecular Probes). Confocal immunoﬂuores-
cence microscopy was performed using a 
Leica TCS-NT system.
2.7 Quantiﬁcation of lesion size and 
axon regrowth 
The investigator quantifying cavity size 
and axonal regeneration was blinded for 
the group identity of each analyzed sec-
tion. The lesion cavity and graft sizes 
were quantiﬁed by surrounding respec-
tive structures with a digital pen in a 1 out 
of 7 series of Nissl stained sagittal sec-
tions of each animal using the NIH Image 
J 10.2 software. For the quantiﬁcation of 
axon (neuroﬁlament immunoreactive axo-
nal proﬁles) and CST axon growth  (BDA 
labeled axonal proﬁles) within the graft, 
one sagittal section per animal through 
the main portion of the respective graft 
was chosen. Digital brightﬁeld images of 
neuroﬁlament-DAB or BDA-DAB visual-
ized sections were captured using a Spot 
CCD camera, model 2.2.1 (Diagnostic In-
struments, Michigan, USA) attached to a 
Leica DMR microscope at 200x magniﬁ-
cation. The graft–host interface was deter-
mined after inserting the transmitted light 
condenser, which allows to discriminate 
between the orderly tissue architecture of 
the host and the randomly organized cell 
graft. The number of pixels representing 
the labeled axons was assessed using 
NIH Image J software. 
2.8 Statistical analysis 
All data are expressed as mean ± SEM. 
Comparisons of NPC cultures with SC/
NPC co-cultures were made by using a 
Student’s T-test. Comparisons of cyst size 
and axonal regeneration were made using 
the Kruskal-Walis nonparametric analysis 
of variance, followed by Dunn’s multiple 
comparison post hoc testing. For all sta-
tistical tests, p<0.05 was considered sig-
niﬁcant.
3. RESULTS
3.1 In vitro analysis of NPC/Schwann 
cell interactions. 
The aim of the present study was to inves-
tigate a transplantation paradigm, where 
adult NPC are combined with Schwann 
cells representing a more growth condu-
cive cell population as opposed to ﬁbro-
blasts, which have been employed in a 
previous study 2. Before transplantation, 
we ﬁrst investigated the interaction of 
Schwann cells and NPC (changes in dif-
ferentiation, cell adhesion) in vitro. NPC 
were co-cultured with Schwann cells un-
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der NPC differentiation conditions for 7 
days as previously described 2, 10. Unlike 
ﬁbroblasts, Schwann cells do not attach 
to uncoated cell culture surfaces. There-
fore, Schwann cells were plated on poly-l-
ornithine/laminin coated glass coverslips 
and grown until conﬂuent in NPC differen-
tiation medium (NB medium supplement-
ed with B27 and 5% FCS). Subsequently, 
undifferentiated NPC transduced to ex-
press the reporter gene GFP (GFP-NPC) 
were plated onto a Schwann cell mono-
layer and incubated for 7 days in NPC 
differentiation medium. Since Schwann 
cells have been described to express glial 
and neuronal markers relevant for NPC 
differentiation 16, 17, we ﬁrst checked for 
cross-immunoreactivity of Schwann cells 
for the NPC differentiation markers A2B5, 
beta-III-tubulin, GFAP and RIP (Fig. 1A-D). 
Schwann cells displayed only strong im-
munoreactivity for beta-III-tubulin, which 
is commonly used to indicate early neuro-
nal differentiation in NPC. However, beta-
III-tubulin positive Schwann cells were 
clearly distinguishable by their promi-
nent nucleus and compact morphology 
as opposed to rather small nuclei and 
ﬁne processes of beta-III-tubulin immu-
noreactive NPC. Co-cultured NPC were 
immunoreactive for markers identifying 
glial precursor cells (A2B5 expression), 
astroglia (GFAP), oligodendroglia (RIP) 
and neurons (beta-III-tubulin) (Fig. 1E-H) 
in accordance with previous studies 1, 2. 
The expression of these markers in NPC 
was quantiﬁed to detect a potential inﬂu-
ence of co-cultured Schwann cells on the 
differentiation pattern of NPC (Fig.1I). The 
presence of Schwann cells signiﬁcantly 
Figure 1: Primary Schwann cells induce glial differentiation in NPC in vitro. The differentiation markers for 
NPC, (A, E) A2B5 for glial precursor cells, (B, F) beta-III-tubulin for neurons, (C, G) GFAP for astroglia and 
(D, H) RIP for oligodendroglia (all shown in red), were investigated for their cross-reactivity with primary 
Schwann cells (A-D). Of these markers, Schwann cells strongly expressed beta-III tubulin (B), whereas GFAP 
immunoreactivity was rather weak (C). Reporter gene (GFP) expressing NPC (green) are immunoreactive 
for A2B5, beta-III tubulin, GFAP and RIP (E-H). (I) The quantiﬁcation of respective immunocytochemical 
stains revealed that co-culturing of NPC and Schwann cells signiﬁcantly increased the proportion of GFAP 
expressing astroglia, while A2B5 expressing glial precursor cells were signiﬁcantly reduced (p<0.05). A-H 
Hoechst 33342 as nuclear counterstain (blue). Epiﬂuorescence micrographs. Scale bar A-H 20µm.
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reduced the proportion of A2B5 posi-
tive glial precursor cells (5% ± 1.3 ver-
sus 1.1% ± 0.1), whereas the proportion 
of GFAP positive astroglia was increased 
from 31.3% (± 1.8) in the NPC differentia-
tion condition compared to 41.8% (± 2.9) 
in the Schwann cell-NPC co-culture dif-
ferentiation condition. Beta-III tubulin and 
RIP immunoreactivity was not altered by 
co-cultured Schwann cells. 
After 7 days of co-culture, NPC, which 
were initially plated onto Schwann cell 
monolayers, were completely separated 
from Schwann cells (Fig. 2A-C). GFAP-
positive astrocytes with a stellate mor-
phology reminiscent of reactive astroglia 
appear to seal off the ‘NPC compartment’ 
from the ‘Schwann cell compartment’, 
whereas Schwann cells represented by 
GFP negative Hoechst stained nuclei are 
Figure 2: NPC and Schwann cells become segregated in vitro and in vivo. (A) After 7 days of co-culturing 
Schwann cells and GFP expressing NPC (green) in differentiation medium, NPC and Schwann cells (identiﬁed 
by GFP-negative Hoechst 33342 counterstained nuclei) appear completely segregated on the poly-l-ornithine/
laminin coated cell culture surface. GFAP positive processes (red) co-localized with GFP expressing NPC seal 
off the NPC from the Schwann cell area (arrowheads). Overlay GFP (green), GFAP (red) and Hoechst 33342 
(blue). (B) GFP (green) and Hoechst 33342 (blue). (C) GFAP (red) and Hoechst 33342 (blue). (D) SC/FF grafts 
ﬁll out the lesion defects with GFP-expressing Schwann cells (green) densely distributed throughout the 
graft. Doublelabeling with GFAP (red) indicates that the SC/FF graft is delineated from the adjacent host 
parenchyma by a astroglial border. (E) Identical situation with NPC/SC/FF grafts. GFP-expressing Schwann 
cells (green), GFAP (red). (F) Immunohistochemical detection of BrdU prelabeled NPC reveals that the vast 
majority of NPC has migrated from the NPC/SC/FF graft (dashed line) into the surrounding host spinal cord. 
A-C epiﬂuorescence micrographs, D, E confocal ﬂuorescence micrographs, F brightﬁeld micrographs. 
Orientation in D-F: rostral is to the left, dorsal to the top. Scale bar A-C 50 µm, D, E 73 µm and F 87 µm.
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arranged in compact streams in between 
patches of GFP positive NPC. 
Taken together, Schwann cells induced 
a shift of adult NPC from immature to 
mature astroglial differentiation in vitro. 
The segregation of co-cultured NPC and 
Schwann cells suggests that a homoge-
nous distribution of these cell populations 
after transplantation in vivo is unlikely. 
3.2 Cyst replacement, cell survival 
and differentiation of grafted 
NPC.
The size of the cystic lesion defect in the 
various grafting conditions (Table 1) was 
quantiﬁed, to determine the capacity of 
Schwann cells to maintain co-grafted 
NPC within the cystic lesion environ-
ment. Animals with dorsal column tran-
sections at cervical level receiving either 
1) ﬁbroblasts only (FF), 2) highly puriﬁed 
Schwann cells only (SC), 3) NPC and 
Schwann cells (NPC/SC), 4) ﬁbroblasts 
and Schwann cells (SC/FF) or 5) NPC, 
Schwann cells and ﬁbroblasts (NPC/SC/
FF) were compared with lesioned only 
animals (Lesion). Without grafting, the 
described spinal cord lesion produces 
a cystic lesion cavity within the dorsal 
column measuring 3.68 ± 0.62 mm2 (Fig. 
3A,G). Schwann cell grafts alone (SC) 
or combined NPC/Schwann cell trans-
plants (NPC/SC) allowed only a cyst re-
duction between 53.5 and 46.2% of its 
original size (Fig. 3C,D,G). Increasing the 
number of transplanted Schwann cells in 
these conditions did not further diminish 
the lesion defect (data not shown). Only 
the addition of primary ﬁbroblasts (5% 
of the total number of grafted Schwann 
cells) dramatically improved the cyst 
replacement reducing the lesion size 
by 89.4% (SC/FF), 81.5% (NPC/SC/FF) 
and 88% (FF) (Fig. 3B,E,F,G). 
Both regeneration promoting cell popula-
tions, Schwann cells and NPC, survived 
after transplantation into the acutely in-
jured spinal cord (Fig. 2D-F). Schwann 
cells expressing the reporter gene GFP 
were restricted to the former cystic le-
sion area without migration into the sur-
rounding host parenchyma in respective 
co-grafting conditions, whereas BrdU-
prelabeled NPC were identiﬁed primarily 
in the spinal cord adjacent to the graft 
(NPC/SC/FF) with few NPC within the 
actual graft. Thus, cystic lesion replace-
ment is mainly accomplished by grafted 
Schwann cells supported by ﬁbroblasts. 
The pattern of Schwann cell/NPC distri-
bution in vivo recapitulates the in vitro 
ﬁnding, where Schwann cells and NPC 
become segregated spontaneously 
within a short period of time (Fig. 2A-
C). The lining of GFAP positive astroglial 
processes along Schwann cells streams 
in vitro is paralleled by a strongly GFAP 
immunoreactive astroglial rim surround-
ing Schwann cell containing co-grafts in 
vivo (Fig. 2D,E). 
In parallel with previous observations, 
the co-grafted NPC mainly differenti-
ated into GFAP positive astroglia (Fig. 
4A, B), fewer GFAP negative grafted 
cells were also found to express APC 
indicating oligodendoglial differentiation 
(Fig. 4C). Rarely, NPC were immunore-
active for NG2, which is expressed on 
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Figure 3: Sufﬁcient cyst replacement requires ﬁbroblast containing grafts. (A) A cervical wire knife dorsal 
column transection typically results in a large cystic lesion defect without therapeutic intervention. (B) Pure 
ﬁbroblasts grafts (FF) replace the lesion cyst, whereas (C) highly puriﬁed Schwann cells (SC) or (D) combined 
grafts of NPC and Schwann cells (NPC/SC) leave the majority of the lesion defect unchanged. As soon as 
5% ﬁbroblasts are added to (E) Schwann cell grafts (SC/FF) or (F) combined NPC and Schwann cell grafts 
(NPC/SC/FF) the lesion defect is almost completely replaced. (G) Quantiﬁcation of the cystic lesion area in 
each grafting paradigm compared to animals with lesions only (Lesion). (** indicates p<0.01, *** indicates 
p<0.001). A-F Brightﬁeld micrographs of sagittal Nissl-stained sections. Orientation A-F: rostral to the left, 
dorsal to the top. Scale bar A-F 400µm.
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immature glial cells, 3 weeks after trans-
plantation (Fig. 4D). As expected, none 
of the grafted NPC displayed the early 
neuronal differentiation marker double-
cortin in vivo (data not shown). 
3.3 Axonal response
As shown above, only ﬁbroblast contain-
ing transplants sufﬁciently replaced the 
cystic lesion defect as a prerequisite to 
build a bridge for axons to regenerate on. 
Three weeks after lesioning and grafting 
the axonal response into the respective 
grafts was assessed quantifying 1) neu-
roﬁlament immunoreactive axons and 2) 
speciﬁcally anterogradely BDA labeled 
corticospinal axons. Co-grafts contain-
ing NPC and Schwann cells (NPC/SC/
FF) elicited the highest overall axonal 
regrowth (6366 ± 841 pixels/mm2) com-
Figure 4: NPC combined with Schwann cells differentiate into astroglia and oligodendroglia in vivo. The 
differentiation pattern of grafted NPC was assessed by identifying respective differentiation markers (red and 
green) co-localized (arrowheads) with BrdU prelabeled NPC (blue) within the adjacent spinal cord parenchyma. 
Grafted NPC co-localized with (A) APC and GFAP, or (B) GFAP alone indicate astroglial differentiation, 
whereas (C) co-localization with APC, but not with GFAP, depicts oligodendroglial differentiated NPC. (D) Few 
grafted NPC could be matched with NG2, a marker for glial restricted progenitor cells. Confocal ﬂuorescence 
micrographs. Orientation in all micrographs rostral to the left, dorsal to the top. Scale bar A-D 10 µm.
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pared to co-grafts with Schwann cells 
(SC/FF; 4998 ± 1008 pixels/mm2) and 
pure ﬁbroblasts grafts (FF; 3632 ± 347 
pixels/mm2) as assessed by the density 
of neuroﬁlament positive axonal proﬁles 
(Fig. 5). Analysis of neuroﬁlament ex-
pression does not allow to distinguish 
between axonal regrowth from CNS 
derived axons versus ingrowth from pe-
ripheral nerve derived axons through the 
dorsal root entry zone. Therefore, corti-
cospinal axons were speciﬁcally antero-
gradely labeled using BDA and quanti-
ﬁed (Fig. 6). The degree of corticospinal 
axon regrowth was signiﬁcantly reduced 
in Schwann cell containing co-grafts 
Figure 5: Axonal growth is enhanced into Schwann cell containing grafts. Immunohistochemical analysis of 
200kD neuroﬁlament expression reveals that the density of neuroﬁlament expressing axons within respective 
grafts increases from (A) FF over (B) SC/FF and (C) NPC/SC/FF grafts, which is conﬁrmed by (D) quantiﬁcation 
of neuroﬁlament density (* indicates p<0.05). A-C dashed lines outline the graft/host border. Brightﬁeld 
micrographs. Orientation in A-C: rostral to the left, dorsal to the top. Scale bar A 125 µm, B, C 100 µm.
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(SC/FF; 1601 ± 628 pixels) compared to 
pure ﬁbroblast grafts (FF; 6879 ± 1797) 
(Fig. 7A,B,D). NPC/SC/FF co-grafts did 
not signiﬁcantly alter the degree of CST 
axon regeneration (Fig. 7C,D; 5105 ± 
3553). Thus, as soon as Schwann cells 
are added to the grafting paradigm, CST 
regeneration is dramatically impaired. 
By combining Schwann cells with NPC, 
this impaired regeneration can be re-
versed, but only up to a degree of axo-
nal regeneration observed with pure ﬁ-
broblast grafts.
Figure 6: Schwann cell containing grafts impair corticospinal axon regeneration. Brightﬁeld microscopical 
analysis of anterogradely BDA-labeled dorsal corticospinal axons shows the regenerative response of CNS 
axons into (A) FF (B) SC/FF and (C) NPC/SC/FF grafts. Dashed lines outline the graft/host interface. (D) 
As determined by quantiﬁcation of BDA labeled corticospinal axon proﬁles, CST regeneration is massively 
reduced in animals with SC/FF grafts. (*indicates p<0.01). A-C brightﬁeld micrographs. Orientation in A-C: 
rostral to the left, dorsal to the top. Scale bar A-C 100 µm.
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3.4 Schwann cell and NPC induced 
remyelination
Both, grafted Schwann cells and NPC 
have the capacity to remyelinate axons 
following spinal cord injury. Therefore, 
the expression of Schwann cell (P0) and 
oligodendroglia speciﬁc (myelin oligo-
dendrocyte-speciﬁc protein; MOSP) my-
elin-associated molecules within the graft 
was analyzed. In both grafting paradigms 
containing Schwann cells (SC/FF and 
NPC/SC/FF), strong P0 immunoreactiv-
ity restricted to the graft site was detect-
able (Fig. 7A,B). The close spatial asso-
ciation of P0 labeling with neuroﬁlament 
positive axons indicates that regenerating 
Figure 7: Only peripheral type myelin can be identiﬁed within co-grafts. PNS myelin indicated by P0 
immunoreactivity (red) is abundant throughout Schwann cell containing grafts such as (A) SC/FF and (B) 
NPC/SC/FF grafts. (C) P0 (red) and neuroﬁlament immunoreactive (green) structures within Schwann cell 
containing grafts display a close spatial correlation (arrowheads), which indicates remyelination of regenerating 
axons by grafted Schwann cells. Overlay. (D) Neuroﬁlament. (E) P0. (F) MOSP immunoreactivity representing 
CNS myelin was virtually absent both in co-grafts without (SC/FF) and co-grafts with (NPC/SC/FF) NPC. 
Confocal ﬂuorescence micrographs. Orientation: rostral to the left, dorsal to the top. Scale bar A, B, F, G 200 
µm, C-E 18 µm.
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axons within the graft become remyelin-
ated by grafted Schwann cells (Fig. 7C-E). 
In contrast, virtually no immunoreactivity 
for CNS myelin was identiﬁable in any 
of the grafting conditions including NPC 
containing grafts (NPC/SC/FF) (Fig. 7F,G), 
which is not surprising knowing that the 
majority of co-grafted NPC leave the graft 
site (Fig. 2F). The only means to attribute 
(re-)myelination to grafted NPC is to co-
localize BrdU prelabeled NPC with CNS 
myelin immunoreactivity. However, the 
antigen retrieval procedure required to 
detect BrdU is not compatible with immu-
nohistochemical analysis of CNS myelin. 
Therefore, the degree of remyelination 
promoted by co-grafted NPC outside 
of the graft cannot be determined in the 
present study.
4. DISCUSSION
The aim of the present study was to inves-
tigate whether Schwann cells represent a 
more favorable cell population to be co-
grafted with adult NPC instead of primary 
ﬁbroblasts. Unlike ﬁbroblasts, Schwann 
cells alone or in combination with NPC 
do not replace the cystic lesion defect 
developing following spinal cord injury. 
Schwann cells augment overall axonal 
regrowth, however, regeneration of cor-
ticospinal axons is impaired as soon as 
Schwann cells are introduced. Within the 
graft, remyelination by Schwann cells is 
observed, whereas almost all co-grafted 
NPC migrate into the adjacent spinal cord 
parenchyma, thus precluding remyelin-
ation through NPC derived oligodendrog-
lia within the graft. 
Adult NPC represent a promising cell-
based strategy following spinal cord in-
jury. However, adult NPC alone are not 
sufﬁcient to replace typically developing 
cystic lesion defects 1. In a recent study, 
we were able to demonstrate that ﬁbro-
blasts and extracellular matrix produced 
by ﬁbroblasts provide a scaffold for NPC 
to adhere to, thus maintaining co-graft-
ed NPC within the lesion site 2. Primary 
Schwann cells, which were highly puriﬁed 
(>99%) from adult sciatic nerves using 
MACS and consecutively introduced into 
co-grafts with NPC instead of ﬁbroblasts, 
were not able to sufﬁciently replace cys-
tic lesion defects in the present study. 
Once ﬁbroblasts were added, even in low 
amounts, lesion replacement was almost 
complete. This ﬁnding is in line with previ-
ous studies, which report diminished in-
jury induced cavitation with Schwann cell 
grafts containing a signiﬁcant proportion 
of ﬁbroblasts either by grafting less pure 
Schwann cell suspension grafts (95-98%) 
8 or by grafting Schwann cells combined 
with 5% ﬁbroblasts 18. Apparently, highly 
puriﬁed Schwann cells alone do not pro-
duce sufﬁcient extracellular matrix com-
ponents qualitatively and quantitatively to 
replace cystic lesion defects or to serve 
as a platform for co-grafted NPC follow-
ing transplantation into the injured spinal 
cord. 
Another highly relevant aspect of any cell-
based regenerative approach in the injured 
spinal cord is that grafted cells not only 
replace the lesion defect, but also inte-
grate into the host spinal cord, thus build-
ing a continuous transition from the spinal 
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cord into the graft and back into the spinal 
cord. Schwann cells have been shown to 
promote substantial axonal regrowth into 
the graft, however, axons failed to reenter 
the distant spinal cord 19. Schwann cells 
become sealed off by the surrounding spi-
nal cord, which has been demonstrated 
by the upregulation of growth inhibitory 
extracellular matrix components such as 
chondroitin sulfate proteoglycans around 
Schwann cell grafts 20, preventing proper 
integration into the host. In parallel, we 
observed that CNS derived adult NPC and 
Schwann cells become separated in vitro 
and in vivo. Astroglial cells differentiated 
from NPC form glia limitans-like boundar-
ies along streams of Schwann cells, which 
exactly recapitulates the segregation of 
astrocytes and Schwann cells in co-culti-
vation experiments 21. As a consequence 
in vivo, the vast majority of NPC became 
segregated from the Schwann cell en-
riched graft milieu migrating into the ad-
jacent host spinal cord. Accordingly, the 
absence of co-grafted NPC at the lesion 
site excludes signiﬁcant NPC induced 
cell-contact mediated axon regeneration, 
which has contributed to the signiﬁcant 
CST axon regrowth after co-grafting with 
ﬁbroblasts 2. Since  considerable amounts 
of host-derived Schwann cells are shown 
to spontaneously migrate into the lesion 
site after the initial injury 14, the inﬂuence 
of Schwann cells on migration of already 
differentiated NPC needs to be investigat-
ed at long time periods after the injury.
In vitro, Schwann cells induced a differ-
entiation shift from A2B5 expressing glial 
precursor cells towards GFAP expressing 
astroglia. The exact molecular differentia-
tion factors responsible for this differentia-
tion shift were not determined in the pres-
ent study. Likely candidates are LIF and 
CNTF, which are known to be released by 
Schwann cells and to induce astroglial dif-
ferentiation 22-25. Since we did not observe 
a shift towards neuronal differentiation in 
NPC/Schwann cell co-culture conditions, 
it was not surprising to see that adult NPC 
as part of NPC/SC/FF co-grafts differen-
tiated exclusively into glial cells. In line 
with previous ﬁndings 1, 2, NPC expressed 
markers resembling astroglial and oligo-
dendroglial differentiation after transplan-
tation.  Thus, neither in vitro nor in vivo 
studies indicate that Schwann cells might 
express molecular cues, which instruct 
neuronal differentiation. 
Schwann cell containing co-grafts induced 
a differential axon regrowth response. 
CST axonal regrowth into Schwann cell 
containing co-grafts was virtually absent 
replicating previous ﬁndings 8, 13, in con-
trast to ﬁbroblast grafts, which elicited at 
least minimal CST regrowth in our lesion 
paradigm. This is remarkable because 
Schwann cells are considered to have 
an intrinsic axon regenerative capacity, 
whereas ﬁbroblasts are perceived as axon 
growth inhibitory serving mainly as cellu-
lar source for growth factor production 
following transgene transfer. Most likely 
the pronounced segregation of Schwann 
cells by glia limitans formation and chon-
droitin sulfate proteoglycan upregulation 20 
is responsible for the poor CST regrowth 
into Schwann cell containing grafts. This 
notion is supported by an in vitro study, 
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which demonstrated a clear segregation 
and glial limitians formation in astrocyte/
Schwann cell versus astrocyte/ﬁbroblast 
co-cultures 21. Once NPC are added to 
Schwann cell grafts (NPC/SC/FF) they 
appear to compensate for the impaired 
CST regeneration in SC/FF grafts up to 
the level of pure ﬁbroblasts grafts. One 
can speculate that NPC co-grafted with 
Schwann cells and ﬁbroblasts may have 
promoted limited cell-contact mediated 
axonal regrowth across the graft-host 
border into the graft, which is still signiﬁ-
cantly less compared to NPC/ﬁbroblast 
co-grafts examined in a previous study 2. 
The neuroﬁlament density, reﬂecting the 
overall axonal regeneration was increased 
into Schwann cell containing co-grafts. 
Due to the nature of the applied lesion 
(dorsal column transection), transected 
ascending proprioceptive axons most 
likely accounted for the increased neu-
roﬁlament density within Schwann cell 
containing grafts, since dorsolateral or 
ventral axon tracts remain intact. Possi-
bly, these sensory projections with their 
neurons located in the dorsal root ganglia, 
as opposed to CST axons with their neu-
rons in the motorcortex, show a robust re-
generative response in a peripheral nerve 
like milieu such as Schwann cell grafts, 
which might explain the differential axon 
regrowth response. 
Schwann cell transplants have been de-
scribed to remyelinate CNS axons in a 
phenotypically appropriate manner 13, 
26 and to restore nerve conduction of le-
sioned CNS axons 27. In the investigated 
grafting paradigms co-grafted Schwann 
cells expressed P0, which is exclusively 
expressed in peripheral myelin, indicat-
ing robust Schwann cell promoted remy-
elination in the spinal cord lesion site. No 
relevant expression of CNS myelin could 
be detected within NPC containing grafts, 
which is obviously due to the observed 
migration of NPC into the adjacent host 
spinal cord. 
Taken together, the failure to replace 
cystic lesion defects and the impaired 
regeneration of severed CST axons into 
Schwann cell grafts precludes the com-
bination with NPC for a clinically relevant 
cell-based regenerative approach. This 
does not mean that pure Schwann cell 
grafts may not be beneﬁcial. Schwann 
cells readily remyelinate CNS axons and 
elicit regeneration of spinal and supraspi-
nal axons 20. Recent studies have dem-
onstrated that Schwann cells are even 
superior to olfactory ensheathing cells 
and elicit partial functional recovery 8. In 
respect to NPC, future studies need to in-
vestigate alternative approaches such as 
application of natural/synthetic matrices, 
to maintain NPC within the lesion defect 
as a prerequisite to allow cell-contact me-
diated axon regeneration across the injury 
site, proper target reinnervation and ulti-
mately functional recovery.
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Loss of gene expression in lentivirus- and 
retrovirus- transduced neural progenitor cells is 
correlated to migration and differentiation in the 
adult spinal cord
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1. INTRODUCTION
Gene therapy holds great potential for the 
treatment of several central nervous sys-
tem (CNS) disorders. Delivery of therapeu-
tic molecules by gene therapy has been 
shown to halt or delay the progression of 
neurodegenerative diseases 1-3 or to aug-
ment the regenerative capacity after CNS 
injury 4-9. 
Different cell types including Schwann 
cells, ﬁbroblasts, astrocytes and neural 
progenitor cells (NPC) have been used for 
ex vivo gene delivery 1, 2, 5, 10, 11. NPC are 
particularly interesting due to their ability 
to give rise to both new neurons and glia 
and thus to replace lost spinal cord tissue 
in an organotypically appropriate manner 
12, 13. Adult NPC can be isolated from the 
patient’s own neural tissue by minimally 
invasive biopsies 14, 15, propagated in vitro 
16 and serve as autologous cell grafts in 
the lesioned spinal cord 17. Cellular deliv-
ery of therapeutic genes via NPC grafts 
will likely require long-term transgene 
expression for the treatment of genetic 
deﬁciencies or chronic neurodegenera-
tive diseases. In contrast, short-term, 
transient gene expression might be more 
desirable under certain conditions, e.g. to 
induce differentiation of grafted NPC into 
a speciﬁc phenotype that is able to en-
hance regeneration in the injured spinal 
cord 18. 
To genetically modify NPC, MLV-based 
retroviral and lentiviral vectors have been 
used in several studies as these viruses 
allow stable integration of the transgene 
into the host genome 19, 20. We and others 
ABSTRACT
Gene transfer into multipotent neural progenitor cells (NPC) and stem cells may pro-
vide for a cell replacement therapy and allow the delivery of therapeutic proteins into 
the degenerating or injured nervous system. Previously, murine leukemia virus-based 
retroviral vectors expressing GFP from an internal EF-1alpha promoter, and lentiviral 
vectors expressing GFP from a hybrid CMV/ß-actin promoter have been described to 
be resistant to stem cell speciﬁc gene silencing. Therefore, we investigated whether 
these viral vectors allow stable in vivo gene expression in genetically modiﬁed NPC 
isolated from the adult rat spinal cord. In vitro, NPC genetically modiﬁed to express 
GFP using the described retroviral vector showed strong GFP expression in undiffer-
entiated NPC. However, in vitro differentiation resulted in the loss of GFP expression 
in 50% of cells. Grafting of BrdU prelabeled NPC to the spinal cord resulted in a loss 
of GFP expression in 70% and 95% of surviving NPC at 7 and 28 days post grafting, 
respectively. The loss in gene expression was paralleled by the differentiation of NPC 
into a glial phenotype. Transgene downregulation although less profound was also ob-
served in cells modiﬁed with lentiviral vectors, whereas in vivo lentiviral gene transfer 
resulted in stable transgene expression for up to 16 months. Thus, in vivo gene expres-
sion in genetically engineered neural progenitor cells is temporally limited and mostly 
restricted to undifferentiated NPC using the viral vectors tested. 
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have previously shown that MLV-based 
retroviral vectors can efﬁciently trans-
duce primary adult rat NPC in vitro 13, 21. 
However, the downregulation of gene ex-
pression is a major obstacle for the per-
sistent gene transfer into stem cells and 
adult NPC for long-term gene delivery 13, 
21-23. Retroviral silencing has been attrib-
uted to reduced transcriptional initiation 
at the promoter caused by the binding of 
trans-acting factors to silencer elements 
that are located in the viral long terminal 
repeats (LTRs). Furthermore, chromatin 
condensation caused by de novo cyto-
sine methylation of CpG sequences lo-
cated within LTRs may also contribute to 
transgene downregulation 22, 24. The con-
struction of viral vectors lacking silencer 
elements, the inclusion of improved posi-
tive regulatory elements 25 and the use of 
internal promoters have been reported to 
improve duration of gene expression 26. 
Lentiviruses could potentially be suscep-
tible to the same silencing mechanisms 
as retroviruses 27. However, recent reports 
have indicated that lentiviral vectors are 
more resistant to stem cell speciﬁc gene 
silencing in various types of stem cells 28, 
29. The ability of lentiviral vectors to induce 
stable transgene expression in adult NPC 
has not been investigated to date. 
In the present study we compared 3 dif-
ferent viral vector systems for their abil-
ity to mediate stable gene expression in 
NPC after engraftment into the adult spi-
nal cord. Under these conditions NPC are 
known to differentiate into glial pheno-
types. MLV-based retroviral vectors con-
taining a Xenopus EF1a enhancer/pro-
moter or a 5’ LTR to express the reporter 
gene green ﬂuorescent protein (GFP), or a 
lentiviral vector containing a hybrid CMV/
ß-actin promoter were used to modify pri-
mary adult NPC. Two of these viral vec-
tors have previously been described to be 
resistant to stem cell speciﬁc gene silenc-
ing in embryonic neural precursors 26 and 
mouse embryonic stem (ES) cells, respec-
tively 28. Our data indicate that the inves-
tigated viral vectors allow stable gene ex-
pression in undifferentiated NPC in vitro, 
whereas the vast majority of neural pro-
genitor cells lose transgene expression 
after engraftment into the spinal cord. In 
contrast, in vivo lentiviral gene transfer re-
sults in long-term, stable GFP expression 
in the adult rat CNS.
2. MATERIALS AND METHODS
2.1 Animal subjects
Adult female Fischer 344 rats weighting 
160-200 g were housed under standard 
laboratory conditions with 12 h light dark 
cycle. All experiments were carried out in 
accordance with institutional guidelines 
for animal care. Animals had ad libitum 
access to food and water throughout the 
study. All surgical procedures were per-
formed under anesthesia using a cocktail 
of ketamine (62.5 mg/kg; WDT, Garbsen, 
Germany), xylazine (3.175 mg/kg; WDT, 
Garbsen, Germany) and acepromazine 
(0.625 mg/kg, Sanoﬁ-Ceva, Düsseldorf, 
Germany) in 0.9% sterile saline solution.
2.2 Preparation of adult NPC
Adult NPC were isolated and cultured as 
described 13, 16. Brieﬂy, rats were deeply 
122
Adult NPC lose transgene expression
anesthetized and killed by decapitation. The 
region of the complete cervical enlargement 
(spinal cord level C3 through T1) was dis-
sected. After removal of the dura, the tissue 
was minced, washed in sterile Dulbecco’s 
phosphate buffered saline/D-glucose (4.5g/l; 
PAA Laboratories, Linz, Austria) and digest-
ed in a solution of papain (0.01%; Worthing-
ton Biochemicals, Lakewood, USA), neutral 
protease (0.1%; Roche, Mannheim, Ger-
many), DNase I (0.01%; Worthington Bio-
chemicals) and 12.4 mM MgSO4, dissolved 
in Hank’s balanced salt solution (HBSS; 
PAA Laboratories, Linz, Austria) for 30 min 
at 37°C. The digested tissue was washed 
three times in DMEM-HAMS F12 (Pan Bio-
tech, Aidenbach, Germany), supplemented 
with 10% fetal calf serum (FCS; Pan Bio-
tech, Aidenbach, Germany). The cells were 
transferred to culture dishes containing 
serum-free growth medium (Neurobasal 
medium with B27 supplement (Gibco, Karl-
sruhe, Germany), 2 µg/ml heparin (Sigma) 
20 ng/ml recombinant human FGF-2 (R&D 
System, Wiesbaden, Germany), 20 ng/ml re-
combinant human EGF-2 (R&D System, Wi-
esbaden, Germany). Until the ﬁrst passage, 
cells were grown in uncoated cell culture 
ﬂasks to form neurospheres. Neurospheres 
were then dissociated using Acccutase (In-
novative Cell Tech, San Diego, USA) and the 
NPC were subsequently grown as adherent 
monolayer cultures on poly-l-ornithin/lam-
inin (P-Orn/Lam) coated cell culture ﬂasks, 
Cell culture medium was changed twice per 
week. Cell cultures were passaged after 
reaching conﬂuence, approximately every 
other week. 
2.3 Production of viral vectors
The retroviral plasmid pLXSN-GFP (Fig. 
1A) is based on the plasmid pLXSN (Clon-
tech, Heidelberg, Germany) and was con-
structed and used to transduce NPC as 
described 13. GFP expression in this plas-
mid is driven by the 5’LTR, and a neomy-
cin resistance gene driven by an internal 
SV 40 promoter allows for the selection of 
transduced cells.  The retroviral plasmid 
pCLE-GFP (Fig. 1B) is based on the plas-
mid pCLE (generous gift from N. Gaiano,) 
26. This plasmid contains the human cyto-
megalovirus enhancer-promoter fused to 
the Moloney murine leukemia virus LTR at 
the TATA box in the 5’ U3 region 30 and an 
Xenopus EF-1 alpha regulatory element 
as internal promoter to drive transgene 
expression. To allow selection of cells 
that stably integrated the transgene, the 
internal ribosome entry site and the hu-
man placental alkaline phosphatase gene 
of pCLE were replaced by the SV40 pro-
moter and a neomycin resistance gene. 
The GFP coding sequence was cloned 
into the multiple cloning site resulting in 
the plasmid pCLE-GFP.
For retrovirus production, 293T cells were 
grown in Iscove’s Modiﬁed Dulbecco’s 
Medium (IMDM; Pan Biotech, Aidenbach, 
Germany), with 10% FCS and were trans-
fected with the retroviral plasmid (pCLE-
GFP and pLXSN-GFP, respectively) and 2 
packaging plasmids coding for the vesic-
ular stomatitis virus (VSV) envelope and 
the retroviral gag/pol sequences. Retro-
virus-containing supernatants were col-
lected, ﬁltered through a 0.45 µm syringe 
ﬁlter and stored at -80°C.
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For lentiviral vector production, a self-
inactivating lentiviral plasmid 31 derived 
from pRRL 32 was used. The plasmid pLV-
GFP (p156sinRRLpptCAG-GFP-PRE, Fig. 
1C) containing a GFP expression cassette 
driven by the CMV/ß-actin hybrid pro-
moter (CAG) 33 has been described pre-
viously 28. This plasmid also contains a 
woodchuck posttranscriptional response 
element (WPRE) to increase gene expres-
sion 31. For lentivirus production a third 
generation lentivirus packaging system 
was utilized as previously described 34. 
Viral supernatants were concentrated by 
ultracentrifugation. Titers of GFP express-
ing virus were determined by transduc-
tion of 293T cells using serial dilutions. 
Viral vector stocks were also assayed for 
p24 antigen levels using an HIV-1 p24 
speciﬁc ELISA kit (DuPont). Titers of GFP 
expressing virus were 5 x 108 IU/ml (231 
µg/ml p24). For in vitro transduction, GFP 
expressing lentivirus was diluted as de-
scribed below.
2.4 Transduction of NPC with 
retroviral and lentiviral vectors
Adult NPC were genetically modiﬁed to 
express the reporter gene GFP as previ-
ously described 13. Brieﬂy, adult NPC from 
passage number 4 to 6 cultures were 
plated in sub-conﬂuent densities (10,000 
cells/cm2) on P-Orn/Lam coated cell cul-
ture ﬂasks. The cells were incubated for 8 
hrs on two consecutive days with retro-
virus containing supernatants (pCLE-GFP 
or pLXSN-GFP) supplemented with 1 µg/
ml Polybrene (Sigma). Approximately 60% 
of all cells displayed GFP ﬂuorescence 2 
days following the transduction.  To select 
for GFP expressing cells that integrated 
the retroviral vector, G418 (500 µg/ml ac-
tive concentration; Gibco Karlsruhe, Ger-
many) was added to the growth medium 
GFP NeoRSV40
eGFP
ppt WRPE
NeoR
eGFP
SV40
CAG
EF1a
A. pLXSN-GFP
B. pCLE-GFP
C. pLV-GFP
Figure 1: Schematic representation of viral constructs. (A) In the retroviral vector pLXSN-GFP, reporter gene 
expression is driven by the promoter/enhancer sequences of the Moloney murine leukemia virus derived 5’ 
LTR. (B) In contrast, the retroviral vector pCLE-GFP uses the Xenopus EF-1alpha regulatory elements (EF1a) 
as an internal promoter. Furthermore, pCLE-GFP contains a hybrid 5’ LTR that consists of the immediate early 
region of the human cytomegalovirus enhancer-promoter fused to the Moloney murine leukemia virus long 
terminal repeat at the TATA box in the 5’ U3 region. Both pLXSN-GFP and pCLE-GFP contain a neomycin 
resistance gene (NeoR) under control of the SV40 early promoter (SV40), which allows selection of transduced 
cells. (C) The lentiviral vector pLV-GFP contains the compound chicken ß-actin cytomegalovirus enhancer/ 
promoter (CAG) followed by a ß-globin intron for GFP expression. Furthermore, pLV-GFP contains a central 
polypurine tract of HIV-1 (ppt), a woodchuck hepatitis virus posttranscriptional response element (WRPE) and 
a self-inactivating deletion in the 3’LTR.
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for 6 weeks. This concentration has pre-
viously been determined to completely 
eliminate all untransfected NPC within 3 
weeks. Successful incorporation of the 
transgene into all NPC was conﬁrmed by 
GFP ﬂuorescence using an inverted ﬂuo-
rescence microscope (Olympus IX 70). 
Following G418 selection, cells were cul-
tivated in the absence of G418.
For the transduction of NPC with lentivi-
ral vectors (pLV-GFP), low passage NPC 
were split 1:3 into coated T-75 ﬂasks (5.4 x 
106 cells/ﬂask). On the following day GFP 
expressing lentiviral vectors were added 
and cells were cultivated for 2 days, when 
GFP expression was sufﬁcient for ﬂuores-
cent activated cell sorting (FACS). Flow 
cytometry analysis and ﬂuorescence mi-
croscopy indicated that 80% of the cells 
were positive for GFP before FACS and 
over 99% expressed GFP after FACS. 
Following FACS, cells were kept in culture 
and passaged twice before transplanta-
tion.
2.5 Immunocytochemistry of cultured 
NPC
Cells of monolayer cultures were detached 
using Accutase (Innovative Cell Tech, San 
Diego, USA) and plated on P-Orn/Lam 
coated glass coverslips in growth medi-
um. To induce differentiation, NPC were 
incubated for up to 21 days in differen-
tiation medium (Neurobasal medium with 
B27 supplement and 5% FCS, Pan Bio-
tech, Aidenbach, Germany, 13, 35.
The following antibodies were used to 
analyze the differentiation pattern of adult 
NPC in vitro: rabbit-anti-GFP for GFP ex-
pressing cells (Molecular Probes, Leiden, 
The Netherlands; at 1/1000) mouse-
anti-A2B5 for glial committed progeni-
tors (Chemicon, Hofheim, Germany; at 
1/100), mouse-anti-GFAP for astroglia 
(Chemicon, Hofheim, Germany; at 1/600), 
mouse-anti-GalC for oligodendroglia 
(Chemicon, Hofheim, Germany; at 1/500) 
and mouse-anti-beta-III-tubulin for early 
neuronal differentiation (clone 5G8; Pro-
mega, Mannheim, Germany; at 1/500). 
Cells were ﬁxed in 4% paraformaldehyde 
in PBS, washed three times with tris-buff-
ered saline (TBS), blocked with TBS con-
taining 3% donkey serum/0.1% Triton-X 
(TBS++) and incubated overnight with pri-
mary antibody in TBS++ at 4°C. To label 
cell surface markers, Triton-X was omit-
ted. The following day, cells were washed 
with TBS and incubated with ﬂuorescein 
linked secondary donkey-anti-rabbit anti-
bodies and rhodamine-X linked secondary 
donkey-anti-mouse antibodies (Jackson, 
Hamburg, Germany; at 1/1000) in TBS++ 
for 2h. Finally, nuclei were counterstained 
with Hoechst 33342 (2 µg/ml in TBS; 
Sigma). The coverslips were mounted 
onto glass slides using Prolong-Antifade 
(Molecular Probes, Leiden, Netherlands). 
For the immunocytochemical analysis, 8 
bit monochrome pictures were taken at 
20x magniﬁcation on a ﬂuorescent micro-
scope (Leica DMR) equipped with a Spot 
CCD camera model 2.2.1 (Diagnostic In-
struments, Sterling Heights, USA). 
2.6 Surgical procedures
Adult NPC virally transduced to express 
GFP were incubated for 48 hrs before 
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transplantation with a 1 µM solution of the 
proliferation marker bromodeoxyuridine 
(BrdU; Sigma) in growth medium, which 
results in labeling of more than 95% of all 
NPC. GFP expression was conﬁrmed us-
ing an inverted ﬂuorescence microscope 
(Olympus IX 70) just before harvesting the 
cells. An aliquot of the cells was counted 
in a Neubauer hemocytometer using try-
pan blue staining and the cells were re-
suspended in Dulbecco’s PBS to yield a 
ﬁnal concentration of 105 cells/µl. 
A total of 27 animals was used in the ex-
periments. Animals were anesthetized us-
ing a cocktail of ketamine, xylazine and 
acepromazine as described above and re-
ceived injections of NPC transduced with 
the retroviral vector pCLE-GFP (n=12) or 
the vector pLXSN-GFP (n=3) into the cer-
vical spinal cord. The ligament between 
the cervical vertebrae C3 and C4 was in-
cised and a 2 µl cell suspension (105 cells/
µl) was injected 1 mm deep into the spinal 
cord parenchyma through a stereotacti-
cally guided pulled glass micropipette 
(40 µm internal diameter) using a Pico-
spritzer II (General Valve, Fairﬁeld, USA). 
Animals with pCLE-GFP transduced cells 
were sacriﬁced after 2 days (n=4), 7 days 
(n=4) or 28 days (n=4), animals receiving 
pLXSN-GFP transduced NPC were sac-
riﬁced after 28 days (n=3). The lentivirus-
transduced cells were grafted into the 
thoracic spinal cord at level T7/8 (n=3) as 
described above and were sacriﬁced after 
28 days. 
To control for potential unspeciﬁc label-
ing from unincorporated BrdU or death 
of BrdU prelabeled cells, a suspension of 
BrdU prelabeled NPC (105 cells/µl) was 
lysed by repeated freeze-thaw cycles and 
injected into 2 animals (2 µl per animal). 
Two additional animals received an injec-
tion of 2 µl PBS used to wash the cells 
after BrdU incubation before grafting.
For direct injection of lentiviral vectors, 
animals (n=5) were anesthetized as de-
scribed above and received a small lami-
nectomy at T7/8. Lentiviral vectors (2 µl) 
were injected 1 mm deep into the spinal 
cord through a pulled micropipette us-
ing a Picospritzer at a rate of 1 µl/min. 
Pipettes were left in place for one addi-
tional minute before withdrawal. 5 animals 
received lentiviral vectors containing the 
coding sequence for GFP and were killed 
at 14 days (n=3), 10 months (n=1) and 16 
months (n=1). 
2.7 Histological analysis
Two days, 7 days and 28 days after cell 
injections, and 14 days, 10 months and 
16 months after lentivirus injections, ani-
mals were deeply anesthetized and trans-
cardially perfused with 100 ml phosphate 
buffered saline followed by 250 ml 4% 
paraformaldehyde in 0.1M phosphate 
buffer. The brains and spinal cords were 
dissected, post ﬁxed overnight and cryo-
protected in 30% sucrose. Sagittal 35 µm 
sections were cut on a freezing microtome 
and processed for immunohistochemistry. 
Every seventh section was immediately 
mounted and Nissl stained to localize the 
injection site. 
For brightﬁeld immunohistochemical 
analysis of BrdU prelabeled cells, sections 
were rinsed in TBS (0.1M) and incubated 
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for 1h in 50% formamide/2xSSC (0.3 M 
NaCl, 0.03M sodium citrate) at 65ºC. Sec-
tions then were rinsed in 2xSSC, incu-
bated for 30 min in 2 N HCl at 37ºC, and 
rinsed for 10 min in 0.1 M boric acid pH 
8.5. After rinsing in TBS, sections were in-
cubated in TBS++ for 1h, transferred into 
rat-anti-BrdU primary antibody (Harlan 
SeraLab, Loughborough, UK; at 1/500) in 
TBS++ and incubated overnight at 4°C on 
a rotating platform. On the second day, 
the sections were washed in TBS and 
incubated for 1h with a biotinylated don-
key-anti-rat secondary antibody (Jackson, 
Hamburg, Germany; at 1/2000) in TBS++. 
After several rinses in TBS, the sections 
were incubated for 1h with avidin biotinyl-
ated peroxidase complex (Vector Elite Kit, 
Vector Laboratories, Wertheim, Germany; 
at 1/1000). Labeling was developed us-
ing a 0.05% solution of 3,3,8-diamino-
benzidine, 0.01% H2O2, and 0.04% nickel 
chloride in TBS for 5 min. Sections were 
mounted, dehydrated and coverslipped 
using Neo Mount (Merck, Darmstadt, 
Germany). The brightﬁeld immunohisto-
chemical analysis was performed with a 
Leica DMR microscope equipped with a 
Spot CCD camera model 2.2.1 (Diagnos-
tic Instruments, Michigan, USA). 
Double/triple immunoﬂuorescence la-
beling was performed to assess GFP 
expression of NPC and lentivirus trans-
duced cells in the spinal cord, and the dif-
ferentiation pattern of grafted adult NPC. 
The following primary antibodies were 
used: mouse-anti-nestin for uncommitted 
progenitor cells (clone 401, Pharmingen, 
Heidelberg, Germany; at 1/500), guinea 
pig-anti-NG2 for glial restricted precursor 
cells (; generous gift B. Stallcup, Burnham 
Institute, La Jolla, USA; at 1/200), mouse-
anti-GFAP for astroglia (Chemicon, Hof-
heim, Germany; at 1/600), mouse-anti-
APC that is directed against the N-ter-
minal segment of APC for immature and 
mature astrocytes and oligodendrocytes 
36 (Oncogene, Darmstadt, Germany; at 
1/1000) and goat-anti-doublecortin for 
young neurons (Santa Cruz, Heidelberg, 
Germany; at 1/100), all visualized using 
Cy-5 linked donkey secondary antibodies 
(Jackson, Hamburg, Germany; at 1/1000). 
The BrdU-prelabeled grafted cells were 
identiﬁed with a rat-anti-BrdU antibody 
(Harlan SeraLab, Loughborough, UK; at 
1/500) and visualized using Rhodamine-
X linked donkey secondary antibodies 
(Jackson, Hamburg, Germany; at 1/1000). 
GFP expressing cells were visualized us-
ing a rabbit-anti-GFP antibody (Molecular 
Probes, Leiden, Netherlands; at 1/750) or 
a goat-anti-GFP antibody (Rockland Gil-
bertsville, PA; at 1/1500). 
To identify BrdU prelabeled NPC sections 
were pretreated as described above fol-
lowed by incubation with the primary an-
tibodies in TBS++ overnight at 4°C on a 
rotating platform. The following day, sec-
tions were rinsed and incubated with ﬂuo-
rescence (rhodamine-X, ﬂuorescein, Cy5) 
conjugated secondary antibodies made in 
donkey (Jackson, Hamburg, Germany; at 
1/1000) in TBS++ for 2 h. After ﬁnal rins-
ing steps in TBS, sections were mounted 
onto glass slides and coverslipped with 
ProLong Antifade Kit (Molecular Probes, 
Leiden, Netherlands). Immunohistochem-
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ical analysis was performed with a confo-
cal ﬂuorescence microscope (Leica TCS-
NT). 
For the quantiﬁcation of BrdU/GFP 
double-labeled cells, confocal micro-
graphs containing the epicenter of the 
graft were taken at 40x magniﬁcation. 
From each animal, 3 independent im-
age stacks were selected from differ-
ent sections. Since GFP labeling in NPC 
was restricted to the injection site, cells 
were only quantiﬁed at the transplan-
tation site. Therefore, between 15-20 
optical sections through the z-axis of 
the 35 µm thick section were analyzed. 
Co-localization was conﬁrmed once the 
GFP marker was spatially associated to 
the nuclear BrdU prelabeling through 
subsequent optical sections in the z-
axis. BrdU positive cells and GFP/BrdU 
positive cells were counted from each 
animal to obtain a representative total 
count. Finally, the mean percentage of 
BrdU/GFP double labeled cells and the 
standard error of the mean (SEM) was 
calculated for each time point. Group 
comparisons were made using an analy-
sis of variance followed by Tukey’s post-
hoc testing. 
3. RESULTS
3.1 In vitro gene expression using 
the retroviral vector pCLE-GFP
Previously, we have shown that neural 
stem cells derived from the adult spi-
nal cord can be transduced in vitro to 
express GFP using the retroviral vec-
tor pLXSN-GFP 13 (Fig. 1A). However, 
in vivo gene expression was lost in the 
majority of cells 21 days after transplan-
tation into the adult injured spinal cord 
13. Because this loss in gene expression 
is likely due to the silencing of the LTR 
used to express the transgene, we in-
vestigated whether retroviral vectors 
with an internal promoter could increase 
the duration of gene expression. The 
retroviral vector pCLE-GFP derived from 
pCLE 26 contains a hybrid 5’ LTR and an 
internal Xenopus EF1a enhancer/pro-
moter to drive GFP expression (Fig. 1B). 
Adult spinal cord derived NPC were ef-
ﬁciently transduced and showed robust 
GFP expression after selection for G418 
resistance. GFP expression was stable 
for at least 4 weeks over more than 5 
passages in vitro after removal of G418 
from the cell culture medium (Fig. 2A). 
To determine if differentiation of NPC 
results in a downregulation of trans-
gene expression 37, NPC were cultivated 
in differentiation medium (NB medium, 
supplemented with B27 and 5% FCS; 
no G418) for up to 21 days 13, 35. After 7 
days of incubation in the differentiation 
medium, 99.2% ± 0.48 of the cells were 
GFP positive (Fig. 2B, 2I). Immunocy-
tochemical staining showed that these 
cultures mainly contained beta III tubu-
lin positive neuronal cells (13.4% ± 3.6, 
Fig. 2F, 2J) and GFAP positive astrocytes 
(31.3% ± 1.8, Fig. 2G, 2K). Only a small 
amount of GalC positive oligodendro-
cytes and A2B5 positive glial precursor 
cells could be identiﬁed (Fig. 2E, H). Af-
ter 14 days of incubation in the differen-
tiation medium, however, a considerable 
proportion of the pCLE-GFP transduced 
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Figure 2: In vitro analysis of NPC transduced with pCLE-GFP. (A) Under proliferation conditions and (B) after 
7 days of cell culture under differentiation conditions virtually all NPC transduced with the retroviral vector 
pCLE-GFP expressed the reporter gene GFP (green). (C) After 14 days and (D) after 21 days of cell culture 
under differentiation conditions, many pCLE-GFP transduced NPC lost GFP expression (arrowheads). (E) 
Immunocytochemical analysis of the differentiated cells showed that A2B5 positive glial restricted progenitor 
cells, (F) beta III tubulin positive young neuronal cells, (G) GFAP positive astrocytes and (H) GalC positive 
oligodendrocytes could be found to express GFP (green) in vitro after 7 days of in vitro differentiation. 
All differentiation markers are shown in red. Hoechst 33342 was used as nuclear counterstain (blue). 
Epiﬂuorescent micrographs, scale bar: 75 µm in (A-D), 20 µm in (E-H). (I) Bar graphs showing the proportion 
of GFP expressing cells, (J) beta III tubulin expressing young neurons and (K) GFAP expressing astrocytes of 
the total amount of cells present in the culture after 7, 14 and 21 days of in vitro differentiation (n=3, mean ± 
SEM, * p<0.05, ** p<0.01). 
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NPC lost GFP expression, resulting in 
a signiﬁcant reduction in GFP-labeled 
cells to 70.2% ± 9.4 (p<0.05; Fig. 2C, 2I). 
After 21 days of in vitro differentiation, 
the proportion of pCLE-GFP transduced 
NPC that still expressed GFP was fur-
ther reduced to 52.4% ± 5.4 of the total 
amount of plated cells (p<0.01; Fig. 2D, 
2I). The amount of beta III tubulin posi-
tive cells increased to 46.3% ± 4.5 at 14 
days and to 57.2% ± 6.6 at 21 days of 
in vitro differentiation (Fig. 2J), whereas 
the amount of GFAP positive cells de-
creased to 12.4% ± 6.0 at 14 days and 
11.0% ± 4.7 at 21 days (Fig. 2K). Only 
very few GalC positive oligodendrocytes 
and no A2B5 positive glial precursor 
cells could be identiﬁed at 14 and 21 
Figure 3: Genetically modiﬁed NPC migrate in the spinal cord and lose transgene expression. (A) 2 days 
post-transplantation, the majority of the BrdU prelabeled NPC were concentrated in a cloud of cells at the 
injection site. (B) 7 days and (C) 28 days post-transplantation, many of the grafted cells migrated into the host 
parenchyma and were scattered in the host spinal cord. (D) Two days post-transplantation, GFP (green) could 
be detected in most of the BrdU prelabeled NPC (red) directly at the injection site. Cells that migrated away 
from the injection site had already downregulated GFP expression (arrowheads). (E) At 7 days post-grafting, 
the number of GFP expressing cells was further diminished, while many other cells expressed only very low 
levels of GFP (arrowheads, compare also D’’ with E’’). (F) 28 days post-transplantation, GFP labeling had 
nearly disappeared. Scale bar: 250 µm in (A-C), 60 µm in (D), 80 µm in (E, F). 
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days of in vitro differentiation. Because 
the proliferation of NPC ceases over 
the ﬁrst 7 days of cultivation in differ-
entiation medium, the observed decline 
in GFP expression was not due to the 
proliferation of non-transduced cells. 
Rather the percentage of GFP-labeled 
cells decreased over time as the pro-
portion of cells expressing neuronal and 
glial differentiation markers increased. 
3.2 In vivo gene expression in NPC 
grafted to the spinal cord
To investigate whether a similar degree 
and time course of transgene silencing 
would also occur in vivo, undifferentiated, 
pCLE-GFP-transduced NPC were labeled 
with BrdU and grafted to the intact spinal 
cord of adult rats. At 2 days, 7 days and 
28 days post grafting, the spinal cord pa-
renchyma of grafted animals contained 
many BrdU positive nuclei, indicating 
good survival of transplanted NPC (Fig. 
3A-C). Two days post grafting, the major-
ity of BrdU positive nuclei were localized 
in a compact cloud of cells at the trans-
plantation site (Fig. 3A). Surrounding the 
graft epicenter, many BrdU positive nuclei 
resided in the spinal cord parenchyma at 
a lower density, suggesting that a fraction 
of the grafted cells had already migrated 
into the host parenchyma. At 7 days and 
28 days after transplantation, the densi-
ty of BrdU prelabeled nuclei at the graft 
epicenter decreased, and the majority of 
cells had migrated away from the trans-
plantation site (Fig. 3B, C). Control ani-
mals injected with BrdU prelabeled NPC 
lysed by repeated freeze-thaw cycles 
prior to transplantation, or PBS used to 
wash the cells before grafting contained 
none or occasionally very few BrdU la-
beled nuclei. Thus, the BrdU positive cells 
in the spinal cord parenchyma of grafted 
animals originated from surviving, trans-
planted NPC.
Concomitant with the migration of NPC, 
expression of GFP was gradually lost 
(Fig. 3D-F). Two days post grafting, many 
BrdU/GFP double-labeled cells were de-
tected at the graft epicenter (Fig. 3D). 
However, confocal analysis of BrdU posi-
tive cells residing outside the graft epi-
center revealed that these cells almost 
completely downregulated GFP expres-
sion (Arrowheads, Fig. 3D). Quantiﬁcation 
of BrdU/GFP double-labeled cells at the 
graft epicenter indicated that 60.8% ± 6.0 
of the BrdU positive nuclei co-localized 
with the GFP reporter (Fig. 4). At 7 days 
Figure 4: Quantiﬁcation of BrdU/GFP double-labeled 
cells in vivo. Bar graph showing the proportion of 
BrdU-labeled NPC that colocalize with GFP at the 
injection site. There is a signiﬁcant reduction in the 
number of GFP-expressing cells over time. (n=3/time 
point, mean± SEM, ** p<0.01, *** p<0.001).
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Figure 5: GFP expression and differentiation of pCLE-GFP transduced NPC at 2 days after transplantation 
into the spinal cord. The differentiation pattern of grafted NPC was assessed by determining the co-
localization of differentiation markers (red) with BrdU prelabeled nuclei of grafted cells (blue). (A-D) 2 days 
after transplantation, many grafted cells expressed the glial precursor cell marker NG2 (arrow). (E-H) Only very 
few grafted cells could be detected co-localizing with the astroglial marker GFAP (arrows) and (I-L) the mature 
glial marker APC (arrowhead). Only very few GFP expressing cells (green) could be found that co-localized 
with GFAP or APC (A-H, arrows). Confocal ﬂuorescence micrographs, scale bar A-L 25 µm. 
Figure 6: GFP expression and differentiation of pCLE-GFP transduced NPC at 28 days after transplantation 
into the spinal cord. (A-D) At 28 days post grafting, no NG2 immunoreactivity could be detected that co-
localized with the grafted NPC. However, most grafted cells differentiated into glial phenotypes, as indicated 
by (E-H) GFAP and (I-L) APC expression. Although many GFP labeled NPC displayed a complex morphology, 
almost none of these cells could be co-localized with the investigated phenotypical markers (arrowheads, D, 
H, L) Confocal ﬂuorescence micrographs, scale bar A-L 25 µm.  
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post grafting, the fraction of BrdU/GFP 
double labeled cells at the graft epicenter 
decreased to 30.3% ± 5.6 (Fig. 3E, Fig. 
4) and many of the remaining BrdU/GFP 
double positive cells displayed only weak 
GFP expression levels (arrowheads, Fig. 
3E). At 28 days post grafting, only 4.3% 
± 1.5 BrdU/GFP double positive cells 
could be identiﬁed at the graft epicenter, 
indicating that the vast majority of pCLE-
GFP-transduced NPC lost expression 
of the GFP reporter gene within 28 days 
after transplantation into the intact CNS 
(Fig. 3F, 4). Double-labeled cells were only 
quantiﬁed at the injection site, since cells 
migrating for long distances were never 
found to express GFP. Thus, the actual 
proportion of GFP/BrdU positive cells 
in the whole spinal cord was even lower 
than quantiﬁed in this study, especially at 
7 and 28 days post-injection, when long 
distance migration of BrdU prelabeled 
cells could be observed. 
To determine if the loss in gene expres-
sion was correlated to differentiation of 
NPC, colocalization studies of BrdU- and 
GFP-labeled cells with NG2, a marker for 
glial committed precursor cells 38 and the 
glial markers GFAP and APC were con-
ducted. At 2 days post grafting, BrdU 
prelabeled pCLE-GFP-transduced NPC 
mainly expressed NG2 (Fig. 5A-D), few 
cells expressed GFAP (5E-H), and no 
BrdU-labeled cells co-labeled with APC 
(Fig. 5I-L). At 28 days post grafting, NG2 
immunoreactivity had almost completely 
disappeared, while many of the grafted 
pCLE-GFP-transduced NPC differenti-
ated into GFAP positive astrocytes (Fig. 
6E-H) and APC positive glia (Fig. 6I-J). No 
immunoreactivity for the multipotent pro-
genitor cell marker nestin 39 or for the early 
neuronal marker doublecortin 40 could be 
detected at any of the time-points inves-
tigated (data not shown). Strikingly, only 
a very small fraction of GFP/BrdU dou-
ble-labeled cells could be co-localized 
with any of the glial or neuronal markers 
investigated (Arrows, Fig. 5A-D, E-H), 
suggesting that the vast majority of trans-
duced NPC downregulated GFP expres-
sion upon or during differentiation. The 
few NPC that continued to express GFP 
at 28 days post transplantation displayed 
a highly complex morphology without de-
tectable levels of any of the investigated 
differentiation markers (Arrowheads, Fig. 
6D, H, L). 
3.3 Lentiviral gene transfer 
The studies described above indicated 
that the differentiation of NPC might be 
responsible for the discontinued gene 
expression in NPC transduced with MLV-
based retroviral vectors. As lentiviral gene 
transfer into embryonic stem cells 28 41 
and hematopoetic stem cells 42 has been 
shown to be stable after differentiation 
we tested the stability/duration of len-
tiviral gene expression in NPC. In paral-
lel to ﬁndings with the retroviral vectors 
pLXSN-GFP and pCLE-GFP (see above), 
NPC transduced with the lentiviral vec-
tor pLV-GFP (Fig. 1C) showed stable in 
vitro GFP expression in proliferating cells 
(data not shown). Upon transplantation of 
pLV-GFP transduced NPC into the spinal 
cord however, gene expression declined 
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to 29.2% ± 4.7 at 28 days post grafting 
around the injection site (Fig. 7A, B). As 
previously observed for pCLE-GFP trans-
duced NPC, cells remaining close to the 
injection site were more likely to continue 
GFP expression than cells that migrated 
away from the transplantation site (Fig. 
7A). Confocal analysis of grafted cells 
showed that almost no colocalization with 
the glial precursor cell marker NG2 could 
be observed at 28 days (Fig. 7C-F). Of the 
investigated glial differentiation markers, 
only a small fraction of GFP/BrdU-labeled 
cells colocalized with GFAP (arrowheads, 
Fig. 7G-J) or APC (arrowheads, Fig. 7K-N). 
To determine if long-term GFP expression 
could be achieved in differentiated cells in 
vivo, and to exclude the possibility that im-
Figure 7: GFP expression and differentiation of pLV-GFP transduced NPC at 28 days after transplantation 
into the spinal cord. (A, B) Although a larger proportion of lentivirus-transduced NPC continued to express 
GFP compared to MLV-retrovirus-transduced NPC, the majority of the grafted cells lost transgene expression 
28 days after transplantation. (C-F) Similar to pCLE-GFP transduced NPC, no NG2 expressing grafted NPC 
could be found at 28 days post grafting, while most NPC differentiated into (G-J) GFAP expressing astroglia 
and (K-N) APC expressing mature glia. Only few GFP-labeled NPC could be colocalized with the investigated 
phenotypical marker (arrowheads, G-N). Confocal ﬂuorescence micrographs, scale bar A 170 µm, B 32 µm, 
C-N 25 µm.
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mune responses to GFP expressing cells 
provided a selective survival advantage for 
cells that lost GFP expression, we injected 
the same lentiviral vectors expressing GFP 
into the spinal cord. Qualitative analysis of 
gene expression 14 days, 10 months and 
16 months after virus injection indicated 
continued gene expression without any ap-
preciable loss in the amount or number of 
GFP expressing cells (Fig. 8). 
4. DISCUSSION
In the present study, we investigated 
transgene expression in adult rat NPC 
transduced to express GFP using retro-
viral and lentiviral vectors that have pre-
viously been described to be resistant to 
gene silencing in neural progenitor cells 
and stem cells 26, 28. Our ﬁndings indicate 
that the viral vectors tested only allow for 
transient gene expression in adult NPC. 
In vitro differentiation of NPC and in vivo 
differentiation following transplantation to 
the adult spinal cord was paralleled by a 
rapid loss of GFP expression indicating a 
close relationship between NPC differenti-
ation and transgene silencing. In contrast, 
direct in vivo injection of lentiviral vectors, 
resulted in stable GFP expression in both 
neurons and glia for up to 16 months. 
The stable expression of transgenes in 
adult NPC represents an important pre-
requisite to assess and to enhance the re-
generative capacity of NPC grafting to the 
CNS. The introduction of reporter genes 
such as GFP enables the visualization of 
grafted cells to study cell survival, inte-
gration and interaction with the host en-
Figure 8: GFP expression after direct injection of pLV-GFP virus into the intact rat spinal cord. (A) Direct 
injection of lentivirus resulted in high expression levels of transgene in the intact rat spinal cord 2 weeks 
post-injection. (B) No obvious changes in transgene expression level or number of expressing cells could be 
observed at 10 months post-injection. Epiﬂuorescence micrographs, scale bar A, B 200 µm. 
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vironment. Additionally, overexpression of 
speciﬁc genes could allow the differentia-
tion of grafted NPC into regeneration pro-
moting phenotypes thereby overcoming 
differentiation inducing cues in the micro-
environment at the transplantation site 35, 
43. Finally, the intrinsic regenerative ca-
pacity of grafted NPC could be enhanced 
by overexpression of axonal growth and 
neuronal survival promoting factors 44, 45.  
In vitro and in vivo loss of gene expres-
sion in our experiments could be due to 
the toxicity of GFP expression, selective 
survival advantages of cells that lose gene 
expression, elimination of grafted cells, or 
silencing of transgene expression previ-
ously described for many virally trans-
duced cell types 46-48. The ﬁrst three pos-
sibilities seem highly unlikely for several 
reasons: 1) NPC cultivated in vitro under 
proliferation conditions continued to ex-
press GFP without any sign of toxicity or 
loss of gene expression; ; 2) direct injec-
tion of GFP expressing lentiviral vectors 
resulted in long-term stable gene expres-
sion for up to 16 months; 3) grafted cells 
could be identiﬁed in all animals using 
BrdU pre-labeling and 4) a decline in the 
number of GFP expressing cells was also 
observed in vitro in differentiating NPC. 
Although the exact molecular basis of 
transgene silencing remains to be eluci-
dated, DNA-methylation-dependent and 
-independent silencing mechanisms ap-
pear to play important roles 49. Previous 
studies have shown that transgene si-
lencing in stem/progenitor cells precedes 
methylation of newly integrated virus DNA. 
Whether this de novo methylation is a 
consequence of methylation-independent 
silencing or represents a redundant par-
allel pathway is unclear 27. The dramatic 
gene silencing within 1 week post-graft-
ing in the present experiments suggests 
that silencing factors other than the rela-
tively slow acting DNA methylation play a 
signiﬁcant role. Nevertheless, the devel-
opment of viral vectors lacking CpG di-
nucleotides located in the LTR represents 
an important step in preventing methyla-
tion-dependent transgene silencing 24. In-
clusion of insulator elements, which are 
genomic sequences that function as ex-
pression boundaries, might also be able 
to reduce methylation-independent trans-
gene silencing 25. However, it remains to 
be determined whether insulators are also 
able to block the function of trans-acting 
retroviral silencers 50, 51.
Two of the viral vectors used in our stud-
ies have previously been described to be 
more resistant to stem cell speciﬁc trans-
gene silencing compared to retroviral vec-
tors expressing the transgene from the 
5’LTR.  The retroviral vector, pCLE-GFP, 
contains a hybrid 5’ LTR in combination 
with an internal Xenopus EF-1alpha en-
hancer/promoter and has been shown to 
improve transgene expression after injec-
tion into the embryonic mouse CNS 26. 
Our results did not indicate signiﬁcant im-
provements in transgene expression us-
ing this viral vector. Differences between 
mouse and rat CNS progenitors, differ-
ences between adult and embryonic si-
lencing mechanisms, or differences in the 
multiplicity of infection might have con-
tributed to the observed lack of extended 
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gene expression. 
The tested lentiviral vector pLV-GFP re-
ported to be resistant to stem cell speciﬁc 
silencing in murine ES cells 28 only resulted 
in a slightly higher number of transgene 
expressing NPC close to the injection site. 
Lack of gene silencing in lentivirus-trans-
duced ES cells has been attributed to the 
deletion of enhancer/promoter regions 
in the LTR regions of the virus construct 
and intrinsic resistance to long-term DNA 
methylation-dependent silencing of human 
derived lentiviral vectors in murine cells 
28. Whether this viral vector is sufﬁcient 
to induce stable transgene expression in 
rat stem cells has not been investigated. 
The observed differences could therefore 
be due to cell-speciﬁc or species-speciﬁc 
differences. Recent studies in lentivirus-
transduced embryonic rat NPC using an 
internal mouse phosphoglycerate kinase 
1 promoter have observed a similar de-
cline in gene expression 52. 
Consistent with previous reports 13, 17, 
NPC grafted to the spinal cord differ-
entiated rapidly into glial lineages. NG2 
expressing BrdU-labeled cells however 
could only be detected at 2 days post-
injection. Cells that continued to express 
GFP 7 and 28 days post-grafting typically 
resided close to the graft epicenter, simi-
lar to retrovirus-transduced NPC grafted 
to the striatum of hemiparkinsonian rats 
23. Strikingly, a lack of GFP expression in 
cells that migrated away from the injec-
tion site could be observed as early as 2 
days post transplantation, indicating that 
migration of the grafted cells closely cor-
relates with the silencing of transgene ex-
pression. Although some GFP expressing 
cells displayed highly complex morpholo-
gies at 4 weeks post transplantation, only 
relatively few GFP expressing cells could 
reliably be co-localized with the tested 
differentiation markers, conﬁrming earlier 
observations 23.
In summary, the viral vectors investigat-
ed in the present experiments can only 
be employed to induce transient gene 
expression in rat NPC. Studies using vi-
ral vectors to introduce transgenes into 
NPC have to be carefully controlled for 
transgene expression levels throughout 
the entire experiment as only a speciﬁc 
subset of cells might continue to express 
the gene of interest. To accomplish stable 
transgene expression in adult rat NPC, vi-
ral vectors need to be developed that are 
both resistant to methylation-dependent 
and -independent silencing mechanisms. 
Viral vectors that can also persist with-
out integration into the host cell genome, 
such as adeno-associated viruses, might 
be able to at least partially overcome 
stem cell speciﬁc silencing in stem/pro-
genitor cells 53. Whereas expression of 
reporter genes, survival promoting factors 
in chronic neurodegenerative diseases, 
and genes to correct genetic deﬁciencies 
are generally sought to be long-lasting, a 
loss of gene expression that is correlated 
to cell differentiation as observed in the 
current experiments might be ideal to ex-
press genes necessary for the phenotypi-
cal speciﬁcation of stem and progenitor 
cells.
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In vivo high resolution MRI of neuropathological 
changes in the injured rat spinal cord
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1. INTRODUCTION
Magnetic resonance imaging (MRI) repre-
sents a powerful means to non-invasively 
visualize pathomorphological changes in 
humans following spinal cord injury 1, 2. 
MRI ﬁndings correlate with histopatho-
logical sequela observed after spinal cord 
injury such as edema, hemorrhage and 
secondary degenerative changes such as 
cyst formation. Moreover, MRI allows to 
predict the severity of neurological deﬁ-
cits after spinal cord injury 3. On an ex-
perimental level, regenerative strategies 
have been validated in animal models of 
spinal cord injury, which promote func-
tional and structural recovery. In particular, 
cell based transplantation strategies hold 
great promise in regenerating the injured 
spinal cord 4-10. Ultrastructural restoration 
in animals is primarily assessed by post 
mortem microscopical analysis of spinal 
cord parenchyma. In order to be able to 
monitor regenerative strategies in clinical 
applications, non-invasive imaging tech-
niques are mandatory. Only animal stud-
ies allow the direct correlation of in vivo 
MRI data with histological post mortem 
data as a prerequisite for proper interpre-
tation of MRI ﬁndings in human studies 
after therapeutic interventions. Anatomi-
cal structures that must be resolved in 
mice or rats are ﬁve to ten times smaller 
than in humans. This implies that volume 
elements in imaging data are smaller by a 
factor of roughly 100 to 1000. MRI studies 
of the spinal cord of rodent models, wide-
ABSTRACT 
Magnetic resonance imaging (MRI) is the most comprehensive means to assess struc-
tural changes in injured central nervous system (CNS) tissue in humans non-invasively 
over time. The few published in vivo MRI studies of spinal cord injury in rodent models 
using ﬁeld strengths up to 7 T suffer from low spatial resolution, ﬂow, and motion arti-
facts. The aim of this study was to assess the capacity of a 17.6 T imaging system to 
detect pathological changes occurring in a rat spinal cord contusion injury model ex 
vivo and in vivo. Therefore seven adult female Fischer 344 rats received a contusion 
injury at thoracic level Th 10, which caused a severe and reproducible lesion of the 
injured spinal cord parenchyma. From 2 to 58 days post-injury, high-resolution MRI 
was performed ex vivo (n=2) or in vivo in anesthetized rats (n=5 spinal cord injured + 1 
intact control animal) using 2D multi-slice spin and gradient echo imaging sequences, 
respectively, combined with electrocardiogram triggering and respiratory gating. The 
acquired images provided excellent resolution and gray/white matter differentiation 
without signiﬁcant artifacts. Signal changes, which were detected with ex vivo and in 
vivo MRI following spinal cord injury, could be correlated with histologically deﬁned 
structural changes such as edema, ﬁbroglial scar and hemorrhage. These results dem-
onstrate that MRI at 17.6 T allows high-resolution structural analysis of spinal cord 
pathology after injury.
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ly used to assess the efﬁcacy of regenera-
tive strategies following spinal cord injury, 
require a sufﬁciently high signal-to-noise 
ratio (SNR) in order to resolve small-scale 
structures with satisfactory contrast. Fur-
thermore, respiratory motion and blood 
ﬂow may induce image artifacts. Struc-
tural changes occurring after spinal cord 
injury such as edema, cystic defects, 
atrophy and hemorrhage have been de-
tected in several MRI based in vivo stud-
ies. 11-18 19. However, partial volume effects 
resulting from a lower spatial resolution in 
these studies reduced the reliability to ex-
actly allocate and interpret signal changes 
seen with MRI. Furthermore, studies dem-
onstrating an acceptable spatial resolu-
tion employed implantable coils, which as 
opposed to surface coils require an ad-
ditional invasive procedure. In the present 
study, we investigated, whether high ﬁeld 
MRI at 17.6 T would allow superior spatial 
resolution and thus improved detection of 
structural changes in the adult rat spinal 
cord following a deﬁned contusion injury 
ex vivo and in vivo. 
2. MATERIALS AND METHODS
2.1 Animals
The spinal cord injury and imaging ex-
periments were conducted using young 
adult female Fisher 344 rats (n=8) weigh-
ing 160-180g. Ex vivo MRI was performed 
in 2 spinal cord injured animals, in vivo 
MRI in 5 spinal cord injured (Table 1) and 
1 uninjured rat. All experiments were car-
ried out in accordance with the European 
Communities Council Directive (86/609/
EEC) and institutional guidelines for ani-
mal care. All efforts were made to mini-
mize the number of animals used, as wells 
as their suffering.
2.2 Surgical procedures
For the surgical procedure animals under-
went anesthesia made up of a mixture of 
ketamine (62.5mg/kg body weight; WDT, 
Garbsen, Germany), xylazine (3.175mg/
kg body weight; WDT, Garbsen, Ger-
many) and acepromazine (0.625mg/kg 
body weight, Sanoﬁ-Ceva, Düsseldorf, 
Germany) in 0.9% sterile saline solution. 
Rats received spinal cord contusion inju-
ries using the Inﬁnite Horizon (IH) spinal 
cord injury device (Precision Systems & 
Instrumentation, Lexington, USA) as pre-
viously described 20. A laminectomy was 
performed at thoracic level Th 10 to ex-
pose the dorsal portion of the spinal cord. 
The animals were suspended by attach-
ing Adson forceps to the rostral Th 9 and 
caudal Th 11 vertebral bodies. Particular 
care was taken to align the exposed spi-
nal cord perpendicular to the axis of the 
Impactor. The 2.5 mm stainless steel im-
pounder tip was lowered to approximately 
3–4 mm above the surface of the exposed 
spinal cord. The contusion injury was ﬁ-
nally induced by applying an impact force 
of 2 Newton (equals 200 kilodyne) to the 
exposed spinal cord at a velocity of 130 
mm/sec. Overlying muscle layers were 
sutured and the skin was closed. Postop-
eratively, animals were kept warm, placed 
on beds of sawdust and given manual 
bladder evacuation twice per day for a 
period of up to 10 days as necessary and 
received intramuscular injections of 10 
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mg Cotrimoxazol (Ratiopharm, Ulm, Ger-
many) once daily for a period of 10 days. 
Animals regained automatic neurogenic 
bladder function after 5 to 10 days.
2.3 MR scanner
All MR imaging experiments were con-
ducted on a vertical Bruker 750 wide bore 
magnet system (Bruker Biospin, Rhein-
stetten, Germany) at 17.6 T with a bore 
size of 89 mm.
2.4 In vivo MR imaging
Anesthesia was induced by inhalation of 
4% isoﬂurane and maintained with 2% 
isoﬂurane in carbogen (95% oxygen and 
5% carbon dioxide). Body temperature 
was maintained by heating the gradient 
cooling unit to 37 ± 2°C. 
A total of 5 rats underwent in vivo MRI be-
tween 2 and 58 days after thoracic spinal 
cord contusions were applied (Table 1). 
An uninjured rat with an intact spinal cord 
served as control. An animal gradient sys-
tem with 57 mm inner diameter and 0.2 
T/m was used. Due to space restrictions 
within the gradient system, imaging of the 
rat spinal cord in wide bore magnets was 
not possible with commercially available 
hardware. Therefore, a probehead and 
surface coil were custom-built to provide 
maximum space for adult rats as de-
scribed 21. The surface coil was designed 
as a transmit-receive coil in a half-cylin-
drical carrier mounted on an optimized 
probebase. The probebase included bal-
ancing units (baluns), which are important 
at higher frequencies due to the increased 
sensitivity of the electrical setup to imbal-
ances.
To avoid artifacts caused by blood ﬂow 
and respiratory motion a triggering unit 
(RAPID Biomedical, Wuerzburg, Ger-
many) for combined electrocardiogram 
(ECG) triggering and respiratory gating 
was used. 
A multi-slice 2D spoiled gradient echo se-
quence was used with a TE around 4 ms, 
depending on the exact spatial resolution 
used, and a TR around 200 ms depending 
on the heart rate. Up to 9 slices were ac-
quired per scan. Using surface coils, gra-
dient echo sequences are advantageous 
for transmission, as they are far less sen-
sitive to radio frequency (RF) inhomogeni-
ties. Two interleaved multi-slice data sets 
were acquired to cover a full 3D volume. 
The spatial resolution was at least 78 x 
78 µm in-plane with a slice thickness of 
370 µm in axial slices and 156 x 98 µm in-
plane with a slice thickness of 370 µm in 
sagittal slices. Each series took between 
15 and 20 minutes.
2.5 Ex vivo MR imaging
For ex vivo MRI, one animal was perfused 
at 2 weeks and another animal at 4 weeks 
after the contusion injury with 150 ml cold 
0.1 M phosphate buffered saline (PBS) fol-
lowed by 400 ml 4% paraformaldehyde in 
PBS. Spinal cords were removed and post-
ﬁxed overnight in 4% paraformaldehyde in 
PBS and then left for 1 day in PBS con-
taining 30% sucrose at 4°C. This ﬁxation 
procedure is required for the histological 
evaluation following ex vivo MRI. For the 
actual imaging process, spinal cord speci-
mens were transferred into 5 mm wide 
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NMR tubes (Wilmad, Buena, NJ, USA) 
ﬁlled with PBS containing 30% sucrose. 
Air bubbles were removed from the tube 
using a vacuum pump and leaving each 
sample at a pressure of approximately 50 
mbar for around 10 minutes.
A gradient system with 1 T/m and an inner 
diameter of 40 mm was used with a com-
mercial 5 mm linear birdcage resonator 
as transmit- and receive coil. The sample 
was kept at 20±1°C during imaging experi-
ments.
Positioning of the sample was performed 
using a 3D low-resolution gradient echo 
sequence. A 2D multi-slice spin echo with 
an echo time (TE) of 7.5 ms, a repetition 
time (TR) of 2 s, 24 signal averages (NA), 
and a total scan time 3.5h was used. With 
a ﬁeld of view (FOV) of 6 x 6 mm and an 
acquisition matrix of 256 x 256, the spatial 
resolution was 23 x 23 µm in-plane with 
a slice thickness of 300 µm. A total of 30 
slices was acquired in axial direction and 
14 slices in sagittal direction.
2.6 Histology
Animals were transcardially perfused with 
a 0.9% saline solution followed by 4% 
paraformaldehyde in PBS 2 days after the 
ﬁnal in vivo MRI. The spinal cords were 
removed, postﬁxed overnight in 4% para-
formaldehyde in PBS and left for one day 
in PBS containing 30% sucrose. Sagittal 
35 µm thick sections of the thoracic spinal 
cord containing the injured area were cut 
with a cryostat. Every seventh section was 
mounted immediately on glass slides for 
Nissl staining. In the remaining sections, 
Prussian blue staining and light level im-
munohistochemistry was performed for a 
more detailed morphological analysis of the 
contused spinal cord tissue. Prussian blue 
staining, which was employed to detect he-
mosiderin deposits, was performed as fol-
lows: sections mounted on gelatin coated 
slides were immersed in a solution of 4% 
potassium ferrocyanide and 4% HCl for 
15 min. After several rinses sections were 
counterstained with Vector Nuclear Fast 
Red solution (Linaris, Wertheim, Germany) 
for 5 min and dehydrated before coverslip-
Table 1: Time table of in vivo MRI scans for each individual animal.
animal # 1. MRI scan
(days post-injury)
2. MRI scan
(days post-injury)
3. MRI scan
(days post-injury)
Histology
1 18 25 39 no1
2 18 25 393 no1
3 6 38 58 no1
4 2 38 -- yes2
5 2 134 585 yes2
1 animals died during or shortly after last MRI scanning procedure.
2 animals sacriﬁed one day after the last MRI scan.
3 illustrated in Fig. 5
4 illustrated in Fig. 4A-C
5 illustrated in Fig. 4D-F
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ping with Neo Mount (Merck, Darmstadt, 
Germany). For immunohistochemistry, the 
following primary antibodies were used: 
mouse-anti-GFAP (for astrogliosis; DAKO, 
Glostrup, Denmark; at 1/2000), goat-
anti-collagen type III (for the ﬁbrous scar; 
Southern Biotechnology, Birmingham, 
USA, at 1/100) and mouse anti-rat mono-
cytes/macrophages (clone ED1; Chemi-
con, Hofheim, Germany, at 1/1000). The 
sections were blocked in TBS + 3% don-
key serum + 0.1% Triton-X, and incubated 
with the primary antibody in TBS + 3% 
donkey serum + 0.1% Triton-X overnight 
at 4°C on a rotating platform. The following 
day, sections were incubated with the sec-
ondary antibody (biotinylated donkey IgG, 
Jackson, Hamburg, Germany; at 1/1000) in 
TBS containing 3% donkey serum + 0.1% 
Triton-X. Sections were incubated with avi-
din-biotinylated-peroxidase complex (Vec-
tor Elite kit; Linaris, Wertheim, Germany) 
followed by development for 3–15 min in 
a 0.05% solution of 3,3’-diaminobenzi-
Figure 1: In vivo MRI of intact spinal cord at 17.6 T. A,B show sagittal scans through the thoracic spinal 
cord. Acquisition parameters: slice thickness 239 µm, FOV 40 x 30 mm, in plane resolution 156 x 117 µm, 
TR approx. 200 ms (depending on heart rate), TE 4.4 ms. C,D display axial scans through the thoracic spinal 
cord. Acquisition parameters: slice thickness 500 µm, FOV 17.7 x 35.5 mm, in plane resolution 69x69 µm, 
TR and TE as above. Scale bar 2 mm (A) A more lateral sagittal scan depicts primarily white matter (lower 
signal) with some longitudinally oriented more hyperintense structure, reﬂecting the gray matter of the lateral 
ventral horn. Cerebrospinal ﬂuid appears hyperintense, vertebral bodies are hypointense. (B) Most of the 
spinal cord parenchyma displayed here represents gray matter (hyperintense) surrounded by white matter 
tracts (hypointense) in a paramedian sagittal scan through the spinal cord. (C) An axial scan through the 
thoracic spinal cord allows the clear distinction between the typical butterﬂy appearance of the spinal cord 
gray matter and the surrounding hypointense white matter. Also of note, spinal roots can be clearly identiﬁed 
at this level. (D) A subsequent scan more caudally shows the spinal cord in cross-section away from the spinal 
root entry zone. 
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Figure 2: Axial ex vivo MRI scans of contused 
rat spinal cord. Axial slices of ex vivo MRI show 
microscopy grade visualization of morphological 
changes in the injured rat spinal cord 4 weeks after 
contusion injury at midthoracic level. Acquisition 
parameters: 2D multi-slice spin echo, slice thickness 
300 µm, FOV 6x6 mm, in plane resolution 23 x 23 
µm, TE 7.5 ms, TR 2 s. Scale bar 1 mm. A-L show 
consecutive sections in the rostral-caudal direction. 
In rats the dorsal columns contain not only ascending 
proprioceptive projections, which are located in 
the dorsal half of the dorsal column. The crossed 
corticospinal tract projects in the ventral half of the 
dorsal columns, unlike humans, where the majority of 
corticospinal axons are located in the lateral columns. 
(A-F) In sections rostral to the contusion site, the 
spinal cord morphology is still maintained with a clear 
differentiation of white and gray matter. Note the loss 
of signal in the dorsal part of the dorsal columns 
(arrowheads) identical with ascending proprioceptive 
projections. (G-I) At the lesion center, the spinal cord 
diameter is reduced, and gray and white matter can 
no longer be separated. Hypointensities located in 
the center (G) reﬂect hemosiderin deposits. (J-L) 
Caudal to the lesion, the gray-white matter contrast 
is preserved. Both in rostral and caudal scans (B-
D,J-L) hyperintense signals are found in the dorsal 
columns consistent with cystic defects (see also 
Fig. 3). Hypointensities in axial scans rostral to the 
lesion correspond to ascending sensory projections, 
whereas in caudal scans they represent the area of 
the corticospinal tract (J-L; arrowheads).
dine (DAB), 0.01% H2O2 and 0.04% nickel 
chloride in TBS yielding a brown-black 
reaction product. Sections were mounted 
onto gelatin-coated glass slides, air-dried, 
dehydrated and coverslipped with Neo 
Mount (Merck, Darmstadt, Germany). The 
histological analysis was performed using 
a Leica DMR microscope equipped with a 
Spot CCD camera model 2.2.1 (Diagnostic 
Instruments, Michigan, USA).
3. RESULTS
3.1 In vivo MRI of intact spinal cord
Gradient echo MRI with ECG triggering 
and respiratory gating yielded high reso-
lution images of intact thoracic rat spinal 
cord in vivo without signiﬁcant motion arti-
facts (Fig. 1). The typical butterﬂy-shaped 
gray matter could be clearly distinguished 
from the less intense surrounding white 
matter axonal tracts. The cerebrospinal 
ﬂuid surrounding the spinal cord appeared 
as a small hyperintense rim adjacent to the 
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spinal cord due to its longer T2 and T2
* re-
laxation times. With the applied sequence 
vertebral bodies appeared completely 
dark, while vertebral disks were bright.
3.2 Ex vivo MRI of contused spinal 
cord
Spin echo images of excised spinal cord 
4 weeks after a thoracic contusion injury 
revealed a signal pattern away from the in-
jury epicenter in axial slices (Fig. 2), which 
was almost identical to in vivo gradient 
echo images in unlesioned animals (Fig. 1 
C,D). Gray matter was hyperintense com-
pared to white matter. The central canal 
could be clearly identiﬁed. The gray/white 
matter differentiation completely vanished 
at the contusion center (Fig. 2 G,H). The 
homogenous hyperintense signal, which 
was pronounced in the spinal cord center 
and diminished towards the surface of the 
cord in all directions, was only interrupted 
by areas of signal loss in the center of the 
cord, which were conﬁned mostly to the 
gray matter (Fig.2 G). Trauma induced 
hemorrhage and consecutive hemosiderin 
deposits are the likely pathologic corre-
lates for this signal free area, which have 
been described to occur frequently within 
the spinal cord gray matter after injury 17. 
Hypointensities within the lesion center 
(in particular in sagittal MR scans) - not as 
pronounced as the described hemosiderin 
associated changes - corresponded to im-
munoreactivity for collagen type III, but not 
GFAP, in sagittal histological sections (Fig. 
3 B,J,N), thus representing components of 
the ﬁbrous rather than the gliotic scar. The 
overall diameter of the cord was reduced, 
in particular the dorsolateral columns were 
symmetrically diminished in volume (Fig. 
2 G,H), reﬂecting substantial irreversible 
Figure 3: Sagittal ex vivo MRI scans of contused rat spinal cord and corresponding histology. Midthoracic 
contusion injury 4 weeks post lesioning, same specimen as Fig. 2. Acquisition parameters: 2D multi-slice spin 
echo, slice thickness 208 µm, FOV 20x6 mm, in plane resolution 23 x 78 µm, TE 7.5 ms, TR 2 s. Scale bar 2 mm. 
A-D Ex vivo MRI scans from lateral to medial. E-H Corresponding Nissl stained sections. I-L Corresponding 
GFAP immunostained sections. M-P Corresponding collagen type III immunostained sections. Homogenous 
hyperintensities at the injury center (A) correspond to cystic lesion defects in histological sections (E,I,M). 
In other sections. mixed hypo-/hyperintensities in the lesion center (B,C; arrows) are associated either with 
cystic lesion defects, hemosiderin deposits or ﬁbrotic scar formation (F,N,G,O; arrows). A hypointensity 
following the path of the dorsal corticospinal tract caudal to the lesion - corresponding to hypointensities in 
the dorsal columns in axial MR scans (see Fig.2) - is highlighted by arrowheads (B).
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atrophy as soon as 4 weeks after injury. 
In some Nissl stained sections (Fig. 3 G) 
all types of organized tissue were absent, 
suggesting a developing ﬂuid-ﬁlled cavity. 
However, corresponding MRI scans did 
not display a homogenous hyperintensity 
(Fig. 3 C), which would be the MR equiva-
lent of a cystic lesion defect. Instead, only 
a small hyperintense band - the correlate of 
the true cystic lesion defect - surrounded a 
hypointense core. Thus, it is likely that this 
hypointense area contained non-organized 
material (inﬂammatory cells and cell debris 
mixed with hemosiderin deposits), which is 
regularly lost during the process of histo-
logical analysis.
Remote from the lesion center, some neu-
roanatomically restricted signal changes 
could be observed (Fig. 2 A,J-L; Fig. 3 B). 
Caudal to the lesion center, hypointensi-
ties strictly conﬁned either to the former 
main dorsal corticospinal tract caudal to 
Figure 4: Sagittal in vivo MRI scans of contused rat spinal cord and corresponding histology. In vivo MRI in 
adult rats at 2 and 8 weeks after thoracic contusion injury displays signal changes, which parallel the ex vivo 
MRI data. Acquisition parameters: 2D multi-slice gradient echo, A-C slice thickness 311 µm, FOV 30 x 30 
mm, in plane resolution 117 x 117 µm, TE 4.4 ms, TR approx. 200 ms (depending on heart rate). D-F slice 
thickness 300 µm, FOV 40 x 25 mm, in plane resolution 156 x 98 µm, TE 3.7 ms, TR 200 ms (depending on 
heart rate). Scale bar A-F 5 mm, G-O 1 mm.  Consecutive sagittal MR scans are shown at 2 weeks (A-C) and 
8 weeks (D-F) post injury with corresponding histological Nissl (G-I) and Prussian Blue (J-L) stained sections, 
and sections processed for ED1 immunohistochemistry (macrophages, monocytes) (M-O), all from the same 
animal. Arrows in A,B highlight the site of the impact. Hypointensities along ascending and descending axon 
projections in the dorsal columns (B,E) correlate with hemosiderin deposits (K) rather than macrophage/
monocyte inﬁltration (O) (respective areas are highlighted by arrowheads). These changes increase from 2 
weeks (C) until 8 weeks (G) post injury. The clear reduction in cord diameter over time (B versus E; C versus 
F) corresponds to the atrophy seen in histological sections (G-O).
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the lesion or to the ascending propriocep-
tive pathways (gracile fascicle) rostral to 
the lesion were identiﬁed. Hyperintense 
regions within the dorsal columns rostrally 
and caudally (Fig. 2 B-D,J-L; 3 A,B) can be 
attributed to cystic necrotic zones, which 
were identiﬁed in the corresponding sag-
ittal histological sections (Fig.3 F). There 
was no difference in overall signal changes 
compared to the spinal cord sample, which 
was taken 2 weeks after the contusion in-
jury (data not shown).  
3.3 In vivo MRI of contused spinal 
cord
Five animals with spinal cord contusions at 
thoracic level applied by the IH Impactor 
and one intact animal were analyzed with 
MRI at 2, 6 and 8 weeks postoperatively. 
Only 2 out of 5 injured animals survived 
the MR imaging procedure and were thus 
obtainable for histological evaluation. The 
majority of signal changes observed in ex 
vivo spin echo images in the contused spi-
nal cord were almost identical to in vivo 
gradient echo images of the contused spi-
nal cord. The cord diameter was reduced 
at the lesion center; in particular, the dor-
solateral aspects were atrophic (Fig. 4 A-F; 
5 E,F), which was conﬁrmed by identical 
ﬁndings in corresponding Nissl stained his-
tological sections. Towards the lesion epi-
center, the gray/white matter differentiation 
completely vanished (Fig. 5 D-G). The sig-
nal pattern of the gray matter in the intact 
spinal cord (Fig. 1 C,D) was replaced by 
hypointense areas in the center of the cord 
surrounded by a hyperintense rim dorsally 
Figure 5: Axial in vivo MRI scans of contused rat spinal cord. In vivo MR axial scans in adult rats 6 weeks 
post injury. Acquisition parameters: 2D multi-slice gradient echo, slice thickness 370 µm, FOV 20 x 20 mm, 
in plane resolution 78 x 78 µm, TE 4.2 ms, TR approximately 200 ms (depending on heart rate). Scale bar 2 
mm. Scans rostral to the contusion (A-C), at the lesion center (D-G) and caudal to the lesion (H). The clear 
differentiation between white and gray matter disappears over subsequent sections. At the lesion center, 
hypointensities are surrounded by hyperintensities, which are less pronounced towards the cord surface 
(E,F). The dorsal aspect of the spinal cord at the lesion site appears more homogenously hyperintensive, 
most likely representing cystic changes (D,E; arrowhead). Signs of atrophy are present in the dorsolateral 
spinal cord (E,F)
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and ventrally (Fig. 5 D-G). As described in 
ex vivo MRI (Fig. 2 F,G), the hypointensities 
at the lesion center represent hemosiderin 
deposits, which are remnants of the hem-
orrhage caused by the trauma correspond-
ing to dark areas in Nissl and Prussian Blue 
stained sections (Fig. 4 K,N). In addition, 
hypointensities were found conﬁned to the 
dorsal columns rostral and caudal to the 
lesion, both in sagittal and axial scans (Fig. 
4 B,E; 5 H), which are also paralleled by ex 
vivo MRI ﬁndings. These hypointensities 
could be correlated with hemosiderin de-
posits as depicted by Prussian Blue stain-
ing of corresponding spinal cord sections 
(Fig. 4 K). There was no correlation with 
areas of macrophage/monocyte inﬁltration 
(Fig. 4M-O), which are - besides location 
adjacent to the injury center - commonly 
identiﬁed in white matter tracts remote 
from the lesion site highlighting areas of 
ongoing wallerian degeneration (N. Wei-
dner, unpublished observation). 
In Nissl stained histological sections (Fig. 
4 H), small cigar shaped cystic areas de-
creasing in size rostrally were identiﬁed, 
which represent areas of beginning post-
traumatic syrinx formation. In in vivo MRI, a 
corresponding signal was not clearly iden-
tiﬁable (Fig.4 B,E). Most likely, the chosen 
sagittal imaging planes did not include the 
location of the central canal.
4. DISCUSSION
This study was undertaken to evaluate the 
capabilities of high ﬁeld (17.6 T) MRI to 
identify morphological changes occurring 
after experimental spinal cord contusion 
injury in adult rats. Findings from this study 
will serve as a basis for future preclinical 
experiments employing high ﬁeld MRI to 
monitor cell-based regenerative strategies 
in the injured spinal cord, which might be-
come a relevant therapy for spinal cord in-
jured human subjects. 
Thus far, only a few publications are avail-
able describing ﬁndings of morphological 
changes obtained by MR imaging in vivo 
in spinal cord injured rats 11-19. Of these, 
only two MRI studies investigated spinal 
cord contusion injuries 16, 18, which are 
considered to closely mimic pathomor-
Table 2: A comparison of the different spatial resolution in previous rat spinal cord injury in vivo MRI studies. 
If one study used different resolutions, the highest resolution is quoted.
Voxel volume
(nl)
In-plane-Resolution
(µm)
Slice thickness
(µm)
Field strength
(T)
Coil type Reference
2.25 78x78 370 17.6 T surface coil present study
12.2 78x156 1000 1.9 T implanted 11
304 780x780 500 1.5 T surface coil 12
17.3 76x76 3000 4.7 T surface coil 13
76 195x195 2000 2.1 T surface coil 14
not provided 2800 2 T surface coil 15
80 200x200 2000 4.7 T birdcage coil 16
12.7 130x98 1000 2 T implanted 17
8.1 78x104 1000 7 T implanted 18
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phological changes occurring after spinal 
cord injury in human subjects. In all previ-
ous studies, only a very limited resolution 
was achieved at ﬁeld strengths ranging 
from 1.5 up to 7 T. Lower ﬁeld strengths 
limit the achievable spatial resolution due 
to SNR restrictions. Therefore, in-plane 
resolution and slice thickness have to be 
reduced. The best resolution was achieved 
with implanted coils 11, 17, 18, which improve 
the SNR compared to surface coils, but 
require an additional surgical procedure. 
Despite the use of a surface coil, we were 
able to achieve a spatial resolution at 17.6 
T, which is four times higher than the best 
previously reported resolution with an im-
planted coil (Table 2). White and gray mat-
ter differentiation 13, 16, 17, the delineation of 
cyst formation and hemorrhage from sur-
rounding intact spinal cord parenchyma 
have been reported 13, 17. However, none of 
these studies was able to spatially allocate 
respective signal changes as precise as in 
the present study. The ability to visualize 
signal changes at a high spatial resolution 
will become particularly relevant for future 
MRI studies employed to track the survival 
and migration of a small number of para-
magnetically labeled transplanted cells in 
the injured spinal cord in small animals 22.
Both ex vivo and in vivo MRI of injured rat 
spinal cords consistently depicted hypoin-
tensities in the dorsal columns rostral and 
caudal to the contusion injury at thoracic 
level. The comparison with corresponding 
histological sections revealed that these 
hypointense areas represent hemosiderin 
deposits due to trauma induced hemor-
rhage rather than wallerian degeneration, 
which has also been described to induce 
hypointensities following spinal cord injury 
23. Both, neuropathological and the neuro-
radiological studies frequently report struc-
tural changes representing hemorrhage 
following spinal trauma 17, 24, 25. However, 
respective changes are observed in the 
gray matter accentuated in and adjacent 
to the lesion center. To our knowledge, ex-
tensive white matter MRI signal changes 
representing hemosiderin deposits as ob-
served in the present study have not been 
described yet. Field strength dependent 
changes in terms of relaxation rates and 
the higher spatial resolution seem to have 
increased the contrast in regions of iron 
deposition 26, thus allowing visualization 
of relatively discrete hemosiderin deposits 
within the spinal cord. Whether the signal 
changes observed in this animal model of 
spinal cord injury reﬂect pathological se-
quels of this disease condition in humans 
remains to be determined. In case, hemo-
siderin deposits reﬂecting a former hem-
orrhage are more widespread than previ-
ously thought, free radicals accumulating 
after an intraspinal hemorrhage might fur-
ther contribute to the poor intrinsic regen-
erative capacity of the injured mammalian 
spinal cord 27. 
Ex vivo and in vivo MRI results show a mis-
match of MR images and corresponding 
histological sections (Nissl stains) in regard 
to the extent of cystic defects. In histo-
logical sections, we frequently observe a 
rather large cystic lesion defect upon mi-
croscopic analysis, which overestimates 
the true size of cystic changes. During the 
preparation of histological sections from 
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contused spinal cord tissue, non-organized 
material such as cell debris, macrophages 
mixed with remnants of previous hemor-
rhages ﬁlling the cyst in part is lost. In con-
trast, MR signal changes in corresponding 
areas are much more diverse, displaying 
not only hyperintensities reﬂecting cystic 
degeneration as suggested by histology, 
but in addition hypointensities represent-
ing hemosiderin and cell debris. Thus, in 
vivo visualization by MRI provides invalu-
able additional information, which cannot 
be obtained from histological examination. 
For example, it is extremely important to 
differentiate between these alterations in 
cell transplantation approaches. Trans-
planting cells in a milieu rich in inﬂamma-
tory cells and hemosiderin will decrease 
the survival rate of transplanted cells, thus 
jeopardizing the transplantation success 
28. Analyzing these changes over time us-
ing MRI will help to establish the optimal 
timing and location for transplantation after 
injury.
A signiﬁcant limitation for small animal im-
aging at 17.6 T at this point is the reported 
poor survival rate of rats induced by the 
scanning procedure. Even though a cus-
tom-built probe head was used to over-
come spatial restrictions 21, the tight ﬁtting 
of experimental animals can sometimes 
lead to insufﬁcient air circulation resulting 
in a rise of the isoﬂurane concentration 
around the animal. Furthermore the gradi-
ent cooling unit was maintained at 37°C 
± 2°C throughout the imaging protocol 
to keep the animal at body temperature. 
Since only the temperature of the gradient 
cooling unit, but not the actual body tem-
perature of the animals, was monitored, it 
is conceivable that the temperature of the 
animal was beyond physiological levels, 
thus contributing to the observed mortal-
ity. The present study was conducted to 
investigate the capabilities of high ﬁeld 
MRI to monitor structural changes occur-
ring after spinal cord injury in rats. Results 
demonstrate that MR imaging at 17.6 T us-
ing a surface coil provides extremely high-
resolution visualization of structural chang-
es occurring in the rat spinal cord follow-
ing a contusion injury ex vivo and in vivo, 
which is superior to the best known spatial 
resolution even with implantable coils. The 
achieved spatial resolution allows to ex-
actly localize morphological changes such 
as cyst formation and hemosiderin deposi-
tion, which are sometimes not even seen 
with histological analysis of spinal cord in-
jured animals over time. In principle, in vivo 
high resolution MRI should allow repeated 
structural analysis in individual animals, 
which would also help to signiﬁcantly re-
duce the number of animals required for 
preclinical investigations. However, the 
problem of poor animal survival during MR 
imaging needs to be solved. 
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Summary and discussion
In this thesis, the possibilities and limita-
tions of cell-based therapies after spinal 
cord injury are explored. Particularly, the 
potential of adult derived neural progeni-
tor cell (NPC) grafts to function as a per-
missive Substrate for axonal regeneration 
was investigated. Therefore, NPC were 
isolated from the adult rat spinal cord, 
propagated and were grafted to animals 
that received an acute spinal cord injury. 
Furthermore, techniques that are essential 
for the application of cell-based therapy 
were developed, including the prepara-
tion of graft material, ex vivo gene therapy 
and the development of non-invasive in 
vivo imaging techniques.
1. GRAFT PROPERTIES ESSENTIAL 
FOR REGENERATION OF THE 
INJURED SPINAL CORD
The main rationale for the use of NPC 
grafts in the injured spinal cord is the abil-
ity of NPC to replace lost spinal cord cells 
with cells that originally are present within 
the central nervous system (CNS). Since 
the adult CNS milieu however does not al-
low substantial regeneration, a simple sub-
stitution of CNS cells at the tissue defect 
that typically develops due to the injury 
most likely is not sufﬁcient. The objective 
therefore is to mimic the axonal outgrowth 
pattern of the developing CNS, by trans-
planting NPC grafts 1, 2. In order to reach 
this goal, grafted NPC ﬁrst must be able 
to: 1) replace the lesion cyst that typically 
develops after the wire knife spinal cord 
injury, 2) offer trophic support and correct 
guidance cues to the regenerating axons 
in analogy to Schwann cell function in the 
injured peripheral nervous system and 3) 
replace lost spinal cord cells by differenti-
ating into mature CNS cells that become 
functionally integrated into the spinal cord 
cytoarchitecture. 
1.1 Lesion cyst replacement
The replacement of the lesion defect that 
develops after spinal cord injury (SCI) 
represents an important prerequisite to al-
low substantial axonal regeneration in the 
injured spinal cord. Since the used wire 
knife model of SCI induces a single cys-
tic lesion cavity without inducing massive 
inﬁltration of peripheral cells, this model 
is very well suited to study the capacity 
of various cell grafts to restore lost spinal 
cord tissue. Although NPC survive trans-
plantation into the acutely lesioned spinal 
cord, grafts of NPC alone are not able to 
replace the lesion defect since the NPC 
migrate away from the graft site (Chapter 
2). Until so far, only the co-transplanta-
tion of NPC with ﬁbroblasts allowed le-
sion cavity repair in combination with the 
successful delivery of NPC at the lesion 
site (Chapter 3). Experiments in which 
Schwann cells replaced the ﬁbroblasts 
showed that although lesion cyst could 
be restored, the co-grafted NPC migrated 
into the spared spinal cord parenchyma, 
away from the Schwann cells that resided 
at the graft site (Chapter 4b). 
1.2 Trophic- and guidance support 
for axonal regeneration by NPC
In the NPC-ﬁbroblast co-grafted ani-
mals, regenerative sprouting of lesioned 
axons was induced when compared to 
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animals that received grafts of ﬁbroblasts 
alone. Moreover, corticospinal tract (CST) 
regeneration was signiﬁcantly induced 
by 170% in NPC-ﬁbroblast co-grafted 
animals when compared to animals that 
received grafts of ﬁbroblasts only (Chap-
ter 3). The ability of NPC to induce regen-
erative sprouting of lesioned CST axons 
without the need of additional applica-
tion of neurotrophic factors represents 
a unique property of NPC. This has only 
been unambiguously shown before with 
the grafts of olfactory ensheating cells 3, 4. 
It has been reported that neural stem cells 
derived from the neonatal mouse cerebel-
lum secrete by themselves various neu-
rotrophic factors including nerve growth 
factor, brain-derived neurotrophic factor, 
and glial cell line-derived neurotrophic 
factor 5. Whether the unmodiﬁed adult de-
rived NPC that are used in the presented 
studies also secrete neurotrophic factors 
has not been investigated so far. 
Regenerative sprouting of lesioned CST 
axons within the graft area of animals that 
were co-grafted with NPC and ﬁbroblasts 
was observed along glial ﬁbrillary acidic 
protein (GFAP) expressing grafted NPC 
(Chapter 3). These GFAP expressing cells 
are notably distinctive to the reactive as-
troglia that normally can be identiﬁed at 
the lesion site. First, both in the intact and 
the injured adult spinal cord, astrocytes 
mainly display a typical stellate morphol-
ogy. The GFAP expressing cells that favor 
regenerative sprouting of lesioned axons 
however mostly appear as cells that pos-
sess a more elongated shape. Further-
more, a large proportion of the GFAP ex-
pressing grafted cells can be co-labeled 
with antibodies against brain lipid-bind-
ing protein (BLBP). BLBP is a marker for 
radial glial cells and immature astrocytes 
or astrocyte precursors 6. We therefore 
postulate that the grafted NPC that differ-
entiate into astroglila maintain an imma-
ture phenotype while serving as a scaf-
fold for sprouting axons. This hypothesis 
is further validated by the fact that adult 
astrocytes are shown to be inhibitory to 
axonal regeneration 7, 8 It remains unclear 
whether all differentiating NPC are able 
to function as a permissive Substrate for 
CNS axon regeneration. Grafts consisting 
of homogenous populations of NPC de-
rived cells could allow the identiﬁcation of 
speciﬁc NPC phenotypes that augment 
axonal regeneration. Therefore further ex-
periments need to be conducted that al-
low manipulation of NPC fate.
It remains unclear whether the co-grafted 
ﬁbroblasts alter NPC function to stimu-
late outgrowth, or whether the ﬁbroblasts 
are solely needed to retain the co-grafted 
NPC at the lesion site. In the peripheral 
nerve injuries, ﬁbroblasts have been de-
scribed to induce the production of ex-
tracellular matrix (ECM) and basal lamina 
components by Schwann cells 9. Further-
more, the co-culture experiments of GFP 
expressing NPC with ﬁbroblasts at least 
suggest that the morphology of the differ-
entiating GFP expressing NPC is changed 
towards a more bipolar shape, a morpho-
logical phenotype that can be spatially 
associated with regenerating axons in 
vivo (Chapter 3).
The invasion of ﬁbroblasts from the me-
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ninges has been associated in the litera-
ture with astroglial scarring, a detrimental 
event for axonal regeneration 10. Never-
theless, the presence of ﬁbroblasts in co-
grafts does not appear to prevent axonal 
regeneration in these experiments. Co-
cultured ﬁbroblasts do not induce the for-
mation of a glia limitans like structure in 
vitro, which is in contrast to Schwann cells 
(Chapter 3, 4b). Therefore, the effect of the 
presence of ﬁbroblasts within the lesioned 
area on axonal regeneration needs to be 
further investigated e.g. by grafting a NPC 
ﬁlled artiﬁcial matrix. If such a NPC-load-
ed matrix allows substantially more re-
generative sprouting than the matrix only, 
the notion that undifferentiated NPC per 
se are capable of inducing regenerative 
sprouting of lesioned CNS axons would 
be further strengthened 11. 
The direction of the observed regenerative 
sprouting of axons into the graft occurs 
randomized, which reduces the likelihood 
of axons to completely bridge the graft 
and reenter the spinal cord parenchyma 
distal to the lesion site and reinnervate 
target structures. Moreover, since the 
cytoarchitecture of the spinal cord axon 
projections is highly organized, oriented 
sprouting of lesioned axons is essential if 
the native organization of the spinal cord 
axon projections have to be reinstalled. 
Therefore, it is most likely that introduc-
ing directive cues are an important aspect 
in order to allow sprouting axons to align 
to their correct targets. Different methods 
have been proposed to induce a more 
oriented axonal sprouting, including the 
induction of a chemoattractive neuro-
trophic factor gradient or by transplanting 
an anisotropic matrix that consists of ori-
ented pores that bridges the lesion site 12, 
13. Especially the use of an oriented aniso-
tropic guidance matrix is of great interest, 
since it eventually also could replace the 
co-grafted ﬁbroblast as a Substrate to re-
tain the grafted NPC at the lesion site. 
1.3 Appropriate replacement of lost 
spinal cord cells
In order to study fate and function of the 
used NPC upon transplantation, grafted 
cells need to be identiﬁed in vivo using a 
method that allows the reliable co-localiza-
tion with phenotypical markers. Through-
out this thesis, NPC are prelabeled using 
the thymidine analogue Bromodeoxyuri-
dine (BrdU). BrdU is incorporated in the 
DNA of proliferating cells prior to trans-
plantation, which later can be visualized 
using immunocytochemical methods 14. 
Although BrdU prelabeling represents a 
reliable method for the identiﬁcation of 
grafted cells, it is a far from ideal technique 
since the label is restricted to the cell nu-
cleus. Therefore, to reliably co-localize the 
BrdU label with phenotypical markers that 
mostly are located in the cytoplasm can 
be problematic (Chapter 2). Furthermore, 
BrdU immunohistochemistry is preceded 
by an antigen retrieval protocol that is not 
compatible with immunohistochemical 
myelin stainings, which complicates the 
identiﬁcation of grafted NPC that adapted 
to an oligodenroglial phenotype (Chapter 
4b). A possible solution for this problem 
is the labeling of the grafted cells with a 
genetic marker. Therefore, it was tested 
161
Chapter 7
whether NPC could be genetically modi-
ﬁed to express the cytoplasmatic marker 
green ﬂuorescent protein (GFP) using var-
ious retro- and lentiviral vectors. Although 
undifferentiated NPC strongly expressed 
GFP, transgene expression was rapidly 
lost after transplantation of the GFP ex-
pressing NPC into the spinal cord (Chapter 
5). The development of improved vectors 
that are able to induce stable transgene 
expression in adult derived NPC therefore 
is of great importance, in order to allow 
reliable cytoplasmatic labeling of grafted 
cells.
The grafted BrdU positive NPC were 
found to differentiate into glia only (Chap-
ter 2, 3, 4b). At 3 weeks post transplan-
tation, the grafted NPC mainly expressed 
the astroglial markers GFAP. Furthermore, 
the grafted NPC differentiate into glial 
cells that ﬂawlessly integrate into the host 
tissue (Chapter 2, 3, 4b). The grafted NPC 
thus were able to build a reticulum that 
continues into the host parenchyma, with-
out being sealed of by a rim of reactive 
astrocytes, which often can be observed 
when other cell types are grafted into the 
injured spinal cord 15, 16. Whether substi-
tuted astroglial cells become functionally 
integrated as well has not been investi-
gated yet.
The grafted NPC did not uniformly differ-
entiate into GFAP expressing cells. NPC 
that adapted to oligodendroglial lineages 
could be detected at the lesion site as 
well (Chapter 2, 3, 4b). The introduction of 
new oligodendrocytes at the lesion site by 
NPC has several implications. First, it has 
been described in detail earlier that oligo-
dendroglia and oligodendrocyte precur-
sor cells can be associated with extracel-
lular matrix molecules that are inhibitory 
to axonal sprouting 17, 18. In the described 
ﬁbroblast-NPC co-graft experiment, the 
negative effect of the present oligoden-
droglia on corticospinal axonal sprouting 
appears to be outweighed by the factors 
that instead induce axonal regeneration 
(Chapter 3). The newly formed oligoden-
drocytes further could have the potential 
to remyelinate both demyelinated spared 
axons and regenerating axons. Although 
it has been shown that grafted glial pro-
genitor cells possess the capacity to re-
myelinate axons in the adult spinal cord 
19, additional investigations are needed to 
analyze whether indeed remyelination oc-
curs in the applied SCI model. Neverthe-
less, it is most likely that remyelination is a 
critical aspect of future therapies that aim 
to induce functional regeneration in the 
injured spinal cord 20, 21.
The phenotype in which the grafted NPC 
differentiate is primarily determined by 
cues in the micro-environment at the site 
of transplantation 22, 23, which not neces-
sarily reﬂects the differentiation pattern 
desired and required for optimal axonal 
regeneration and functional recovery 11. 
The over-expression of individual genes, 
which drive neural stem cells into speciﬁc 
phenotypes, has been demonstrated to 
generate homogenously differentiated cell 
populations 24, 25. Neural stem cells modi-
ﬁed in this way for transplantation might 
be able to override the differentiation in-
ducing signals of the host environment at 
the injury site of grafted cells into speciﬁ-
162
Summary and discussion
cally growth promoting phenotypes. It is 
most likely that only a transient expres-
sion of fate determining genes is preferred 
to induce the differentiation of NPC into a 
speciﬁc phenotype 11. Therefore, the viral 
vectors that are described in this thesis 
may very well serve as a tool to reach this 
goal (Chapter 5).
Although at least a proportion of the used 
NPC have the capacity to differentiate 
into neuronal phenotypes (Chapter 2, 3, 
4b), the micro-environment at the non-
neurogenic regions of the adult CNS re-
stricts the differentiation of the grafted 
NPC to glial lineages 22. This however, 
does not impair the usefulness of the 
employed NPC since it was investigated 
whether NPC grafts are able to support 
regenerative sprouting of disrupted axons 
by providing a growth-permissive Sub-
strate. Alternatively, functional recovery 
in the injured SC could be induced when 
NPC-derived neuronal cells function as 
a signaling relais that bridges the lesion 
site. This means that lesioned axons must 
project on the grafted neuronal cells that 
on their turn must innervate either spared 
spinal cord projections or the original tar-
get regions. Particularly embryonic stem 
cells have gained much attention to reach 
this goal since these cells appear to pos-
sess the potential to differentiate into neu-
rons when grafted in the adult spinal cord 
26. Alternatively, fetal CNS tissue derived 
neurons also are shown to functionally in-
tegrate into the injured spinal cord cytoar-
chitecture 27. The engraftment of neuronal 
cells by inducing neuronal differentiation 
of adult derived NPC in the adult spinal 
cord could serve as an interesting alterna-
tive to fetal derived graft material. Previ-
ous research however showed that neu-
ronal differentiation of adult derived NPC 
that ere grafted to the injured spinal cord 
is extremely difﬁcult to achieve 11. 
2. ARE NPC GRAFTS ABLE 
TO INDUCE FUNCTIONAL 
RECOVERY AFTER SCI?
The promising results showing contact-
mediated regenerative sprouting of corti-
cospinal axons raise the question whether 
it is able to induce functional regeneration 
by grafting adult derived NPC in the in-
jured spinal cord. Since the used dorsal 
wire-knife lesion of the CST at the cervical 
level only represents an incomplete lesion 
that does not lead to permanent func-
tional deﬁcits 28, the clinical relevance of 
the potential of grafted NPC to function 
as a scaffold for regenerating CNS axons 
needs to be tested in a SCI animal model 
that possesses a relevant functional cor-
relate to the structural injury. Thoracic 
contusion models that are combined with 
various locomotor tests represents the 
most clinical relevant SCI animal model 
and is very well established in the litera-
ture 29-31. The reduced reproducibility of 
the injury however has great implications 
for the application of cell-based therapy 
in contusion injuries. Especially in more 
chronic injuries, the size and the exact lo-
cation of the rather diffuse injury site var-
ies from subject to subject. It is evident 
that the exact placement of the cell graft is 
essential for the functional outcome. Non-
invasive in vivo imaging of the lesion site 
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could serve as important tool to reach this 
goal, moreover since high ﬁeld magnetic 
resonance imaging (MRI) was shown to 
allow the non-invasive, high-resolution vi-
sualization of pathomorphological chang-
es such as hemorrhage, tissue degenera-
tion and cyst formation in the rat spinal 
cord following contusion injury (Chapter 
6). Unlike after transsection- or aspira-
tion injuries of the spinal cord, contusion 
injuries only induce the development of a 
limited lesion cavity defect at the lesion 
epicenter (Chapter 6). The tissue defect at 
the lesion epicenter of contusion injuries 
therefore more likely represents a mix-
ture of tissue debris, inﬁltrated immune 
cells and unorganized tissue. Since the 
lesion defect needs to be replaced by a 
graft in order to allow axonal regeneration 
over the lesion site, it is very well possible 
that a simple injection of large amounts of 
cells at lesion site induces an additional 
injury to the remaining spinal cord tissue 
that surrounds the lesion site and that is 
likely to contain spared axons. 
3. ISOLATION OF AUTOLOGOUS 
NPC FOR SPINAL CORD REPAIR
The NPC that are used throughout this 
thesis are isolated from the adult spinal 
cord. Even though the grafted cells are 
typed as progenitor cells, at least a pro-
portion of the used NPC possess stem 
cell characteristics including multipoten-
cy and self-renewal 22. Although it remains 
unclear whether the NPC that are isolated 
from the adult spinal cord represent the 
same cell type as the NPC that are iso-
lated from the subventricular zone (SVZ) 
or the hippocampus, both cell popula-
tions share most of their stem cell proper-
ties 32. It should be noted the actual neural 
stem cell that is present in the SVZ and 
hippocampus of the adult brain expresses 
GFAP in vivo and possesses the proper-
ties belonging to astroglial cells 33, 34. It is 
however very unlikely that the GFAP ex-
pressing cells that are shown to support 
regenerative axonal sprouting in this the-
sis represent undifferentiated neural stem 
cells, The expression of GFAP by the 
grafted NPC is only induced after trans-
plantation, together with an immediate 
decline of cell proliferation of the grafted 
cells and the upregulation of other mature 
glial markers (Chapter 2, 3, 4b). Previous 
studies that investigated neural stem cell 
activity in the adult spinal cord did not de-
scribe the presence of GFAP expressing 
neural stem cells 22, 35. 
Crucial for the applicability of a cell based 
therapy using progenitor / stem cells is 
the availability of sufﬁcient amounts of 
cell material. In this respect, adult derived 
NPC have a decisive advantage over 
embryonic- and fetal derived progenitor 
cells. Even when the ethical concerns that 
are associated with the use of embryonic- 
and fetal derived progenitor cells are not 
considered, the limited availability of these 
cells most likely will result in logistic prob-
lems. Moreover, the use of adult derived 
NPC allows the advantageous autologous 
transplantation mode in which the receiv-
ing patient functions as his own tissue do-
nor, preventing the occurrence of side ef-
fects that are associated with graft rejec-
tion or immune suppression. In a previous 
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study, we were able to show that in the 
rat, sufﬁcient amounts of adult derived 
autologous NPC can be isolated using the 
minimal invasive brain biopsy technique, 
without inducing unacceptable additional 
damage. These NPC furthermore are able 
to induce axonal regeneration in the in-
jured spinal cord of the donor animal 36.
The puriﬁcation of speciﬁc sub-popula-
tions of glial progenitor cells from the 
heterogenous progenitor cell population 
represents a promising method to further 
enhance the capacity of NPC grafts to in-
duce regeneration in the lesioned spinal 
cord. The Schwann cell puriﬁcation meth-
od that employs magnetic-activated cell 
separation (MACS) as described in this 
thesis (Chapter 4a) can be adapted to en-
able the separation of speciﬁc NPC sub-
populations for grafting purposes 37, 38.
4. COMBINING NPC GRAFTS 
WITH ADDITIONAL TROPHIC 
SUPPORT
An additional promising means to further 
enhance the sprouting response of le-
sioned axons is the local overexpression 
of neurotrophins such as neurotrophic 
factor-3 (NT-3), brain-derived neurotrophic 
factor (BDNF), glial cell line-derived neu-
rotrophic Factor (GDNF) or nerve growth 
factor (NGF), which previously has been 
shown to enhance regenerative sprout-
ing of CST axons 16, 39-42. A very attractive 
method to reach this goal would be to in-
duce over-expression of NT-3 by grafting 
transduced NPC in an ex vivo gene therapy 
approach. The stable over-expression of 
transgenes in NPC however is very prob-
lematic due to gene silencing (Chapter 5). 
Of all vectors tested, only transient gene 
expression could be achieved that was 
rapidly downregulated upon transplanta-
tion of the transduced cells into the spinal 
cord. The local delivery of trophic factors 
in the CNS alternatively can be induced 
by direct injection of lentiviral vectors in 
the CNS parenchyma, which is sufﬁcient 
to allow transgene expression for up to 16 
months (Chapter 5).
In none of the observed cases, the re-
generative sprouting of the CST was able 
to completely bridge the lesion site and 
sprout into the distal portion spinal cord 
parenchyma. Therefore, the observed re-
generative sprouting must be further en-
hanced before a functional correlate of the 
observed regenerative sprouting is likely 
to evolve. Unlike the sprouting of lesioned 
axons from the spinal cord tissue into the 
graft, the reentering of sprouting axons 
from the graft into the distal spinal cord 
tissue is extremely difﬁcult to achieve, 
which most likely is related to the devel-
opment of the glial scar that surrounds 
the cellular graft (Chapter 4b). When the 
lesioned axons sprout into a graft that is 
more permissive for axonal regeneration 
than the surrounding spinal cord tissue, 
the sprouting axons are not very likely to 
reenter the distal spinal cord tissue 43. This 
problem can only be solved partially by 
the local overexpression trophic factors at 
the graft site, since this creates an “oasis 
of trophic factors” inside the inhospitable 
spinal cord milieu 43, 44. A possible solution 
could be the creation of a neurotrophic 
gradient over the lesion site. By using in-
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jections of a lentiviral vector, a NT-3 gradi-
ent could be established, which promoted 
axonal regeneration beyond the lesion site 
and into the distal spinal cord tissue. 45
5.  FINAL CONCLUSIONS AND 
OUTLOOK
Syngenic adult derived neural progenitor 
cells are able to survive transplantation in 
the acutely lesioned spinal cord and dif-
ferentiate into glial phenotypes. When co-
grafted with ﬁbroblasts, GFAP expressing 
grafted NPC are able to replace the le-
sion defect and are able to induce con-
tact mediated axon guidance and regen-
erative sprouting, which is in analogy with 
the peripheral nervous system in which 
Schwann cells function as a guiding sub-
strate. NPC that are co-grafted with highly 
puriﬁed Schwann cells however migrate 
away from the lesion site, which is paral-
leled with a reduced axonal outgrowth. A 
close investigation of NPC that are trans-
duced to express ectopic genes by using 
different viral vectors revealed that in vivo 
gene expression in genetically engineered 
neural progenitor cells is temporally lim-
ited and mostly restricted to undifferenti-
ated NPC. 
Additional experiments in small animal 
models of SCI will have to be conducted 
in order to further evaluate the capacity 
of autologous NPC grafts to induce func-
tional axonal outgrowth of the injured 
spinal cord before even considering the 
application in human patients. Moreover, 
it remains unclear in which extent promis-
ing results that are obtained using animal 
models of SCI are transferable to the hu-
man situation. It ﬁrst must be unambigu-
ously shown that neural progenitor cell 
mediated regenerative sprouting is able 
to induce target reinnervation and regain 
of function without inducing adverse side 
effects such as allodynia, chronic pain 
and muscle spasms. Furthermore, the 
risks that are associated with the isola-
tion, propagation and transplantation of 
neural progenitor cells in human subjects 
remain to be established. The promising 
results that are partially described in this 
thesis nevertheless justify further research 
efforts in order to reveal the full poten-
tial of adult derived NPC. The combina-
tion of MRI imaging to monitor structural 
regeneration and longitudinal behavioral 
studies of spinal cord injured rats would 
greatly facilitate the veriﬁcations of the 
observed structural regeneration in func-
tional relevant small animal models of SCI. 
This allows direct correlation of structure 
with function. Furthermore, the ability to 
visualize pre-labeled cells, at high resolu-
tion in situ, represents an important pre-
requisite for preclinical studies with the 
objective to develop an effective and safe 
therapy that is able to at least partially 
relieve the devastating consequences of 
spinal cord injury.
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Het ruggenmerg bevat een groot gedeelte van alle verbindingen tussen de hersenen en 
de rest van het lichaam, samengepakt op een kleine ruimte. Een letsel aan het ruggen-
merg heeft daarom vaak zwaarwegende gevolgen, omdat een relatief kleine beschadi-
ging een groot gedeelte van de verbindingen kan verbreken. Het daaruit resulterende 
functieverlies is meestal onomkeerbaar omdat het centrale zenuwstelsel (CZS) van 
hogere werveldieren, en dus ook van de mens, een zeer beperkte capaciteit heeft om 
reeds ontstane schade te herstellen. Ondanks de grote vorderingen die de medische 
wetenschap de laatste 50 jaar heeft gemaakt is er nog steeds geen effectieve therapie 
beschikbaar die regeneratie in het CZS mogelijk maakt. Dit gebrek aan perspectief 
in combinatie met het feit dat de meeste dwarslaesie patiënten jonge volwassenen 
zijn zorgt ervoor dat een ruggenmergletsel een zware belasting vormt voor zowel het 
slachtoffer als ook voor de maatschappij in het algemeen.
Er zijn meerdere oorzaken aan te wijzen die voor het gebrek aan zelfherstellend vermo-
gen van het beschadigde ruggenmerg verantwoordelijk zijn. Het is daarbij van belang 
om aan te merken dat het niet in de eerste plaats de beschadigde axonen zijn die geen 
nieuwe verbindingen kunnen aangaan, maar dat vooral de algemene omstandigheden 
zoals die in het CZS voorkomen een eventueel herstel van de verbindingen tegenwer-
ken. Een therapie die gebaseerd is op het transplanteren van adulte neurale progenitor 
cellen (NPC) is een veelbelovende methode om herstel na ruggenmergletsel mogelijk 
te maken. NPC zijn ongespecialiseerde cellen die veel op stamcellen lijken en die uit 
het CZS-weefsel van volwassen individuen gewonnen kunnen worden. Het is dus in 
principe mogelijk dat de dwarslaesiepatiënt zelf als donor fungeert. Onder de juiste 
omstandigheden kunnen geïsoleerde NPC gekweekt en vermeerderd worden. Daar-
naast zijn nakomelingen van NPC in staat om uit te groeien tot de drie belangrijkste 
celtypes van het CZS: neuronen, astrocyten en oligodendrocyten. NPC zijn daarom in 
staat om de cellen die door een beschadiging van het ruggenmerg verloren zijn ge-
gaan organotypisch te vervangen. Aangezien er onder normale omstandigheden geen 
spontane regeneratie in het CZS mogelijk is, is het simpelweg vervangen van CZS-cel-
len waarschijnlijk niet voldoende. Doel van het transplanteren van NPC is daarom het 
opnieuw creëren van de omstandigheden zoals die tijdens de aanleg van de axonale 
verbindingen tijdens de ontwikkeling voorhanden zijn. 
In de studies die in dit proefschrift beschreven zijn wordt deze hypothese getest door 
NPC te transplanteren in het beschadigde ruggenmerg van de rat. Hiervoor wordt er 
gebruik gemaakt van een proefdiermodel voor traumatisch ruggenmergletsel waarbij 
het belangrijkste deel van de piramidebaan wordt doorgesneden. De piramidebaan is 
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de directe verbinding tussen de motorcortex in de hersenen en het ruggenmerg. Direct 
aansluitend worden er in de ruimte die ontstaat door het letsel de te bestuderen cellen 
getransplanteerd. De piramidale axonen worden ten slotte een week na het ruggen-
mergletsel gemarkeerd waardoor een eventueel herstel van de piramidale axonen zeer 
speciﬁek aan te tonen is.
Een belangrijke voorwaarde voor het mogelijk maken van axonaal herstel na ruggen-
mergletsel is het vervangen van de cyste die op de plaats van het ruggenmergletsel 
ontstaat. Een transplantaat bestaande uit enkel NPC blijkt echter niet in staat te zijn 
om de cyste te vervangen aangezien de getransplanteerde cellen van de plaats van 
transplantatie weg migreren zonder dat het beschadigde weefsel wordt gerepareerd 
(Hoofdstuk 2). Door de NPC echter gezamenlijk met andere cellen te transplanteren is 
het mogelijk om het weefseldefect door het transplantaat te vervangen. Het zijn vooral 
ﬁbroblasten die het mogelijk maken om voldoende NPC in de cyste te transplanteren 
(Hoofdstuk 3). Worden de NPC gezamenlijk met Schwann cellen getransplanteerd is 
het weliswaar mogelijk om de cyste door Schwann cellen te vervangen, de NPC in het 
transplantaat worden echter door de Schwann cellen afgestoten en migreren in het 
ruggenmergweefsel (Hoofdstuk 4b).
Getransplanteerde NPC stoppen met delen en differentiëren in meer ontwikkelde neu-
rale celtypes (Hoofdstuk 2). Opvallend daarbij is dat de getransplanteerde cellen nau-
welijks meer te onderscheiden zijn van de reeds aanwezige neurale cellen. Dit wijst erop 
dat de getransplanteerde cellen in staat zijn om naadloos in het bestaande weefsel te 
integreren. Om de functie van deze cellen te kunnen vaststellen is het van groot belang 
dat de getransplanteerde cellen betrouwbaar geïdentiﬁceerd kunnen worden. In dit 
proefschrift zijn daarvoor 2 verschillende methodes gebruikt. Enerzijds zijn de getrans-
planteerde NPC gemarkeerd met de thymidine analoog Bromodeoxyuridine (BrdU). Het 
BrdU wordt in het DNA van de te transplanteren NPC ingebouwd en kan door middel 
van immunohistochemische kleuringreacties zichtbaar gemaakt worden. Anderzijds is 
geprobeerd om de te transplanteren cellen genetisch te markeren door middel van 
virale transductie. De NPC worden hiervoor genetisch gemanipuleerd waardoor deze 
het groen ﬂuorescerende eiwit GFP produceren. GFP producerende NPC kunnen na 
transplantatie door middel van ﬂuorescentie microscopie zichtbaar gemaakt worden. 
In een gedetailleerde studie die deel uitmaakt van dit proefschrift blijkt echter dat alle 
virale vectoren die getest werden enkel en alleen in staat zijn om ongedifferentieerde 
NPC te markeren. Na differentiatie van de NPC onder celkweek omstandigheden of na 
transplantatie van de cellen in het ruggenmerg, blijkt dat de meeste NPC stoppen met 
het produceren van GFP en dus hun markering verliezen (Hoofdstuk 5). Dit betekend 
dus ook dat het toedienen van herstel bevorderende groeifactoren door middel van het 
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transplanteren van genetisch gemanipuleerde NPC niet goed mogelijk is. 
De getransplanteerde cellen blijken enkel in gliacellen te differentiëren, waarbij de 
meeste cellen het eiwit GFAP exprimeerden hetgeen typisch is voor astrocyten. Daarbij 
valt op dat de meeste van deze GFAP exprimerende cellen een afwijkend langgerekt ui-
terlijk hebben, en het eiwit BLBP bevatten, hetgeen erop wijst dat deze astrocyten nog 
onrijp zijn (Hoofdstuk 2, 3, 4b). Verder neemt een kleiner deel van de getransplanteerde 
cellen de vorm aan van oligodendrocyten. Dit zijn gliacellen die de myelineschede rond 
de axonen kunnen vormen. Of de getransplanteerde NPC daadwerkelijk in staat zijn 
om nieuwe myelineschedes te vormen kan echter niet worden aangetoond, omdat een 
kleuring die de myelineschede zichtbaar maakt niet te combineren is met de gebruikte 
BrdU markering (Hoofdstuk 2, 3, 4b). Een mogelijke oplossing voor dit probleem is het 
ontwikkelen van verbeterde methodes om de getransplanteerde NPC met bijvoorbeeld 
GFP te markeren.
Naast het vervangen van cellen die door de beschadiging van het ruggenmerg verloren 
zijn gegaan moeten de getransplanteerde NPC in staat zijn om het herstel van bescha-
digde axonen te ondersteunen. Als voorwaarde hiervoor moeten de getransplanteerde 
NPC daadwerkelijk op de juiste plaats in het traumatische weefseldefect blijven zitten. 
Zoals beschreven in dit proefschrift lukt dit het beste in dieren die getransplanteerd 
worden met een mengsel van NPC en ﬁbroblasten. In deze groep blijkt dan ook de 
meeste regeneratie van beschadigde axonen plaats te vinden. Bovendien blijken bij 
deze dieren piramidale axonen in het transplantaat te groeien (Hoofdstuk 3). Dit is op-
vallend want juist piramidale axonen staan erom bekend dat deze zich uiterst moeilijk 
kunnen herstellen. Typerend hierbij is dat herstellende axonen contact opnemen met 
getransplanteerde NPC die zich hebben ontwikkeld tot onrijpe astrocyten (Hoofdstuk 
3). Worden de NPC gezamenlijk met Schwann cellen getransplanteerd vindt er welis-
waar in geringe mate axonaal herstel plaats, een herstel van piramidale axonen blijft 
echter nagenoeg uit. (Hoofdstuk 4b).
Er kan dus geconcludeerd worden dat door middel van het transplanteren van NPC 
na ruggenmergletsel verloren CZS cellen vervangen kunnen worden. Verder zijn de 
getransplanteerde NPC in staat om regenererende axonen te geleiden, hetgeen ver-
gelijkbaar is met de functie van onrijpe gliacellen die gedurende de ontwikkeling de 
aanleg van axonale verbindingen ondersteunen. Deze veelbelovende resultaten roepen 
de vraag op of door het transplanteren van NPC ook functioneel herstel geïnduceerd 
kan worden. Door middel van de beschreven studies kan dit echter niet aangetoond 
worden omdat het gebruikte proefdiermodel geen blijvende uitval van functies veroor-
zaakt. Er zijn dus vervolgstudies nodig waarbij gebruik gemaakt wordt van een functi-
174
Nederlandse samenvatting
oneel relevant diermodel waarin de mate van herstel gemeten kan worden in gedrags-
studies. Het is daarbij van groot belang dat het functioneel herstel gerelateerd kan 
worden aan de structurele reorganisatie die daarbij optreedt. De in vivo imaging door 
middel van magneet resonantie tomograﬁe (MRT) zoals die beschreven is in hoofdstuk 
6 kan daarbij in vergaande mate van dienst zijn. 
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APC adenomatous polyposis coli
Ara-C cytosine arabinoside
ATP adenosine 5’triphosphate
BBB blood-brain barrier
BDA biotinylated dextran amine
BDNF brain derived neurotrophic factor
BLBP brain lipid binding protein
BrdU bromodeoxyuridine
BSA bovine serum albumine
cAMP cyclic-adenosine 5’-monophosphate
cGMP cyclic-guanosine 5’-monophosphate
CMV Cytomegalovirus
CNS central nervous system
CPG central pattern generator
CSPG chondroitin sulphate proteoglycan
CST corticospinal tract
DAB 3,38-diaminobenzidine
DCX doublecortin
DMEM Dulbecco’s modiﬁed essential medium
DNA deoxyribonucleic acid
ECG electrocardiogram
ECM extracellular matrix
EDTA Ethylenediaminetetraacetic acid
EGF epidermal growth factor
FACS ﬂuorescence-activated cell sorting
FCS fetal calf serum
FF ﬁbroblasts
FGF-2 ﬁbroblast growth factor-2
FOV ﬁeld of view
Gal-C galactocerebroside
GAP-43 growth-associated protein-43
GDNF glial-derived neurotrophic factor
GFP green ﬂuorescent protein
HBSS Hank’s balanced salt solution
LTR long terminal repeat
MACS magnet-activated cell separation
MAG myelin-associated glycoprotein
MLV murine leukemia virus
MRI magnet resonance imaging
MW molecular weight
NB medium Neurobasal medium
N-CAM neuronal cell adhesion molecule 
NF200 Neuroﬁlament 200 kD fragment
NGF nerve growth factor
Ng-R Nogo receptor
NPC neural progenitor cells
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Abbreviations
NSC neural stem cell
NT-3 neurotrophic factor-3
NT-4/5 neurotrophic factor-4/5
OEC olfactory ensheathing cells
OMGP oligodendrocyte myelin glycoprotein
p75-LNGR p75 low afﬁnity NGF receptor
PBS phosphate-buffered saline
PFA paraformaldehyde
PNS peripheral nervous system
P-Orn/Lam poly-L-Ornithin/laminin
RAG regeneration-associated genes
RF radiofrequency
SC Schwann cells
SC spinal cord
SCI spinal cord injury
SD standard deviation
SEM standard error of the mean
SNR signal-to-noise ratio
SVZ subventricular zone
TBS Tris-buffered saline
TE echo time
TGF-ß transforming growth factor-ß
TR repetition time
TX-100 Triton X-100
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